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The real constitution of things is accustomed to hide itself........ 
 
Everything flows....... 
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ABSTRACT
 
 
Body condition score has been considered an indirect measure of nutritional status and 
nutrition has been demonstrated to interact with reproduction. Adiponectin and leptin, 
because of its insulin sensitising actions and their association with body condition could be 
potential regulators of metabolism during the transition from pregnancy to lactation. The 
work described in this PhD project was designed to investigate the role of metabolic, body 
condition, and dietary factors in regulation of productive and reproductive performance in 
dairy cows, with particular regard to glucose homeostasis and adipokines. A special focus 
was directed to circulating adiponectin and its association with metabolic and hormonal 
status, and reproduction. Interestingly, adiponectin was found to be present in bovine milk 
at concentrations similar those of plasma. Body condition score, GH, insulin, leptin, and 
adiponectin showed a potential to modulate glucose homeostasis and reproductive output. 
Results from this study demonstrated a negative effect of long-term moderately elevated 
insulin concentration on reproductive performance. Additionally, BCS at calving and 
ǻBCS are determinant factors influencing postpartum reproductive recovery and they 
should be basic components of farming monitoring schemes. Although further 
investigation is needed to address the proposed negative relationship between adiponectin 
and GH, and to identify other dietary factors that may modulate circulating adiponectin, 
data from this study support regulatory roles of adiponectin in metabolism and 
reproduction. Moreover, adiponectin holds great promise to serve as a putative target 
molecule that integrates metabolism, reproduction and feeding behaviour. More 
importantly, hypoadiponectinemia could be another alternative mechanism that contributes 
to poor fertility in dairy cows. The incorporation of this new knowledge into the 
development of better nutritional strategies is a key point that is being considered to 
improve the welfare, and reproductive and productive performance in dairy cows. 
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1.Introductionandpurposeofthestudy
 
 
Milk yield is influenced by genetic, nutritional and environmental factors (Rook & 
Thomas, 1983; Garnsworthy & Webb, 1999). On a short term basis, the efficiency of 
nutrient use for milk production is primarily dependent on milk volume, but as milk yield 
increases a lower proportion of total feed intake is used for maintenance (Chilliard, 1992). 
Consequently, the modern high yielding cow loses weight and mobilizes adipose and 
muscle tissue depots to support milk production. Thus, high producing dairy cows 
experience a metabolic stress involving negative energy balance (NEB) in early lactation 
(Bauman & Currie, 1980). The main characteristics of this condition are loss of body 
weight and mobilization of body fat stores because feed intake cannot support the energy 
required for milk yield and maintenance (Beam & Butler, 1999; Butler, 2000; De Vries & 
Veerkamp, 2000). 
 
In general milk production and reproductive performance are highly negatively correlated 
in dairy cows (Macmillan et al., 1996; Royal et al., 2000; Stevenson, 2001; Lucy, 2002; 
Opsomer et al., 2006). In recent decades, genetic improvement in dairy cows has led to a 
dramatic increase in milk yield, which has been accompanied by an inherent decline in 
reproductive performance (Butler, 2000; Royal et al., 2000; Evans et al., 2006; 
Garnsworthy et al., 2008a). Probably, many other reasons (such as nutrition, management, 
and poor expression or detection of oestrus) are at least in the same degree accountable for 
the decreased reproduction performance in dairy cows (Garnsworthy & Webb, 1999; Lucy, 
2001; Dobson et al., 2007). 
 
Nutrition interacts with reproductive performance and this interaction has prominent 
influences on livestock productivity and viability (Butler & Smith, 1989; Garnsworthy & 
Webb, 1999). This interaction is still being investigated, but it seems that the relationship 
between nutrition and reproduction is dynamic, complex, and not well understood (Gordon 
1996; Boland & Lonergan, 2003). The reproductive capacity of the postpartum cow is a 
critical element that determines overall biological and productive efficiency. Thus, failure 
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of cows to resume cyclicity after calving is a critical point that influences the economical 
profitability of the cattle industry (Roberts et al., 1997; Stott et al., 1999; Evans et al., 
2006). 
 
Body condition score (BCS) is an indirect measure of nutritional status (Macmillan et al., 
1996; Garnsworthy, 2006). It is well known that BCS of a cow, especially at certain points 
of its lactation cycle, directly influences fertility (Butler, 2003; Garnsworthy, 2006). This is 
true for a variety of important fertility indices, especially calving interval (Lucy, 2001; 
Oltenacu & Algers, 2005; Dobson et al., 2007). BCS at calving is believed to influence 
reproductive performance due to its influence on tissue mobilization and on uterine 
involution. Moreover, BCS at calving is strongly related with condition loss and 
postpartum NEB, and influences circulating metabolic hormones and metabolites (Roche 
et al., 2009). 
 
Adipose tissue releases a variety of adipokines, which are implicated in energy metabolism 
and reproduction. Leptin and adiponectin are two of the better-studied adipokines, and they 
are considered to have local and systemic effects (Antuna-Puente et al., 2008). Leptin is 
positively correlated with BCS, and NEB causes a notable reduction in plasma leptin 
concentrations (Chilliard et al. 2005). Moreover, leptin has been found to modulate 
nutrient transfer and partitioning by interaction with other hormones including insulin, 
glucagon, glucocorticoids, growth hormone (GH), insulin-like growth factor I (IGF-I), 
cytokines and thyroid hormones (Hill, 2004; Garnsworthy et al., 2008a). Adiponectin 
expresses insulin-sensitizing actions and may be involved in insulin resistance and glucose 
homeostasis (Antuna-Puente et al., 2008). Fat mass may exert direct negative feedback on 
adiponectin secretion (Gordon et al., 2007) and a negative correlation between circulating 
adiponectin and fat mass has been reported in many animal and human models (Kadowaki 
& Yamauchi, 2005). The link between leptin and reproduction is strong and well 
documented (Chilliard et al. 2005), whereas there is only limited evidence that adiponectin 
can directly regulate reproductive functions (Mitchell et al., 2005; Dupont et al., 2008). 
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Insulin is a key hormone in endocrine control which facilitates movement of glucose 
across cell membranes, and thereby regulates the concentration of blood glucose (Guyton 
& Hall, 2006). Glucose is the principal source of energy for life processes in the 
mammalian cell (Kaneko, 2008a). In postpartum cows, decreased insulin reduces glucose 
uptake by insulin-dependent organs such as adipose and muscle tissue, and increases 
glucose availability for the insulin-independent mammary gland (Bossaert et al., 2009). 
Decreased insulin (McGuire et al., 1995) and increased GH (Rhoads et al., 2004) 
concentrations also promote adipose tissue mobilization, resulting in elevated levels of 
circulating NEFA and BOHB, which favours milk yield. During early lactation, glucagon 
concentration increases relative to the dry period to stimulate lipolysis and 
gluconeogenesis, in order to provide the body with the required energy to support the high 
milk production (De Boer et al., 1985). Feeding dairy cows on diets to increase circulating 
insulin concentrations for the first 50 postpartum increased the proportion of cows 
ovulating during this period (Gong et al., 2002). Control of glucose homeostasis through 
dietary modulation of circulating insulin has been a key nutritional strategy to alleviate the 
postpartum dairy cow from the detrimental effects of NEB, and improve reproductive 
performance (Garnsworthy et al., 2009). 
 
The poor fertility of high yielding dairy cows has been the main scientific focus for many 
research groups around the world. Because the genetic makeup of the modern high 
yielding cow is established and it is difficult to change in the short term, much attention 
has been paid to the interaction between nutrition, condition and adipose with reproductive 
performance. Work at the University of Nottingham, in collaboration with other 
researchers, addressed the problem of reduced fertility in dairy cows. The main output of 
this programme was the development of a nutritional strategy which possibly helps cows to 
improve fertility without depressing milk production (Gong et al., 2002; Adamiak et al., 
2005, 2006; Fouladi-Nashta et al., 2005, 2007; Garnsworthy et al., 2008a, 2008b, 2008c, 
2009). This PhD project builds on that programme by utilising existing data and blood 
samples in further laboratory and data analyses. 
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The overall hypothesis was that the reproductive performance of lactating dairy cows is 
affected by nutrition and body condition, and that the related hormonal and metabolic 
profile plays a role in cow fertility. Moreover, the present PhD project was to study the 
effects of different nutritional and condition challenges on metabolic and hormonal profile, 
circulating adipokines, and reproductive performance in dairy cows. A special emphasis 
was directed to circulating adiponectin and its association with metabolic and hormonal 
status, and reproduction.Finally, the major scope of this project was to find evidence for 
the mechanism which possibly associates changes in body condition, diet, and 
physiological stage with changes in hormonal and metabolic profile. This mechanism is 
suggested to be implicated not only in nutrient partitioning but also in reproductive success 
or failure. 
 
 
 
 


2.Reviewofliterature
 
 
2.1.Postpartumnutritionalstrategies
 
The interaction of nutrition with reproduction can be characterized as complicated, 
unstable, and variable (Boland et al., 2001).  Such interaction involves both past and 
present nutritional status, but other factors, such as genetic makeup, animal condition, 
environmental influence, and physiological stage are determinant regulators of nutritional 
effects on reproductive performance (Short et al., 1990; Garnsworthy & Webb, 1999; 
Lucy, 2001; Stevenson, 2001; Robinson et al., 2006). The detrimental impact of negative 
energy balance (NEB) on reproduction evidences how closely nutrition is related with 
reproduction (Nebel & McGilliard, 1993; Butler & Smith, 1997; Santos, 2007, 2009). 
Many nutritional approaches have been applied in periparturient cows in order to overcome 
the adverse consequences of NEB in reproduction, and to maximize cow profitability and 
welfare (Grummer, 1995; Friggens et al., 2004; Beever, 2006). Generally, such nutritional 
strategies are aimed at maintenance of body condition score (BCS) above the figure of 2.0 
or better 2.5 throughout the year; BCS should not fall below 2.0 during the year, and BCS 
should be 2.5 to 3.0 at parturition (Garnsworthy, 2006). All approaches are based on the 
finding that fatter cows at calving eat less food and lose more body fat than thinner cows 
(Garnsworthy, 2006; Chagas et al., 2007). Given that a periparturient cow suffers from 
severe NEB due to decreased appetite and increased milk production (Grummer, 1995), 
most nutritional regimes aim at stimulating cow appetite or increasing the energy 
concentration of feeds, along with preserving high milk production. Consequently, these 
strategies often fail in terms of reproduction because they totally ignore the time taken for 
reproduction recovery after the calving (Beever, 2006). 
 
More recently, researchers have attempted to find if high milk yield could be maintained 
along with high fertility rates in high yielding cows (Gong et al., 2002a, 2002b; Fouladi-
Nashta et al., 2005; Garnsworthy et al., 2008a, 2008b, 2008c, 2009). The most common 
strategy for reducing the degree of NEB in early lactation is to increase dietary energy 
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concentration by increasing the starch or fat components of the ration at the expense of 
forage components (Garnsworthy et al., 2009).  High fat diets with total fat concentration 
over 50 g/kg of dry matter depressed plasma insulin concentration in cows at the onset of 
the breeding period (Garnsworthy et al., 2008b). Conversely, high starch diets induced 
high plasma insulin concentration and increased the proportion of cows ovulating within 
50 days of calving, reduced the intervals from calving to first ovulation, and tended to 
reduce the intervals from calving to first service and to conception (Gong et al., 2002b). 
Moreover, Adamiak et al. (2005, 2006) and Fouladi-Nashta et al. (2005) demonstrated that 
diets designed to increase plasma insulin concentration had negative effects on blastocyst 
rate in heifers and in lactating cows respectively. In addition, Fouladi-Nashta et al. (2007) 
reported that diets with a high fat content had beneficial effects on blastocyst rate in 
lactating dairy cows, although they decreased circulating insulin. The main conclusion of 
all these studies is that dietary induced increases in insulin can be beneficial for resumption 
of oestrous cycles postpartum. However, high insulin concentration might have detrimental 
effects on oocyte developmental processes, basically at the stage of blastocyst. 
Garnsworthy et al. (2009) tested the hypothesis that pregnancy rate will be enhanced by 
feeding a diet that increased plasma insulin until cows resume ovarian cycles, and then 
switching to a diet that decreased plasma insulin during the mating period. This hypothesis 
was confirmed and it is a paradigm how nutritional strategies can impact on reproductive 
defects in high yielding cows without compromising animal welfare and productivity. 








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2.2.Bodyconditionscoreandbodyconditionscoremanagementindairycows
 
Although live weight (LWT) change is a poor indicator of tissue mobilisation during early 
lactation, LWT is widely used as an index of tissue mobilisation. However, simultaneous 
increases in feed intake, gut contents, and water repletion of body tissues may disguise the 
real magnitude of tissue mobilisation measured by LWT (Sutter & Beever, 2000; 
Garnsworthy, 2006; Bewley & Schutz, 2008). Body condition score is a rapid, 
noninvasive, inexpensive, but subjective way of assessing body reserves of cow. It is easy 
applicable at the farm level and might give a more realistic view of the lipid and muscle 
reserves than LWT (Garnsworthy, 2006). Condition score assessment of cow is based on 
palpation and visual examination of the animal at certain anatomical and morphological 
body regions (i.e. assessing the level of fat cover over the transverse processes of the 
lumbar vertebrae and around the tailhead) (Roche et al., 2009). A variety of body condition 
scoring systems were introduced from 1970 to 1980 (Garnsworthy, 2006). All are based on 
the same basic principle of physical and visual examination of the animal, but different 
scales, anatomical regions, and emphasis weights on body reserves assessment are given.  
Garnsworthy (2006), Bewley & Schutz (2008), and Roche et al. (2009) give a list of 
equations to convert BCS from other BCS systems to 1 to 5 UK/US system which is the 
most commonly used. 
 
In recent decades, BCS has been proved a useful management tool for assessing nutritional 
status and energy balance (EB) during lactation in dairy cows. Estimates of BCS are 
significantly correlated with subcutaneous fat (Garnsworthy & Topps, 1982; Domecq et 
al., 1995; Heuer et al., 1999; Garnsworthy, 2006). Ruegg & Milton (1995) reported that 
excessive loss of BCS during early lactation was related to metabolic diseases and 
Gearhart et al. (1990) described BCS at calving as a risk factor for poor reproductive 
performance in dairy cows. However, the major drawback of BCS application and 
usefulness are; the scale of observations may be subjective; and BCS determined by 
different persons and in different studies are not directly comparable. Moreover, although 
BCS is positively correlated with LWT, in early lactation it is not unusual for cows to 
maintain or gain LWT whilst losing condition, due to the variability of gut contents 
”Chapter2Reviewofliterature


8

(Garnsworthy, 1988; Bewley & Schutz, 2008). It is known that subcutaneous fat correlates 
strongly with total body fat (Faulkner et al., 1990; Bewley & Schutz, 2008). Thus, the 
disadvantages of BCS application can be overridden by using ultrasound technology to 
assess subcutaneous fat depth. 
 
Absolute BCS at critical points of the lactation cycle (e.g. BCS at calving, nadir BCS, and 
BCS at drying-off) is as important as BCS change or loss, which is the difference between 
body condition scores assessed at two critical points (Bewley & Schutz, 2008). It is  well 
known that body condition loss and especially BCS at calving affect directly dry matter 
intake (DMI), NEB, fertility, milk yield and composition, and health of high yielding cows 
(Butler, 2003; Garnsworthy, 2006). Garnsworthy & Topps (1982) studied the effect of 
BCS at calving on DMI and milk yield. Their study clearly indicated that fat cows at 
calving ate less and lost more condition than thin or moderate cows over the first 12 weeks 
of lactation. Many other studies (Broster & Broster, 1998; Roche et al., 2009) have shown 
the negative correlation of BCS at calving and BCS loss with DMI in early lactation. It is 
now clear that over-conditioned cows at calving are prone to experience deeper and longer 
NEB and mobilize their body reserves due to reduced feed intake in early lactation. 
Consequently higher BCS at calving is not a recommended approach to alleviate cows 
from severe NEB postpartum because the unfavourable depression in DMI triggers longer 
and deeper NEB along with greater BCS loss (Garnsworthy, 2006). 
 
Body condition score has been considered as an indirect measure of nutritional status 
(Short et al., 1990; Garnsworthy, 2006; Bewley & Schutz, 2008). This implies that BCS is 
affected by diet composition and DMI (Short et al., 1990; Garnsworthy, 2006). According 
to Short et al. (1990) the effect of nutrition on reproduction depends on whether nutritional 
differences exist before or after calving. In addition, they stated that BCS at calving is 
more important than postpartum BCS loss, and consequently nutritional management of 
animals in the dry period is a crucial factor to ensure timely reproductive functionality after 
calving. This study also suggested that the relationship between postpartum anoestrus 
(PPA) and BCS at calving is nonlinear, and that BCS at calving influences postpartum 
DMI. The effect of different diet compositions on thin and fat cows was reviewed by 
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Garnsworthy (2006). The main conclusion was that positive EB in early lactation is not 
unrealistic and it can be achieved under certain combination of BCS and dietary regimes 
(e.g. thin cows fed a high energy diet). 
 
Milk production is the major objective of intensive dairy systems, but genetic improvement 
of cows for higher milk yield results in greater BCS loss in early lactation (Veerkamp et 
al., 2001, 2003; Dechow et al., 2002; Berry et al., 2003; Pryce & Harris, 2006). Dechow et 
al. (2002) suggested that modern genetic selection should be directed to increase milk 
yield, but to minimize the BCS loss postpartum. Buckley et al. (2003) reported that for 
every 100 kg increase in genetic merit for milk yield, there is a loss of 0.02 BCS units 
between calving and first service. Holstein-Friesian is the main breed used in dairy 
systems. Increasing the proportion of Holstein genes from 50 to 100% within this breed, 
results in a mean decrease of BCS by 1 unit (Veerkamp et al., 2001). Body condition score 
is related to milk composition. Pryce et al. (2001), Veerkamp et al. (2001) and Berry et al. 
(2003) proposed that there is a negative genetic correlation between BCS and fat and 
protein contents of milk. Roche et al. (2007a) found that butter fat was positively 
correlated with increasing calving and nadir BCS for a period from 60 to 270 days in milk, 
but milk protein was influenced  positively by nadir BCS and negatively by BCS loss. 
 
Poor or excessive BCS have been associated with health problems and decreased fertility 
in many studies. According to Mulligan et al. (2006a, 2006b), over-fat cows at calving had 
a greater probability of expressing fatty liver, ketosis, retained placenta, calving 
difficulties, and milk fever. Butler & Smith (1989) and Villa-Godoy et al. (1990) 
demonstrated that when NEB coincides with excess BCS then the result is declined 
fertility. Over the last three decades numerous studies showed the negative impact of 
excess or inadequate BCS at calving, BCS loss, and nadir BCS on postpartum reproductive 
performance (Garnsworthy & Topps, 1982; Heuer et al., 1999; Moreira et al., 2000; 
Yamada et al., 2003; Lopez-Gatius et al., 2003; Agenas et al., 2003; Roche et al., 2007b). 
The main conclusions from these studies were that reproductive indices determining 
reproductive efficiency of the herd, such as calving interval, days to first oestrus, days to 
first service, first service conception rate, and number of services, are related to BCS. 
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Garnsworthy (2006) proposed that cows have a target BCS (about 2.5 units) that they try to 
attain in early lactation.  Moreover, he stated that the biological drive for a cow to attain 
the target BCS appears to be as strong as the drive to attain a genetically-determined peak 
milk yield. Furthermore, the genetic correlation between BCS and milk yield is negative; 
the genetic correlations between health and fertility indices and milk yield are negative; 
and BCS loss is positively related to milk yield and negatively to health and fertility 
indices (Veerkamp et al., 2001; Berry et al., 2003; Pryce & Harris, 2006). It is easily 
conceivable that there are marginal BCS targets to be achieved during the lactation cycle of 
the cow for satisfying health, milk yield, and reproductive efficiency.  
 
According to Garnsworthy (2006) BCS management (Figure 2.1) must rely on the 
following basic principles: 
 
1. Body condition score at calving should be allowed to vary no more than 0.5 BCS units 
above cow target BCS. 
2. Cows of low genetic merit for milk yield (target BCS 2.5-3.0) should calve with BCS of 
3.0 or less. 
3.  Cows of high genetic merit for milk yield (target BCS 2.0-2.25) should calve with BCS 
of 2.75 or less. 
4. Body condition score should not fall below 2.0 during the whole lactation. 
5. Body condition score at service should not fall below 2 to 2.5. 
 
According to Chagas et al. (2007) the perfect BCS fluctuation to minimize the effects of 
NEB on health and reproduction is BCS at calving 3.0-3.5 with a nadir BCS of 2.5-3.0. 
Mulligan et al. (2006b) suggested BCS targets of 2.75 at drying-off, 3.0 at calving,  2.75 
at service, and a nadir of 2.75. Coffey et al. (2004) suggested that if there is an ideal BCS 
or BCS loss, then they should be dependent on stage of lactation or/and the productive 
system under which cows are maintained. 
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
Figure 2.1:  BCS management in the modern dairy cow (Based on the suggestions of Garnsworthy (2006), see text for details).
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2.3.Glucosehomeostasisandhomeorhesis
 
The energy contained in foods is made usable by the animal by intricate biochemical 
events that are generally defined as metabolism (Kaneko, 2008a). Traditionally, these 
biochemical events have been separated into the metabolism of three important ingredients 
of food; carbohydrates, proteins, and lipids (Guyton & Hall, 2006). These also are the main 
constituents of animal body tissue and animal products (e.g. milk) (Bauman & Currie 
1980). The dominant circulating carbohydrate is glucose, which is the principal source of 
energy for life processes in the mammalian cell (Guyton & Hall, 2006; Nafikov & Beitz, 
2007). Thus, the major function of glucose is to serve as an energy source for the animal 
cell, and its storage capacity (in the form of glycogen which is a large polymer of glucose) 
is nearly zero (lactating cows have the ability to store only 1% glucose in their livers in the 
form of glycogen) (Kaneko, 2008a).  Cells require a constant supply of this essential 
nutrient, and only relatively small changes are tolerable without adverse effects on the 
health and productivity of the animal (Kaneko, 2008a; Nafikov & Beitz, 2007). 
Fundamentally, glucose, protein and lipid metabolism are coupled to support the 
mammalian cell with a continuous constant flux of glucose which is tightly 
homeostatically and homeorhetically controlled (Bauman & Currie, 1980). The liver plays 
a central role in buffering blood glucose concentration because it supplies and removes 
glucose from circulation. Hepatic glucose metabolism is mostly directed towards supplying 
rather than using glucose (Kaneko, 2008a; Ghanassia et al., 2007). Thus, the ruminant liver 
takes up only small amounts of glucose under normal physiological conditions and it is not 
an insulin dependent organ (Hayirli, 2006). On the other hand, nervous tissue, muscle 
tissue and the mammary gland during lactation are the primarily glucose-utilizing tissues 
of the animal (Brockman, 1978, 1979; Bauman & Currie, 1980; Bauman, 2000; Reynolds, 
2005). Muscle can deposit small quantities of glycogen, but is not able to liberate free 
glucose into the blood stream (without liver intervention) because of deficiency of the 
enzyme glucose-6-phosphatase (Kaneko, 2008a). Foetal tissue in pregnancy and the 
mammary gland during lactation are heavily dependent on maternal circulating glucose 
(Bauman & Currie, 1980; Bell & Bauman, 1997). The nutrient demands for pregnant 
animals at the end of pregnancy are 75% greater than those of non-pregnant animals of a 
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similar LWT. The developing foetus, foetal membranes, gravid uterus, and mammary 
gland contribute to the increased glucose and nutrient demand (Bauman & Currie, 1980). 
Homeothermy and antioxidant balance are also closely related to glucose homeostasis and 
homeorhesis (Ghanassia et al., 2007; Collier et al., 1982; Kadzere et al., 2002). 
 
Centrally, there is a developed anatomical and functional network that monitors glucose 
availability that is involved in glucose homeostasis and food intake regulation (Bruning et 
al., 2000; Krasnow & Steiner, 2006). Basic components of this centrally operating system 
are glucose-sensing neurons (Moran, 2010). These centrally placed glucose-sensing 
neurons are located at different spots of the brain (from the hindbrain to the hypothalamus) 
and together with peripheral glucose sensors, represent an integrated glucose monitoring 
system (Langhans & Geary, 2010). Glucose phosphorylation by glucokinase is the rate-
limiting step in ATP production and it is essential for the effects of glucose on membrane 
potential and ion channel function of glucose-sensing neurons (Moran, 2010). It is 
hypothesized that sensitive glucose-sensing neurons in the brain change their signalling in 
response to the presence (or the amount) of other metabolites and hormones such as 
insulin, leptin, non-esterified fatty acids (NEFA), and Amino Acids (AA). Glucose 
availability influences the expression and turnover of several catabolic and anabolic 
neuropeptides which presumably mediate the effects of glucose-sensing neurons on eating 
(Krasnow & Steiner, 2006; Cone & Elmquist, 2008; Langhans & Geary, 2010). 
 
Fatty acid oxidation (FAO) is closely related to glucose homeostasis and eating behaviour 
(Wade & Schneider, 1992; Drackley, 1999; Ingvartsen & Andersen, 2000; Allen & 
Bradford, 2007). Inhibition of FAO is usually accompanied by a stimulation of eating in 
animals and man and FAO is tightly related to glucose availability by body tissues 
(Langhans & Geary, 2010). Fatty acids and/or fatty acid metabolism can also be sensed 
centrally, in the mediobasal hypothalamus, and this also affects food consumption (Moran, 
2010). 
 
Cows are herbivorous and consume diets that are higher in structural carbohydrates and 
lower in fat (Lewis & Hill, 1983; Allen et al., 2005). Nutrients absorbed by the cow differ 
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markedly from those that are consumed because of the intervention of rumen microflora 
and the subsequent fermentation of organic matter (OM) of feed (Van Houtert et al., 1993). 
OM is partially fermented to volatile fatty acids (VFA: acetic, propionic, and butyric). 
Feed protein is partially degraded to AA and ammonia, which are incorporated into 
microbial protein of high biological value (Allen et al., 2005). Moreover, unsaturated fatty 
acids of feed are biohydrogenated and isomerized to varying degrees (Lewis & Hill, 1983). 
The major fuels for cows are; VFA from ruminal and intestinal fermentation of OM; 
glucose from starch digestion in the small intestine (metabolized primarily to lactate by 
intestinal tissue); NEFA and AA absorbed from the gastrointestinal tract and mobilized 
from body reserves (Lewis & Hill, 1983; Nafikov & Beitz, 2007). Many ruminant tissues 
preferentially utilize acetate rather than glucose, but the mammary gland requires glucose, 
and large quantities are required for milk lactose synthesis (Reynolds, 2005). Insulin 
induced hypoglycaemia in lactating goats and cows resulted in a depression of milk yield 
(Smith, 1971). 
 
The liver is the predominant site of glucose synthesis in the ruminant. Hexokinase activity 
is low in bovine liver and gluconeogenic capacity is high (Brockman, 1978). 
Consequently, for meeting the high demands of mammary epithelial cells for glucose 
precursors, net hepatic glucose production is over 4 kg/d for cows producing about 60 kg/d 
of milk (Reynolds, 2005; Nafikov & Beitz, 2007). An interesting difference between 
ruminants and pigs is that when in positive EB, gluconeogenesis and lipogenesis increase 
in ruminants but only lipogenesis increases in pigs (Nafikov & Beitz, 2007). Ruminants 
normally absorb little glucose, and propionate is the primary gluconeogenic substrate. 
Almost all propionate is taken up by the liver and used for glucose synthesis (Allen et al., 
2005). Propionate is responsible for as much as 80% of glucose produced in lactating 
cows. Underfeeding decreases utilization of propionate and other precursors derived from 
the diet, while the relative usage of lactate, glycerol and AA as gluconeogenic substrates 
increases. Most AAs are potential gluconeogenic substrates and they are considered to be 
the second most important glucose precursor (Reynolds, 2005; Nafikov & Beitz, 2007). 
NEFA is the major source of energy in bovine liver, but the liver has limited capacity for 
fatty acid synthesis or triglyceride export (Allen et al., 2005; Nafikov & Beitz, 2007). 
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Milk yield exerts a pronounced drain on glucose and energy resources (Nafikov & Beitz, 
2007).  In some studies, dairy cows selected for milk yield had lower circulating glucose 
(Harrison et al., 1990; Gutierrez et al., 1999), but this finding was not in line with other 
studies (Barnes et al., 1985; Westwood et al., 2000). Lukes et al. (1989) reported that 
glucose concentrations in high yielding cows are typically low at parturition. Moreover, the 
lower circulating glucose in higher genetic merit cows was observed later in lactation and 
lasted longer than in lower genetic merit cows (Westwood et al., 2000). In terms of 
circulating glucose, genetic merit for milk yield and underfeeding seem to interact 
(Veerkamp et al., 2003).  
 
In dairy cows, two types of physiological regulation are instrumental to metabolic 
coordination during the transition period: homeostasis, which is the maintenance of 
physiological equilibrium, and homeorhesis, which is the orchestrated change in 
metabolism necessary to support a successful transition from one physiological state to 
another (Bauman & Currie, 1980; Bauman, 2000). Given the species of the animal and the 
genetic make-up, environmental factors (such as management, nutrition, disease) can 
modify the interaction between homeostatic and homeorhetic circuits. In many cases of 
improper animal management, the homeostatic control for survival dominates the 
homeorhetic mechanism which is operated to support a physiological function (e.g. 
lactation or reproduction), resulting in a problematic or incomplete adaptation of the 
organism from one state to another (Bauman & Currie, 1980; Friggens, 2003). Such 
maladaptations are common in transition cows when animals, in a short time, need to adapt 
to three completely different conditions (parturition, lactation, and reproductive recovery) 
(Grummer, 1993; Bell, 1995; Bell & Bauman, 1997; Beever, 2006). 
 
Regulation of glucose metabolism and nutrient partitioning involve interaction between 
homeorhetic and homeostatic circuits to ensure maintenance, production, and reproduction 
of the animal. The metabolic adaptations support the successful transition to lactation, 
leading to increased glucose synthesis by the liver and to decreased glucose oxidation by 
peripheral tissues at the beginning of lactation. However, sometimes the great demand of 
glucose is not achieved by the cow, resulting in reproductive failure, decreased 
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productivity, and increased health problems (Bauman, 2000; Bauman et al., 2004). 
Nutrient partitioning and glucose economy are tightly endocrinologically regulated and this 
involves coordination of many organs, tissues, metabolites, and hormones (Bell & 
Bauman, 1997; Leroy et al., 2008, 2010). Pancreatic hormones, adipokines, growth 
hormone (GH), and their relationships appear to play a key role in regulating glucose 
homeostasis and homeorhesis in periparturient cows. These hormones will be discussed in 
the next section. 
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2.4.Pancreatichormonesandadipokines
2.4.1.Insulin
 
Pancreatic hormones play a key role in endocrine regulation and facilitate the movement of 
glucose across cell membranes, thereby adjusting the concentration of blood glucose 
(Brockman 1978, 1979; Sasaki, 2002). When food is consumed by an animal, especially 
carbohydrates, insulin is secreted (Marieb & Hoehn, 2007) and there is no circadian pattern 
of insulin secretion in ruminants (Trenkle, 1978). In general, circulating insulin is 
increased by feeding diets rich in starches but it is decreased by feeding diets rich in fat. 
However, the factors that influence insulin release are poorly documented in cows 
(Bossaert et al., 2008).  Insulin plays an important role in storing excess energy and 
regulates glucose homeostasis along with its counterpart glucagon, (Figure 2.2) (Marieb & 
Hoehn, 2007; Cryer, 2008, Guyton & Hall, 2006). Nevertheless, the role of insulin is not 
constrained only to regulate glucose homeostasis and homeorhesis. Insulin 
interrelationships with GH, insulin like growth factor- I (IGF-I), ovarian function and 
steroidogenesis are partially understood (Webb et al., 2004; Webb et al., 2007). Milk yield 
and milk composition are indirectly associated with the dynamics of nutrient availability in 
mammary gland (Veerkamp et al., 2003), whereas nutrient partitioning is mostly governed 
by insulin (Hayirli, 2006). Also, milk composition may or may not be controlled by 
insulin, and it is uncertain if selection for milk yield has any influence on insulin secretion, 
clearance and responsiveness in the modern dairy cow (Veerkamp et al., 2003). 
 
 
2.4.1.1.Insulinreceptorandglucosetransporters
The insulin receptor is ubiquitous but liver, muscle tissue, and adipose tissue are the main 
areas exhibiting insulin bioactivity (Etherton, 1982). The insulin receptor is a trans-
membrane glycoprotein which belongs to the large class of tyrosine kinase receptors and 
consists of two Į subunits and two ȕ subunits (Sasaki, 2002). Insulin receptors are 
embedded in cell plasma membranes of insulin dependent tissues, with the ȕ subunits 
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passing through the cellular membrane, and Į and ȕ subunits are linked by disulphide 
bonds (Kido et al., 2001; Sesti et al., 2001; Youngren, 2007). The binding of insulin to its 
receptor is the first step of a signalling pathway, triggering the consumption and the 
metabolism of glucose (Sasaki, 2002). Bound by insulin, the insulin receptor is 
phosphorylated from ATP to several proteins in the cytoplasm, including insulin receptor 
substrates (IRS-1 and IRS-2). This latter step activates phosphatidylinositol 3-kinase (PI-3-
K) and leads to an increase in glucose transporter 4 (GLUT4) molecules in the outer 
membrane of myocytes and adipocytes. By this mechanism, there is finally an increase in 
uptake of glucose from blood into muscle and adipose tissue (Kido et al., 2001; Sesti et al., 
2001; Ben-Shlomo, 2002; Youngren, 2007). According to Sasaki (2002) possession of 
insulin receptor by tissue cells does not necessarily mean the tissue cells are responsive to 
insulin. For instance, bovine mammary epithelial cells have insulin receptors during 
lactation, but the tissue appears to be inert to insulin challenges (Laarveld et al., 1985). 
Furthermore, overexposure of adipose cells to high concentration of insulin, down-
regulates expression of insulin receptors, and leads to a loss of receptors from the 
membrane surfaces (Sasaki, 2002). 
 
The uptake of glucose by tissue cells occurs by facilitating diffusion and it requires a 
carrier protein known as glucose transport (GLUT) (Klip et al., 1994; Thorens, 1996; 
Goodyear & Kahn, 1998). GLUT in the plasma membrane exists in two conformational 
states. Extracellular glucose binds to the GLUT, which then alters its shape, discharging 
glucose in to the cell. Two types of GLUT are recognized (Thorens, 1996): 
 
(i) Insulin Independent Glucose Transporters 
GLUT1 is ubiquitously distributed in various tissues (erythrocyte, brain cells, mammary 
epithelial cells, adipose and muscle cells, and endothelial cells) 
GLUT2 (liver, intestine, pancreatic ȕ cells and kidney) 
GLUT3 (brain and/or foetal muscle cells) 
GLUT5 (intestine) 
(ii) Insulin dependent glucose transporters 
”Chapter2Reviewofliterature


19

GLUT4 is primarily located in insulin-sensitive tissues, such as skeletal muscle, cardiac 
muscle, and adipose tissue. 
 
Different tissues contain different types of GLUT (Herman & Kahn, 2006). The tissue 
specific allocation of GLUT determines tissue responsiveness to insulin for uptake of 
glucose (Klip et al., 1994). Among these, only GLUT4 is found in insulin-sensitive tissues 
(muscle and adipose tissue) and requires insulin for uptake of glucose (Sasaki, 2002). In 
the bovine follicle and corpus luteum GLUT1 and GLUT3 act as the major transporters of 
glucose, although GLUT4 may play a supporting role (Nishimoto et al., 2006). GLUT1 is 
the major glucose transporter of lactating mammary epithelial cells (Bell & Bauman, 
1997). GLUT1 expression level was decreased from early to late lactation and become 
barely detectable in the non-lactating udder (Zhao & Keating, 2007). According to Hayirli 
(2006) exogenous insulin may decrease availability of glucose for mammary tissue 
because insulin does not regulate uptake of glucose through GLUT1. 
 
 
2.4.1.2.EffectsofInsulinonglucosemetabolismandbodyreserves
 
In general, insulin plays numerous roles in metabolism of carbohydrates, lipids, and 
proteins in adipose tissue, muscle, and liver in mammals (Aronoff et al., 2004). It is the 
main anabolic hormone in ruminants and acts to preserve nutrients in favour of the animal 
by directing feed nutrients to body stores rather than to milk production (Brockman, 1978, 
1979; Brockman & Laarveld, 1986). The hypoglycaemic effect of insulin action is 
antagonized by glucagon, adrenalin, glucocorticoids, and GH in cattle (Veerkamp et al., 
2003). Plasma insulin concentration is negatively correlated with NEB in postpartum cows 
(Jorritsma et al., 2003) and insulin treatment increases feed intake, LWT, and body fat 
(Wade & Schneider, 1992). The most important effect of insulin in mammals is its 
interplay with glycogen (Aronoff et al., 2004). This short term regulatory mechanism is 
critical for survival of the animal. After a meal, glucose is absorbed and insulin causes its 
storage in the liver in the form of glycogen. Between meals, when blood glucose 
concentration falls, insulin secretion decreases rapidly and liver glycogen splits back into 
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glucose. Glucose is released back into the blood stream and prevents glucose concentration 
from falling too low (Cryer, 2008; Guyton & Hall, 2006). This mechanism of controlling 
glucose homeostasis is stepwise and depends on the simultaneous activation and 
inactivation of several enzymatic circuits in the liver, including inactivation of liver 
phosphorilase, activation of glucokinase, and increased activity of the glycogen synthase 
(Allen & Bradford, 2007; Vernon, 2005; Kokta et al., 2004; Guyton & Hall, 2006). 
Another mechanism which is critical in glucose homeostasis is gluconeogenesis. Insulin is 
a potent inhibitor of gluconeogenesis by decreasing the quantities and activities of the liver 
enzymes which are involved in gluconeogenesis (Hayirli, 2006). Therefore, the main 
impact of insulin on glucose homeostasis is the control of two separate pathways, 
glyconeogenesis and gluconeogenesis (Aronoff et al., 2004; Nafikov & Beitz, 2007). 
 
Insulin was the first hormone discovered to have an impact on adipose tissue depots (Kokta 
et al., 2004; Cryer, 2008). Generally, insulin acts as fat sparer, and this effect is serious and 
just as important as the control of glucose homeostasis (Guyton & Hall, 2006). In fact, 
glucose homeostasis and adipose tissue are linked under the spectrum of insulin activity 
(Ghanassia et al., 2007). That is because insulin increases uptake of glucose by most of the 
body tissues and automatically damps down lipid usage. In adipose tissue, insulin 
facilitates entry of glucose into adipose cells through GLUT4 (Hayirli, 2006). In turn, 
glucose is oxidized to form Į-glycerophosphate, which is used for esterification of free 
fatty acids during lipogenesis. Furthermore, insulin promotes fatty acid synthesis and 
storage in fat tissue depots, especially when dietary carbohydrate intake is high (Kokta et 
al., 2004; Guyton & Hall, 2006). The mechanism by which insulin exerts its effect on 
adipose tissue is not clearly elucidated. However, this mechanism is believed to be based 
on the capacity of insulin to influence the activity of major enzymatic cascades such as 
hormone sensitive lipase (HSL) (insulin blocked), lipoprotein lipase (LPL) (insulin 
activated), and acetyl-CoA carboxylase (insulin activated) (Carmen & Victor, 2006; 
Guyton & Hall, 2006). Moreover, in adipose and muscle tissue, insulin stimulates 
triacylglyceride (TAG) synthesis by supplying fatty acids through stimulation of LPL 
(Ghanassia et al., 2007). Additionally, insulin suppresses lipolysis by lowering the level of 
cAMP and inhibits the activity of protein kinase A and hormone sensitive-lipase 
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(Ghanassia et al., 2007; Brockman, 1978, 1979). Unlike non-ruminants, in which glucose 
is the main precursor for lipogenesis in adipose tissue, ruminants utilize acetate for the 
same purpose (Vernon & Pond, 1997; Nafikov & Beitz, 2007). Although precursors for 
lipogenesis are different, the stimulatory role of insulin on lipogenesis in adipose tissue of 
ruminants and non-ruminants is the same as in hepatic lipogenesis (Brockman & Laarveld, 
1986). 
 
In the liver, insulin promotes lipogenesis and inhibits ketogenesis in both ruminants and 
non-ruminants (Brockman, 1978, 1979). Free fatty acids are taken up by the liver and are 
re-esterified with glycerophosphate, which is derived either from insulin-stimulated 
glycolysis or from glycerol formed by glycerophosphate kinase. Mitochondrial acetyl-
CoA, which is generated by pyruvate dehydrogenase during glycolysis is transferred to the 
cytoplasm and converted to malonyl-CoA by acetyl-CoA carboxylase (Vernon & Pond, 
1997; Vernon, 2005). This is the rate limiting-step for hepatic lipogenesis and it is 
stimulated by insulin. Insulin exerts its antiketogenic effect on the liver by decreasing 
NEFA uptake (Grummer, 1993; Jorritsma et al., 2003). Insulin accomplishes this by 
altering  lipogenesis to lipolysis ratio in adipose tissue in favour of lipogenesis, by 
increasing peripheral tissue ketone usage, by altering enzyme activities (carnitine 
palmitoyltransferase-I and acetyl-CoA carboxylase), and by changing the availability of 
substrates (malonyl-CoA) involved in ketogenesis in the liver (Brockman, 1979; Vernon & 
Pond, 1997; Hayirli, 2006; Vazquez-Vela et al., 2008). 
 
The ability of insulin to lower blood glucose concentrations is impaired during late 
pregnancy and early lactation in small ruminants (Prior & Christenson, 1978; Debras et al., 
1989). This phenomenon is defined as insulin resistance and it is commonly observed in 
cattle (Sano et al., 1991, 1993). Insulin resistance is the state in which physiological levels 
of insulin produce less potent biological responses (Pasquali, 2006; Zavalza-Gomez et al., 
2008) due to decreased insulin responsiveness to glucose and/ or increased metabolic 
clearance (Sano et al., 1993). The molecular mechanism of insulin resistance may be 
placed at; (1) pre-receptor level, which includes decreased insulin production, increased 
insulin degradation, or both; (2) receptor level, which includes decreased number of 
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receptors and decreased binding affinity; and (3) post-receptor level, which includes 
impaired intracellular signalling and translocation of GLUT (Hayirli, 2006). The current 
evidence suggests that the number and affinity of insulin receptors in adipose and muscle 
cells do not change during lactation and that the defect may be downstream of the insulin 
receptors (Ben-Shlomo, 2002; Barbour et al., 2007; Zavalza-Gomez et al., 2008). Glucose 
utilization by insulin dependent tissues is lower in pregnant animals than in non-pregnant 
and lactating animals (Nieuwenhuizen et al., 1998), and ketosis and ketoacidosis decrease 
tissue responsiveness to insulin in cows (Sakai et al., 1993; Steen et al., 1997). During late 
pregnancy and early lactation, the cow directs nutrients towards embryo and mammary 
tissue at a high-level metabolic priority (Bauman & Currie, 1980; Vernon & Pond, 1997). 
This priority coincides with lowered sensitivity of extra-hepatic tissues to insulin (Sano et 
al., 1991, 1993; Nieuwenhuizen et al., 1997, 1998), which presumably plays a key role in 
the development of hepatic lipidosis and ketosis (Steen et al., 1997). Gestational and 
lactational insulin resistance may be a homeorhetic adaptation that serves successful 
development of the foetus and survival of the neonate (Bauman & Currie, 1980; 
Schoenberg & Overton, 2010). Thus, the term insulin resistance may be misleading for 
characterizing this unique and physiological short-term condition in periparturient cows, 
because it may falsely refer to complications or diseases in other species that are largely 
irrelevant to the periparturient bovine model (Schoenberg & Overton, 2010). 
 
Circulating insulin and cerebrospinal levels of insulin are correlated with body adiposity 
and insulin receptors are present in the brain and hypothalamus of many species 
(Havrankova et al., 1979; Masters et al., 1987; Bruning et al., 2000), and cattle (Miller et 
al., 1994; Liu et al., 2009). Male and female mice with genetic deletions of central insulin 
receptors are obese (Moran, 2010), indicating that insulin receptor signalling in the brain is 
important for the control of LWT. Insulin is a potent regulator of feed intake and nutrient 
partitioning in ruminants (Ingvartsen & Andersen, 2000). Moreover, insulin increases VFA 
absorption indirectly by stimulating growth of gut papillae.  This latter effect may prevent 
accumulation of VFA, which stabilizes ruminal pH and allows greater feed intake (Hayirli 
et al., 2002). According to Hayirli (2006) insulin in ruminants interacts directly with other 
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metabolites to regulate feed intake, but ruminants do not overcome hypoglycaemia simply 
by increasing feed intake. 
 
 
2.4.1.3.EffectsofInsulinonmilkyieldandmilkcomposition
 
Insulin is postulated to play an indirect but very important role in milk yield volume and 
composition due to its regulatory control in nutrient partitioning (Herbein et al., 1985; 
Veerkamp et al., 2003). Low insulin decreases the uptake of glucose by insulin-sensitive 
tissues and enhances glucose availability for the mammary gland, which is insulin-
insensitive (Rose et al., 1997; Bossaert et al., 2008). Low circulating insulin is 
genotypically (Veerakamp et al., 2003; Gutierrez et al., 2006) and phenotypically 
associated (Veerakamp et al., 2003) with high milk yield, and insulin has been shown to be 
essential for ruminant mammary tissue development and cell maintenance in vitro (Collier 
et al., 1977; Mackle et al., 2002; Neville, 2006). Correlations between insulin levels and 
breeding values for milk production, butterfat and milk protein have been reported to be 
positive (Veerkamp et al., 2003). However, circulating insulin is unchanged between high 
yielding and low yielding cows (Lukes et al., 1989; Westwood et al., 2000) or even low in 
high genetic merit cows (Gutierrez et al., 1999; Gong et al., 2002b). Circulating insulin is 
lower in high yielding dairy cows than in beef cows, and this difference was probably due 
to decreased insulin secretion in the dairy cows(Veerkamp et al., 2003). 
 
The glucogenic-insulin theory is based on the effects of insulin on nutrient partitioning. 
This theory explains, at least partially, milk fat depression and proposes regulatory 
influences of insulin on butterfat variation in milk (Griinari et al., 1996; Bauman & 
Griinari, 2001). Insulin stimulates fat deposition and inhibits fat mobilization, but the 
ruminant mammary gland is insensitive to changes in circulating insulin. Milk fat 
depression occurs when cows consume diets high in digestible carbohydrates and low in 
fibre, which generate large quantities of propionate and glucose (Bauman & Griinari, 2001; 
Rudolph et al., 2007). High circulating glucose induces release of insulin from the 
pancreas. Increased circulating insulin (two- to five-fold normal) inhibits fat mobilization 
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in adipose stores (Vernon & Pond, 1997; Bauman & Griinari, 2001). Lipogenic precursors 
such as acetate, beta hydroxy butyrate, and diet-derived long chain fatty acids are 
preferably directed to adipose depots rather than to the mammary gland for butterfat 
synthesis. Finally, these changes result in a lack of lipogenic precursors for milk fat 
synthesis and depression of butterfat in milk (Bauman & Griinari, 2001). 
 
In general, insulin increases AA transport and protein synthesis (Veerkamp et al., 2003). 
Circulating AA has been shown to be the major precursors for milk protein synthesis 
(Petitclerc et al., 2000; Baldi et al., 2008). It has previously been demonstrated that 
lactating and non-lactating ruminants respond in the same way to exogenous insulin 
administration by decreasing circulating AA (Brockman, 1978; McGuire et al., 1995; 
Griinari et al., 1997; Mackle et al., 1999). Therefore, there is no evidence to suggest that 
insulin acts directly on the mammary gland to stimulate AA uptake. The decrease in 
circulating AA may be caused by the effect of insulin on other tissues, such as liver and 
muscle. In some studies using the hyper-insulinaemic euglycaemic clamp technique in 
lactating cows (McGuire et al., 1995, Griinari et al., 1997; Mackle et al., 2000), decreases 
in circulating AA was associated with increases in milk protein content. However, this 
needs to be further elucidated. 
 
It has been shown that short term changes in circulating insulin have no direct effect on 
glucose uptake or milk synthesis by mammary epithelial cells in lactating ruminants 
(Laarveld et al., 1985; Nielsen et al., 2001). The mammary gland cannot synthesize lactose 
from any precursor except from glucose (Ohtani et al., 2011). Moreover, there was no 
effect of insulin administration on mammary gland glucose uptake or lactose synthesis and 
glucose turnover in the mammary gland (Brockman, 1979). According to Kronfeld (1963), 
variations in circulating insulin might occur without observable changes in mammary 
consumption of glucose, but low circulating glucose is a more direct cause of milk 
depression than insulin. 
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2.4.1.4.InsulinandtheGH/IGFǦIsystem
 
Insulin may regulate the efficiency of GH signalling in liver and extrahepatic tissues of 
dairy cows (Rhoads et al., 2004). Secretion of GH is elevated in early lactation, and the 
correlation of insulin with GH is negative in dairy cows (Block et al., 2001; Veerkamp et 
al., 2003). Moreover, GH exerts two types of effects on adipose tissue and skeletal muscle; 
insulin-like and anti-insulin-like (Davidson, 1987). The insulin-like effects occur shortly 
after GH exposure and involve increased glucose usage and decreased lipolysis. When 
tissues undergo long-term exposure to GH, cells responsive to insulin-like actions become 
unresponsive and this phenomenon is termed the refractory effect of GH (Mauras & 
Haymond, 2005). The secretory pattern of GH throughout the day (biorhythm) is 
considered to cause a constant refractory state. The anti-insulin-like effects of GH are 
considered to better reflect the physiological action of the hormone. These effects include 
impaired glucose utilization, hyperglycaemia, stimulation of lipolysis, and induction and 
maintenance of the refractory state to insulin-like effects (Davidson, 1987; Mauras & 
Haymond, 2005). Thus, insulin and GH have antagonistic roles in terms of glucose 
homeostasis, with minor insulin-like GH effects to serve possibly as parts of a homeorhetic 
and homeostatic mechanism (Bauman, 1999). 
 
Growth hormone exerts its actions in almost every organ of the body,  directly after 
binding to specific GH receptors (GHR) and/or indirectly after binding to GHR, 
stimulating the production of  insulin-like growth factor-I (IGF-I) (Hull & Harvey, 2000, 
2001; Webb et al., 2004). The liver is the major source of circulating IGF-I (Rosen & 
Pollak, 1999), but many tissues of the body, including ovary, uterus and mammary gland, 
can produce IGF-I (Hull & Harvey, 2000, 2001, 2002; Webb et al., 2004).  IGF-I serves as 
the main negative feedback signal on GH secretion under normal conditions in which GHR 
expression increases proportionally to circulating levels of GH (Hull & Harvey, 2000, 
2001, 2002). IGF-I controls cell growth, differentiation, and maintenance of differentiated 
cell function in many organs. IGF-I biological activity involves both insulin-like metabolic 
action and growth promoting action via endocrine, autocrine, and paracrine mechanisms 
(McGuire et al., 1992; Webb et al., 2004). IGF-I binds to specific cell surface receptors 
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designated type I and type II IGF receptors with different affinity (Rajaram et al., 1997) 
and IGF-I can also interact with the insulin receptor (Rechler & Nissley, 1985). Generally, 
pituitary derived GH or bovine somatotrophin (bST) administration stimulates the 
synthesis and secretion of hepatic IGF-I, but the combination of high GH and low IGF-I is 
common during the postpartum period and may be associated with NEB, underfeeding and 
low circulating insulin in dairy cows (Lucy, 2000; Veerkamp et al., 2003). Moreover, 
selection for milk production in dairy cows increases circulating GH whilst circulating 
IGF-I is lower for selected cows (Veerkamp et al., 2003). 
 
In early lactating dairy cows, GH action to stimulate IGF-I synthesis is compromised, 
resulting in low circulating IGF-I (Vicini et al., 1991; Veerkamp et al., 2003; Rhoads et 
al., 2004). Insulin may be involved in hepatic expression of GHR. It has been shown that 
chronically elevated circulating insulin increases plasma IGF-I in mid and late lactating 
dairy cows, and stimulates hepatic GHR gene expression (Mashek et al., 2001). Also, 
Rhoads et al. (2004)  showed that there was a positive effect of insulin on GHR levels in 
liver and adipose tissue and that this positive effect was accompanied by an  enhanced 
hepatic IGF-I synthesis in periparturient dairy cows. According to Veerkamp et al. (2003) 
the stimulatory effect of GH on IGF-I synthesis may be partly abolished during NEB when 
insulin levels are low. This might be because GH receptor numbers are decreased in the 
liver or because the function of GHR second messenger system has failed. According to 
Lucy (2008), as lactation progresses the somatotrophic axis recovers due to improved EB, 
increased circulating insulin, and enhanced expression of GHR in the liver. 
 
 
2.4.1.5.Insulinandreproduction
Insulin also has the ability to relay metabolic information to the neuroendocrine pathways 
that influence reproduction and ovarian function (Krasnow & Steiner, 2006; Garnsworthy 
et al., 2008a). Many observations from humans and animals with insulin-dependent 
diabetes mellitus or similar defects suggested that insulin plays a key role in reproduction 
(Veerkamp et al., 2003; Kalro, 2003; Krasnow & Steiner, 2006). Rats bearing mutations to 
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central receptors of insulin experienced reduced reproductive performance due to reduction 
in gonadotrophin secretion and impaired folliculogenesis (Bruning et al., 2000). Before the 
advent of insulin in 1921, pregnancies in women who had diabetes mellitus were rare 
(Kalro, 2003). Low circulating insulin, which may occur in diabetic patients, may also 
characterize high genetic merit dairy cows (Veerkamp et al., 2003). Low conception rate 
and low follicular phase progesterone levels have been associated with low circulating 
glucose and insulin in high genetic merit cows (Pryce et al., 1999; Snijders et al., 2001; 
Veerkamp et al., 2003; Webb et al., 2004). 
 
Insulin plays roles in reproduction much more complicated than its glucose regulatory 
action, and it is implicated in follicular development and functionality (Veerkamp et al., 
2003; Garnsworthy et al., 2008a). The ovary has been demonstrated to be the site of action 
for insulin and IGF-I in several species, including dairy cows (Spicer et al., 1990; Spicer & 
Echternkamp, 1995; Webb et al., 2004; Webb et al., 2007; Velazquez et al., 2008). Growth 
factors such as insulin like growth factors (IGF), transforming growth factors (TGF), and
epidermal growth factors (EGF) directly influence follicular growth by enhancing 
granulosa cell proliferation (Webb et al., 2004). The IGF family is likely to be important in 
the process of selection of dominant follicles by potentiating the action of follicle-
stimulating hormone (FSH) on granulosa cell differentiation, and by increasing the 
responsiveness of granulosa cells to FSH during final follicular growth (Garnsworthy & 
Webb, 1999; Webb et al., 2004; Velazquez et al., 2008; Garnsworthy et al., 2008a). In the 
ovary, insulin is present in follicular fluid, insulin receptors are expressed by granulosa 
cells, and insulin stimulates ovarian steroidogenesis (Webb et al., 2004; Krasnow & 
Steiner, 2006). In vitro insulin and/or IGF-I increase progesterone secretion in human and 
bovine granulosa cells (Spicer et al., 1993; Taketani et al., 2008), and IGF-I, along with 
gonadotrophins, stimulates ovarian steroidogenesis (Webb et al., 2004).  This implies that 
the stimulatory effects of insulin on steroidogenesis, at least in part, may be exerted by the 
IGF-I receptor since IGF-I acts together with gonadotrophins to stimulate ovarian 
steroidogenesis (Webb et al., 2004). 
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Several studies related changes in circulating insulin to alterations in pulsatile luteinizing 
hormone (LH) secretion (Downing & Scarramuzi, 1997, Downing et al., 1999; Tanaka et 
al., 2000; Bucholtz et al., 2000). In vitro and in vivo, insulin stimulates GnRH release but 
this occurs only when glucose is available (Arias et al., 1992; Tanaka et al., 2000). On the 
one hand, short term food deprivation is associated with decreased circulating insulin and 
LH pulsatility. On the other hand, refeeding after food deprivation is accompanied by 
increases in both insulin and LH secretion (Krasnow & Steiner, 2006). Thus, it appears that 
reduced insulin concentrations may signal the hypothalamus and pituitary inhibiting LH 
secretion during periods of limited feed intake (Wade & Schneider, 1992). Furthermore, 
dietary induced increases in circulating insulin in early lactation cows may prevent the 
short luteal phase which is characteristic of the first postpartum oestrous cycle (Miyoshi et 
al., 2001). Moreover, insulin seems to influence embryo survival and ovulation in dairy 
cows. Adamiak et al. (2005, 2006) and Fouladi-Nashta et al. (2007) reported that diets 
designed to increase plasma insulin concentration had negative effects on blastocyst rate in 
heifers and in lactating cows, whereas Gong et al. (2002b) observed that the percentage of 
cows ovulating within 50 days postpartum increased from 55 to 90% in cows fed a high 
starch diet that induced higher insulin release in response to feeding. Garnsworthy et al. 
(2009), by adopting a feeding system that combined a glucogenic diet for the first 50 days 
postpartum and a lipogenic diet thereafter, demonstrated that insulin stimulus may play 
different roles in early lactation and in the breeding period in dairy cows. 
 
Experiments in which animals were treated with insulin gave varying results with respect 
to reproduction (Krasnow & Steiner, 2006). The interpretation of experiments in which 
insulin is injected peripherally is complicated due to the hypoglycaemia induced by 
administration of large doses of insulin (Hayirli, 2006). In many instances, adverse effects 
of systemic insulin treatment on reproductive function did not occur if normal circulating 
glucose was maintained (Downing et al., 1999). There are clear indications that postpartum 
glucose concentrations are lower in high genetic merit cows than in low genetic merit cows 
(Snijders et al., 2001; Veerkamp et al., 2003). McClure et al. (1967), Downie  & Gelman 
(1976) and Easdon et al. (1985) stated that low circulating glucose may be responsible for 
infertility in lactating cows and mice. In addition, pregnancy rate was higher in cows with 
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high circulating glucose than in cows with low circulating glucose, and there was a trend 
for pregnancy rate to decline in cows with very high circulating glucose (Pehrson et al., 
1992). Krasnow & Steiner (2006) reviewed many experiments conducted with a variety of 
animal models in order to assess the implications of hypoglycaemia for reproduction. They 
reported that hypoglycaemia may reduce GnRH pulse generator activity, suppress pulsatile 
LH secretion, disrupt oestrous cyclicity and ovulation, decrease the magnitude of the 
steroid-induced LH surge, and impair mating behaviour. Selvaraju et al. (2002) reported 
that insulin and glucose concentrations were higher in cows which subsequently became 
pregnant than in non-pregnant animals. Downing et al. (1999) stated that there is a 
synergism between insulin and glucose at the ovarian level and it is likely the effects of 
short-term nutrition on ovulation rate may be mediated by direct ovarian actions of insulin 
and glucose. Mammals primarily rely on intracellular oxidation of glucose and fatty acids 
to get the energy necessary to support most physiological processes (Wade & Schneider, 
1992). Although peripheral tissues may utilize both glucose and fatty acids, the ovary uses 
glucose as its principal source of energy (Rabiee et al., 1999; Crooker et al., 2007; 
Scaramuzzi et al., 2010). Glucose is available for cellular oxidation and energy production 
not only when its quantity is sufficient in the body, but also when it is capable of entering 
cells, and that latter implies a role for insulin (Wade & Schneider, 1992). It seems that the 
effect of glucose on fertility is primarily related to its properties as a metabolic fuel 
(Veerkamp et al., 2003). Insulin and functional insulin signalling are necessary for full 
reproductive competence. However, insulin by itself is usually insufficient to restore 
reproductive function in the face of extreme metabolic challenges, especially 
hypoglycaemia (Krasnow & Steiner, 2006). This suggests that insulin might influence 
fertility mostly through metabolic fuel partitioning, mainly of glucose, rather than through 
direct effects (Veerkamp et al., 2003). Nowadays, it is believed that the follicle has a well 
developed system to sense glucose and nutritional status (Webb et al., 2004; Gransworthy 
et al., 2008a; Scaramuzzi et al., 2010). This system allows follicle to determine its growth 
and development, mainly by altering FSH induced effects on local oestradiol synthesis, in 
accordance with glucose availability (Webb et al., 2004; Scaramuzzi et al., 2010). 
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2.4.2.Glucagon
 
Glucagon is released into the circulation when glucose is low (Brockman, 1978; Aronoff et 
al., 2004). The main physiological role of glucagon is to stimulate hepatic glucose output 
(glycogenolysis) leading to increased circulating glucose. In this way, Glucagon provides 
the major countregulatory mechanism for glucose homeostasis (Figure 2.2) (Aronoff et al., 
2004). Another main effect of glucagon on glucose metabolism is stimulation of 
gluconeogenesis in the liver (Brockman, 1978; Jiang & Zhang, 2003; Guyton & Hall, 
2006). Enhanced ability of the liver for gluconeogenesis in the presence of glucagon is 
related to increased activity of key gluconeogenic enzymes such as hepatic pyruvate 
carboxylase, and to high exportation rates of gluconeogenic substrates such as alanine, 
pyruvate, lactate, and glutamine (Roden & Bernroider, 2003; Jiang & Zhang, 2003; 
Aronoff et al., 2004). In adipose tissue there are two major effects of glucagon: (1) 
activation of adipose cell lipase that makes increased quantities of fatty acids available to 
other organs of the body; (2) inhibition of triglyceride storage in the liver that prevents the 
liver from removing fats from the blood stream.  The latter makes additional amounts of 
fatty acids available for other energetic needs, for example milk production (Roden & 
Bernroider, 2003; Jiang & Zhang, 2003). In ruminants, the effect of glucagon on adipose 
tissue metabolism seems to be the same as with non-ruminants. Glucagon infusions 
resulted in increased mobilization of fatty acids and glycerol provided that insulin secretion 
was abolished (Brockman, 1978). However, a lipolytic role for glucagon in ruminants has 
not been confirmed in vitro. This suggests that if glucagon has an effect on adipose tissue, 
this is not as potent as the effect of insulin (Brockman, 1978, 1979). Glucagon has no 
direct effect on peripheral AA metabolism, but it promotes uptake of glucogenic 
aminoacids by the liver of sheep in vivo and enhances the conversion of alanine to glucose 
(Brockman, 1978). In vivo studies in sheep suggest that high concentrations of glucagon 
may be ketogenic. Glucagon might exert this action in the liver by activating carnitine 
acyltransferase reaction which is the first step of oxidation of fatty acids (Brockman, 
1979). 

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Figure 2.2:  Short term homeostatic regulation of circulating glucose by the coordinated action of pancreatic hormones. Increased circulating glucose in the 
fed state stimulates secretion of the pancreatic hormone insulin by ȕ cells and subsequent release of insulin into the blood stream. Postprandially, a high 
concentration of insulin stimulates liver cells to increase glucose uptake and storage in the form of glycogen. Moreover, cells from insulin dependent tissues, 
mainly adipose tissue and muscle, increase glucose utilization and as a result circulating glucose declines to the set point and the insulin effect is diminished. 
Preprandially, when circulating glucose is low, Į cells in the pancreas are stimulated to secrete the pancreatic hormone glucagon and gradually its circulating levels 
are increased. Glucagon exerts its effects mainly on the liver, where it increases glycogen breakdown resulting in increased circulating glucose. Shortly, after 
glucagon action circulating glucose increases to the set point and the glucagon effect is diminished (Adapted from Marieb & Hoehn, 2007).
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Generally, insulin is the primary hormonal signal that controls lipid and ketone body 
metabolism in ruminants while glucagon has only secondary effects when circulating 
insulin is low (Brockman, 1979). Glucose availability has been implicated as a limiting 
factor for milk production and the ratio of insulin to glucagon during the lactation is 
believed to be strongly related to the metabolic processes facilitating milk yield (Herbein et 
al., 1985). According to De Boer et al. (1985, 1986), circulating glucagon increases from 
the dry period to early lactation in order to stimulate lipolysis and gluconeogenesis 
providing the body with the required energy to support high milk production. However, 
other studies (Herbein et al., 1985; Kokta et al., 2004) report that circulating glucagon does 
not change during lactation in dairy cows, suggesting almost minimal dependence of cows 
on gluconeogenesis. The role of glucagon stimulus has recently been revaluated in 
periparturient cows. Many studies were conducted to examine any positive effect of 
exogenous glucagon administration on postpartum NEB, glucose homeostasis, milk yield, 
and fatty liver syndrome (Steen et al., 1997; Bobe et al., 2003a, 2003b, 2004, 2007; 
Nafikov et al., 2006; Osman et al., 2008,2010). The results of these studies indicated a 
positive influence of glucagon treatment on prevention of fatty liver without any effect on 
milk yield.
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2.4.3.Leptin
 
Adipose tissue is no longer considered to be just a store of dormant TAGs which are 
mobilized during NEB (Fruhbeck et al., 2001; Vernon, 2005; Ghanassia et al., 2007). 
TAGs are partly interchangeable with glucose, and in this way fat and glucose metabolism 
are coupled (Vernon, 2005; Marieb & Hoehn, 2007).  After the discovery of leptin, the 
scientific views about adipose tissue have changed considerably. Adipose tissue is now 
considered to be not only an active regulator of body weight but also an endocrine organ 
(Houseknecht et al., 1998; Williams et al., 2002; Macajova et al., 2004). It has recently 
become clear that lipid stores play a critical role in regulation of energy homeostasis, 
insulin action, and glucose metabolism (Yildiz & Haznedaroglu, 2006; Kokta et al., 2004; 
Block et al., 2003). Moreover, the amount of body fat is the principal determinant of 
circulating levels of leptin. This means that there is a strong positive correlation between 
body fat and plasma leptin (Schneider, 2004; Zieba et al., 2005). Leptin is positively 
correlated to LWT and adiposity in ruminants. Also, leptin in growing ruminants is 
positively correlated with BCS when other confounding factors are absent. However, the 
correlation between leptin and BCS appears to weaken postpartum when many other 
physiological influences are in action (Hill, 2004). 
 
Leptin effects can be divided to two main categories: (1) central effects in the brain, 
affecting the amount of food consumption, energy homeostasis, and reproduction; (2) 
peripheral effects in the majority of body tissues, affecting nutrient partitioning (Schneider, 
2004; Macajova et al., 2004). Centrally, leptin exerts its function after binding to its long 
form receptor Ob-Rb. In the periphery, leptin action is inextricably associated with its 
binding to short form receptors (Ob-R) and there are at least six isoforms of Ob-R 
(Houseknecht et al., 1998; Fruhbeck et al., 2001; Macajova et al., 2004; Liefers et al., 
2005). Ob-Rb is the primary mediator of leptin actions because it is the only iso-form that 
is capable of relaying full downstream signalling pathways after binding of leptin. Ob-R 
mRNA is expressed in several organs (such as brain, liver, BAT and WAT, skeletal 
muscle, pituitary, ovary, testis, and uterus) where leptin may directly exert regulatory 
actions (Krasnow & Steiner, 2006). Apart from this, short forms of leptin receptors 
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circulate in the blood stream and bind leptin. This mechanism is believed to play a role in 
activation and inactivation of leptin molecule (Kokta et al., 2004; Houseknecht et al., 
1998; Macajova et al., 2004). 
 
Generally, the intricate influences of leptin on glucose homeostasis are exerted by the 
regulatory actions of leptin on feed intake, thermoregulation, lipid metabolism, and 
physical activity (Williams et al., 2002; Zieba et al., 2005; Liefers et al., 2005). Increases 
in adipose depots reflect elevated circulating leptin and enhanced transduction of leptin 
signalling in the brain. This results in decreased food intake and increased energy 
expenditure (Krasnow & Steiner, 2006). Thus, the main central effect of leptin when it 
binds to Ob-R in the brain is suppression of food intake and potential body weight loss due 
to increased metabolic rate (Hill, 2004; Krasnow & Steiner, 2006). In cattle, expression of 
leptin mRNA and/or circulating leptin are rapidly decreased by restriction of energy intake, 
but are increased by refeeding (Chilliard et al., 2005; Krasnow & Steiner, 2006). In the 
periphery, leptin: (1) stimulates free fatty acid (FFA) oxidation and increases glucose 
uptake and metabolism in skeletal muscles; (2) increases lipolysis in adipose tissue; (3) 
decreases glucose output and increases FFA oxidation in the liver (Yildiz & Haznedaroglu, 
2006; Kokta et al., 2004; Macajova et al., 2004). Interestingly, leptin has been found in 
milk (Weyermann et al., 2006; Martin et al., 2006). Although some studies have 
demonstrated leptin transfer from blood to milk by involving leptin receptors expressed by 
mammary epithelial cells, other studies have shown mammary synthesis of leptin (Bonnet 
et al., 2002). Whatever the mechanism, it is not known why leptin is secreted in milk or 
why its receptors exist in the mammary gland.Female ob/ob mice usually fail to lactate 
when leptin treatment is ceased before parturition. Additionally, female ob/ob mice treated 
with leptin for 14.5 days after successful mating were unable to lactate, even if leptin 
treatment was resumed after parturition. This implies a role of leptin in mammary gland 
development and lactation (Krasnow & Steiner, 2006) but it needs to be further 
investigated. 
 
Leptin may be modulated by insulin and GH, and conversely (Casanueva & Dieguez, 
1998; Williams et al., 2002; Zieba et al., 2005; Liefers et al., 2005). Generally, insulin 
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stimulates circulating leptin in rodents and humans, but insulin effects on leptin in 
ruminants are unclear (Houseknecht et al., 2000; Block et al., 2001; Leury et al., 2003; 
Thorn et al., 2008). Insulin is a positive regulator of circulating leptin in lactating dairy 
cows in positive energy balance (Block et al., 2003) and this may imply that cellular 
energy availability is the primary factor regulating leptin synthesis (Block et al., 2001). 
However, the interaction between leptin and insulin could be characterized as quite 
complex and bidirectional (Yildiz & Haznedaroglu, 2006). On the one hand, increased 
plasma leptin promotes peripheral insulin sensitivity. On the other hand, the same levels of 
circulating leptin reduce insulin secretion from pancreatic ȕ cells. This may suggest that 
there is a feedback loop between adipose tissue and pancreatic islets; the so-called 
”Adipoinsular axis”. Any perturbation or deregulation of this axis is likely to contribute to 
development of certain pathologies such as insulin resistance, diabetes, and glucose 
intolerance (Yildiz & Haznedaroglu, 2006; Block et al., 2003; Zieba et al., 2005). A recent 
study suggests that hypoglycaemia (induced by hyperinsulinaemia) inhibits rises in leptin 
in rats. This finding may support the hypothesis that falling glucose levels during a 
prolonged fast, directly or indirectly, signal the adipocyte to reduce leptin secretion (Yildiz 
& Haznedaroglu, 2006). 
 
Human obese patients showed decreased circulating GH and increased circulating leptin 
(Casanueva & Dieguez, 1998). In contrast, acromegalic and anorexia nervosa patients 
expressed decreased circulating leptin and increased circulating GH (Popovic et al., 2001; 
Scacchi et al., 1999). Leifers et al. (2005) suggested that leptin expression in adipose tissue 
is possibly regulated in early lactating cows by the negative impact of GH.  Moreover, 
restriction of energy intake stimulates GH secretion but suppresses leptin expression in 
human and ruminant adipose tissue (Block et al., 2001; Nagatani et al., 2000). According 
to Scacchi et al. (1999) and Dieguez et al. (2000) increased circulating free fatty acids and 
adiposity are mainly responsible for the inhibition of GH secretion. However, it is possible 
that leptin is another hormonal signal controlling GH secretion by acting on somatostatin 
and growth hormone releasing hormone (GHRH) producing neurons (Scacchi et al., 1999; 
Dieguez et al., 2000). Furthermore, GH prevents insulin-induced production of leptin by 
bovine white adipose tissue (WAT) explants (Houseknecht et al. 2000). In contrast, GH 
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administration had no effect on circulating leptin during late pregnancy or early lactation in 
dairy cows (Leury et al., 2003; Block et al., 2003) and GH was potently stimulated by 
exogenous leptin administration in fasting sheep (Nagatani et al., 2000). Although leptin 
can act directly at the bovine anterior pituitary to modulate GH release, this effect is 
greatly dependent on nutritional status of the cow (Zieba et al., 2003). Moreover, GH 
treatment decreased circulating leptin only in pregnant dairy cows (Sauerwein et al., 2004). 
Therefore, the regulatory roles of GH on leptin and vice versa are debatable and largely 
dependent on the endocrine and the metabolic status of animal. 
 
Much attention has been given to whether reproductive function and nutritional status are 
bridged by leptin (Krasnow & Steiner, 2006). Leptin is a potent regulator of the 
hypothalamic pituitary ovary (HPO) axis and reproduction (Hill, 2004; Chilliard et al., 
2005). In the leptin knockout mouse model, males and females are sterile, and treatment 
with leptin supplementation restores fertility (Hill, 2004). In vivo, leptin stimulates 
secretion of GnRH and gonadotrophins (Williams et al., 2002; Hill, 2004; Liefers et al., 
2005; Krasnow & Steiner, 2006), but in vitro inhibits steroidogenesis in the ovary and 
testis (Krasnow & Steiner, 2006; Williams et al., 2002). In vivo, leptin is a potent 
stimulator of LH (Williams et al., 2002; Krasnow & Steiner, 2006).  In ruminants, central 
or peripheral supplementation of leptin to feed-deprived animals completely prevents the 
decreases in LH (Hill, 2004; Liefers et al., 2005; Chilliard et al., 2005). Leptin may serve 
as a trigger for sexual maturation or play a permissive role in initiation of the onset of 
puberty (Williams et al., 2002; Chilliard et al., 2005; Krasnow & Steiner, 2006). Age at 
onset of puberty is affected by mostly feed intake, growth rate and adiposity (Moran et al. 
1989). Elevated circulating leptin precedes sexual maturation in many animals, and it has 
been demonstrated that leptin plays at least a permissive role in onset of puberty (Ahima et 
al., 1997; Garcia et al., 2002). Leptin enhances bovine oocyte maturation (Paula-Lopes et 
al., 2007) and improves the ability of the bovine oocyte to sustain embryonic development 
(Boelhauve et al., 2005). 
 
Leptin roles are not restricted to regulation of reproductive function, but are extended to 
pregnancy and lactation (Hill, 2004; Chilliard et al., 2005). In many animals, including 
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dairy cows, circulating leptin increases during pregnancy and reaches a peak just before 
parturition, at which point it starts to decrease rapidly (Chilliard et al., 2005; Krasnow & 
Steiner, 2006). Normally, increased circulating leptin is accompanied by decreased food 
consumption, but because a sort of central leptin resistance is established, females of many 
species express hyperphagia (Hill, 2004; Krasnow & Steiner, 2006). In the bovine, leptin 
resistance may be considered a successful homeorhetic adaptation because it allows 
pregnant females to consume greater quantities of feed than normal in order to support the 
great energetic demands of the ongoing foetal growth and the imminent lactation (Krasnow 
& Steiner, 2006). Feed intake is already low 2 weeks prepartum and further decreases 
postpartum in dairy cows (Allen & Bradford, 2007). Therefore, modern periparturient 
dairy cows may be an exception displaying earlier hypophagia, although central leptin 
resistance has never been documented. 
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2.4.4.Adiponectin
 
Adiponectin, also known as Acrp30, apM1, AdipoQ, and GBP28, is an adipokine secreted 
by adipose tissue (Fruhbeck et al., 2001; Kadowaki & Yamauchi, 2005; Berg et al., 2002). 
Adiponectin protein form structurally belongs to the complement 1q family, it is 
multimeric, and it is constituted by four main domains. Serum human or mouse 
adiponectin forms a variety of multimers from trimers to high molecular weight (HMW) 
multimers. Oligomerization, proteolytic cleavage, hydroxylation, and glycosylation of 
multimers are shown to play important roles in adiponectin activation and deactivation 
(Kadowaki & Yamauchi, 2005). Adiponectin can exist as full-length or a smaller globular 
fragment, however, almost all circulating adiponectin appears to be as full-length 
adiponectin in plasma (Kadowaki & Yamauchi, 2005; Garaulet et al., 2007; Giannessi et 
al., 2007). It has been postulated that the different adiponectin multimers exert diverse 
effects in various tissues. Thus, adiponectin oligomerization is of high importance and it 
must be considered when adiponectin function is studied in a specific tissue (Garaulet et 
al., 2007; Shetty et al., 2009). 
 
Binding of adiponectin to its receptors is the first step of its biological action. Two kinds of 
distinct but structurally related adiponectin receptors have been identified (AdipoR1 and 
AdipoR2) and they both bind globular and full-length adiponectin with different affinities 
(Ahima, 2006; Garaulet et al., 2007). AdipoR1 and AdipoR2 are abundantly expressed in 
many tissues and organs (Kadowaki & Yamauchi, 2005; Dridi & Taouis, 2009) with 
AdipoR1 predominantly expressed in skeletal muscle and AdipoR2 in liver (Yamauchi et 
al., 2003; Barb et al., 2007). Ohtani et al. (2011) demonstrated the existence of an 
autocrine-paracrine system of adiponectin in bovine mammary gland and the presence of 
adiponectin receptors was shown in human breast cancer cell line MCF-7 (Dieudonne et 
al., 2006). It is known that AdipoR1 knock-out mice are obese and glucose-intolerant and 
they have decreased energy expenditure. In contrast, AdipoR2 knock-out mice are lean, 
with decreased plasma cholesterol levels, and resistant to high-fat-diet induced obesity and 
show increased energy expenditure (Bjursell et al., 2007). This clearly demonstrates that 
both receptors are involved in energy metabolism, although they have opposing effects 
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(Bjursell et al., 2007). According to Gonzalez et al. (2010) it is plausible to hypothesize 
that there is a different correlation between circulating adiponectin and AdipoR1 and 
AdipoR2 expressions. Moreover, AdipoR1 appears to mediate adiponectin effects via 
AMPK, whereas AdipoR2 via PPAR-Į (Kadowaki et al., 2008). Furthermore, nutritional 
status, pregnancy and circulating leptin seem to control circulating adiponectin and 
AdipoR2 expression in tissue specific manner in rats, whereas AdipoR2 expression is not 
correlated with circulating adiponectin (Gonzalez et al., 2010). 
 
The effects of adiponectin on liver and muscle tissue are well documented in human and 
mice (Yamauchi et al., 2001,2002, 2003; Berg et al., 2002; Kadowaki & Yamauchi, 2005), 
but they have not been explored in other domestic animal models and dairy cows. It has 
been reported that adiponectin-deficient mice are insulin-resistant and present lower 
plasma insulin levels after glucose loading than wild-type mice (Kharroubi et al., 2003). 
Moreover, high circulating adiponectin levels were associated with a lower risk of 
development of type 2 diabetes and adiponectin was negatively correlated with circulating 
glucose (Hotta et al., 2000; Weyer et al., 2001; Spranger et al., 2003). The main impacts of 
adiponectin on glucose homeostasis and nutrient partitioning can be summarized as: (1) 
adiponectin decreases glucose output, increases FFA oxidation, and increases influx of 
NEFA in the liver; (2) adiponectin increases FFA utilization and stimulates glucose usage 
in muscle tissue. For these reasons, it is believed that adiponectin generally improves the 
ratio of glucose to FFA and consequently has insulin sensitizing activity (Kershaw & Flier, 
2004; Kadowaki & Yamauchi, 2005; Garaulet et al., 2007; Shetty et al., 2009).  
 
Generally, the mechanism of insulin sensitizing of adiponectin involves activation of 5' 
AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor 
alpha (PPARĮ), increased glucose uptake by GLUT4, increased glycolysis by 
phosphorylation of phosphofructokinase, and increased fatty acid oxidation by inactivation 
of acetyl CoA carboxylase and activation of carnitine palmitoyltransferase I (Yamauchi et 
al., 2001, 2002; Ahima, 2006; Kadowaki et al., 2006; Kamada et al., 2008). According to 
Combs et al. (2001) even a moderate surge in circulating adiponectin can suspend both the 
expression of hepatic gluconeogenic enzymes and the rate of endogenous glucose 
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production. AMPK is a cellular energy sensor that is activated by a rise in the intracellular 
AMP/ ATP ratio. It is believed that adiponectin is a potent activator of AMPK and exerts 
its metabolic effects by activation of AMPK and subsequent deactivation of acetyl-
coenzyme A carboxylase (Yamauchi et al., 2002). This leads to decreased activation of 
malonyl CoA and increased activation of carnitine palmitoyltransferase I. Finally, 
activation of AMPK has been demonstrated to stimulate the recruitment of GLUT4 to the 
plasma membrane from cytoplasm, and to increase glucose uptake (Mullen et al., 2007). 
 
The impact of adiponectin on metabolism in dairy cows is almost unknown and few studies 
have measured adiponectin in cows. Komatsu et al. (2007) assessed adiponectin mRNA 
change in adipose tissue, in peak-, late-, and non-lactating cows.  This study demonstrated 
that adiponectin concentrations reached a peak in non-lactating cows, and this value was 
greater than both peak- and late-lactation adiponectin values. Raddatz et al. (2008) 
measured adiponectin concentrations in lactating Holstein cows for the first 11 weeks of 
lactation. Adiponectin concentrations increased from week 1 to week 4 postpartum and 
then declined to remain at 12-13 ng/ml for the remainder of the study. Circulating 
adiponectin did not correlate with BCS or energy corrected milk yield, and circulating 
adiponectin did not affect resumption of oestrous cycles. Puntenney (2006) examined the 
effect of prepartum dietary treatment, breed (Jersey versus Holstein), and BCS in dairy 
cows.  None of these factors had an effect on circulating adiponectin. Circulating 
Adiponectin was not correlated with NEFA, insulin, glucose, tumour necrosis factor-alpha 
(TNF-Į), and BCS. Ohtani et al. (2011) examined mRNA expression levels of adiponectin 
and its receptors in various bovine tissues and mammary glands at different stages of 
lactation, and the effects of lactogenic hormones (insulin, dexamethasone and prolactin) 
and GH on mRNA expression of adiponectin receptors in cultured bovine mammary 
epithelial cells. AdipoR1 and AdipoR2 mRNAs were widely expressed in various bovine 
tissues, but adiponectin mRNA expression was significantly higher in adipose tissue than 
in other tissues. Although adiponectin mRNA expression was significantly decreased in the 
lactating mammary gland, AdipoR1 mRNA expression was significantly higher at peak 
lactation than at drying off. Moreover, in mammary epithelial cells lactogenic hormones 
and GH up-regulated AdipoR2 mRNA expression but did not change AdipoR1 mRNA. 
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Lemor et al. (2009) reported that AdipoR1 and AdipoR2 mRNA abundance in adipose 
tissue decreased as high yielding cows moved from pregnancy to lactation. 
 
Some evidence suggests that adiponectin could directly regulate reproductive functions. 
Adiponectin and its receptors are present in theca and granulosa cells, oocytes and the 
corpus luteum (Lord et al., 2005; Ledoux et al., 2006; Ramachandran et al., 2007; 
Chabrolle et al., 2007a, 2007b). Adiponectin is also present in porcine and human 
follicular fluid (Ledoux et al., 2006; Chabrolle et al., 2009). Adiponectin may influence 
steroidogenesis, but contradictory results have been reported (Ledoux  et al., 2006; Lagaly 
et al., 2008; Chabrolle et al., 2009; Gutman et al., 2009; Pierre et al., 2009; Maillard et al., 
2010). The response of theca cells to adiponectin may be regulated by LH and IGF-I. 
Supplementation with LH during the late follicular phase may enhance follicular insulin 
sensitivity, resulting in decreased androgen levels through a pathway mediated by 
increased production of adiponectin by the human follicle (Gutman et al., 2009). In the 
ovary, most of the adiponectin-induced modulations in gene and protein expression are 
mediated by AMPK (Chabrolle et al., 2007b) or ERK 1/2- mitogen-activated protein 
kinase (MAPK) dependent pathway (Maillard et al., 2010). In the ovary, the association 
between adiponectin and AMPK suggests that adiponectin may act as a key signal 
regulating the amount of energy required for growth of follicles and oocytes (Dupont et al., 
2008). AdipoR1 or AdipoR2 knock-out mice are fertile, and thus adiponectin is not 
essential for normal ovarian function (Brochu-Gaudreau et al., 2010). It has been 
hypothesized that adiponectin effects on the ovary are mediated through its insulin-
sensitizing traits (Mitchell et al., 2005) and through its effect on IGF-I (Campos et al., 
2007; Dupont et al., 2008; Michalakis & Segars, 2010). Chappaz et al. (2008) concluded 
that when adiponectin was added to media culture, meiotic maturation and embryo 
development of porcine oocytes were influenced positively. This indicates an effect of 
adiponectin on early embryonic development, but it needs to be elucidated further. 
 
Weyermann et al. (2006) and Martin et al. (2006) examined adiponectin and leptin in 
human milk. Both of these studies confirmed the presence of adiponectin in human milk. 
On the one hand, Weyermann et al. (2006) reported that concentrations of adiponectin and 
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leptin varied strongly in maternal serum, cord blood, and breast milk, with only moderate 
correlations between both adipokines in maternal serum and breast milk. On the other 
hand, Martin et al. (2006) found that adiponectin concentrations in human milk are 
associated with stage of lactation, maternal adiposity (BMI), and ethnicity. In addition, 
Bronsky et al. (2006) measured adiponectin in human breast milk and found that milk 
adiponectin did not differ significantly in mothers who delivered boys versus girls. The 
authors also reported that there was a positive correlation between milk adiponectin and 
body weight of mothers before pregnancy, but no correlation between milk adiponectin 
and body weight at time of delivery. 
 
Adiposity and circulating adiponectin are negatively correlated. According to Ishioka et al. 
(2006), canine adiponectin mRNA was detectable only in adipose tissue and obese dogs 
showed heavier body weights but lower circulating adiponectin. In the same study, 
circulating leptin was negatively correlated with circulating adiponectin. Kearns et al. 
(2006) reported that adiposity in horses was positively correlated with leptin and 
negatively correlated with adiponectin. Circulating adiponectin was negatively correlated 
with LWT, BMI, and insulin in humans (Berg et al., 2002; Matsuzawa et al., 2004; Ahima, 
2006). No study has investigated the association of circulating adiponectin with LWT and 
BCS at calving in dairy cows. However, Raddatz et al. (2008) proposed that circulating 
adiponectin is not correlated with BCS in early lactating dairy cows. 
 
Basu et al. (2009) investigated in utero the effect of gender dimorphism of adiponectin in 
humans. In this study it was reported that total adiponectin concentrations were higher in 
female compared with male foetuses. Furthermore, adiponectin was positively correlated 
with neonatal fat mass and percent body fat in female foetuses, and with lean mass in 
males. Many studies suggested higher circulating adiponectin in women compared to men 
(Kern et al., 2003; Silha et al., 2003; Tschritter et al., 2003), but no sexual dimorphism 
was noted between mares and geldings (Gordon et al., 2007). These findings implicate a 
complicacy of other factors, such as reproductive hormones, which possibly are involved 
in the regulation of adiponectin. Oestrogen was found to be negatively correlated with 
adiponectin in women, although pharmacologic doses given to women did not decrease 
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adiponectin levels (Mazaki-Tovi et al., 2005). According to Barb et al. (2007) testosterone 
down-regulates adiponectin expression in adipose tissue, resulting in higher circulating 
adiponectin in females. The effect of testosterone on adiponectin is also unclear, with some 
studies reporting significant a suppressive effect on adiponectin and others reporting no 
effect (Mazaki-Tovi et al., 2005; Mitchell et al., 2005). 
 
Dietary factors may modulate circulating adiponectin (Reis et al., 2010). High 
consumption of magnesium (Qi et al., 2005; Cassidy et al., 2009), caffeine (Williams et 
al., 2008), omega-3 polyunsaturated fatty acids (n-3 PUFA) (Duda et al., 2007), and 
dietary salt (Lely et al., 2007) were associated in humans with higher circulating 
adiponectin. According to Barnea et al. (2006) mice fed a High Fat (HF) diet exhibited 
significantly greater weight gain, abnormal oral glucose tolerance test curves, and elevated 
insulin resistance, although circulating adiponectin remained unchanged compared with 
controls. Jones et al. (2009) studied the effect of HF diet supplementation on a mouse 
model from a period around mating and throughout gestation. The HF diet increased 
maternal adiposity and circulating maternal leptin, and decreased serum adiponectin. 
Cassidy et al. (2009) observed that dietary intakes of carbohydrate, protein, and trans-fat 
were negatively associated with circulating adiponectin in human female twins. Pischon et 
al. (2005) showed that circulating adiponectin was negatively related to glycaemic load, 
but tended to be positively associated with total fat intake in men. Shimabukuro et al. 
(2007) studied the effects of consuming a high-carbohydrate meal, a HF meal, or a 
standard test meal on postprandial circulating adiponectin in healthy humans and found no 
association of circulating adiponectin with type of meal. Reis et al. (2010) reviewed the 
effects of diet components on adiponectin levels in rodent and human models. In this 
review it was concluded that diets rich in saturated fat reduce levels of adiponectin, 
whereas diets rich in PUFA and supplementation with n-3 PUFA increase both gene 
expression and circulating adiponectin. Gordon & McKeever (2005) showed that 
circulating adiponectin in horses did not alter throughout a 24-hour blood sampling period 
and neither dextrose challenge nor oral grain challenge changed circulating adiponectin. 
The effects of dietary components on circulating adiponectin have not yet been 
demonstrated in ruminants.  
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Many studies suggest an important role of adiponectin in regulation of insulin sensitivity, 
however, little is known about the regulatory role of this hormone during pregnancy 
(Mazaki-Tovi et al., 2005). Catalano et al. (2006) investigated the roles of adiponectin in 
regulating glucose and lipid metabolism in human pregnancy. The authors reported that 
circulating adiponectin was lower in the third trimester than in the pregravid condition and 
this hypoadiponectinaemia was reflected by a 2.5-fold decrease in WAT adiponectin 
mRNA, and 25% increase in fat mass. In the same study, insulin infusion decreased high 
molecular weight adiponectin complexes in pregravid women and the suppressive effect of 
insulin on adiponectin was lost during pregnancy. Asai-Sato et al. (2006) studied the long 
term changes in circulating adiponectin during pregnancy and lactation along with its 
relations with prolactin in lean healthy women. They reported that circulating adiponectin 
declined slightly as pregnancy advanced and reached its lowest level during lactation. The 
authors also concluded that the lowest levels of adiponectin during lactation were possibly 
because prolactin influenced regulation of maternal metabolism by suppressing 
adiponectin. Prolactin suppresses circulating adiponectin in mice (Combs et al., 2003), but 
in a transgenic mouse model increased circulating adiponectin and prolactin levels were 
observed (Combs et al., 2004). Another study (Nien et al., 2007), conducted to investigate 
the effect of different levels of adiposity on circulating adiponectin in pregnant women, 
concluded that there was no difference in circulating adiponectin between pregnant and 
non-pregnant women and circulating adiponectin was negatively correlated with 
gestational age only among pregnant women of normal weight. Sir-Petermann et al. (2007) 
reported that circulating adiponectin was lower in women with gestational diabetes 
mellitus (GDM) than in women with normal glucose tolerance. Gao et al. (2008) looked 
for possible associations of TNF-Į, leptin, and adiponectin in mid-trimester women with 
gestational diabetes mellitus. Women with GDM have the highest circulating TNF-Į and 
leptin and the lowest circulating adiponectin compared to those with gestational impaired 
glucose tolerance and to healthy controls at 14–20 weeks of gestation.  
 
Adiponectin involvement in the control of glucose homeostasis in peripheral tissues via 
AdipoR1 and AdipoR2 receptors is beyond any doubt (Shetty et al., 2009; Garaulet et al., 
2007; Giannessi et al., 2007). However, recent studies have implied a central regulatory 
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role of adiponectin. Adiponectin intra-cerebro-ventricular (ICV) infusion in mice led to 
weight loss through increased energy expenditure (Qi et al., 2004). AdipoR1 and AdipoR2 
were discovered to be expressed by neurons (including pro-opiomelanocortin (POMC) and 
neuropeptide Y (NPY) neurons) and astrocytes in the rat hypothalamic nuclei, and 
adiponectin presence was ascertained in cerebrospinal fluid (Steinberg & Kemp, 2007). In 
addition, increased phosphorylation of AMPK in the rat hypothalamus was induced by 
adiponectin (Guillod-Maximin et al., 2009). It has been demonstrated that AMPK 
activation and deactivation in hypothalamic neural cells play a key role in monitoring 
energy status and regulating food intake (Andersson et al., 2004; Minokoshi et al., 2008). 
Leptin and adiponectin control AMPK, with leptin to deactivate (Minokoshi et al., 2008) 
and adiponectin to activate it (Kubota et al., 2007) in hypothalamic neurons. Kubota et al., 
2007 showed that adiponectin binding to AdipoR1 in the murine arcuate hypothalamus 
enhanced AMPK activity and stimulated food intake. The discovery a role for adiponectin 
in stimulating appetite led Kubota et al. (2007) to propose the ‘‘fat-centric’’ hypothesis. 
According to this hypothesis, energy stores are maintained by the opposing central actions 
of leptin and adiponectin (Steinberg & Kemp, 2007). However, this hypothesis needs to be 
further investigated. 
 
Some studies have demonstrated multiple regulatory interactions between adiponectin and 
GH at central and peripheral level. Engström et al. (2003) reported that GH-deficient 
women who followed a nine-month treatment with exogenous GH supplementation 
showed elevated circulating adiponectin compared to controls. Lam et al. (2004) reported 
that circulating adiponectin was low in patients suffering from acromegaly, and circulating 
adiponectin increased after GH-lowering therapies. Fasshauer et al. (2004) demonstrated 
that GH was a putative regulator of AdipoR2 in 3T3-L1 adipocytes and that GH stimulated 
AdipoR2 synthesis was increased up to 4.8-fold during differentiation of 3T3-L1 
preadipocytes. Moreover, this positive effect of GH on AdipoR2 expression could be 
reversed by GH withdrawal for 24 hours. Nilsson et al. (2005) demonstrated that gene 
expression of AdipoR1 and AdipoR2 in human adipose tissue is differentially regulated by 
prolactin and GH. Also, prolactin and GH reduced adiponectin secretion by human adipose 
tissue in vitro and in vivo in mice. Rodriguez-Pacheco et al. (2007) investigated the central 
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role of adiponectin in regulating somatotroph and gonadotroph function. The authors 
showed that short-term adiponectin exposure abolished both basal and stimulated (by 
Ghrelin and GnRH) secretion of GH and LH by rat pituitary cells in vitro. Also, this study 
demonstrated the existence of a complete autocrine/ paracrine system of adiponectin in rat 
pituitary in which both adiponectin and its receptors are expressed. Thus, adiponectin 
seems to regulate energy expenditure, body reserves, and reproduction by playing a 
complicated central and peripheral role similar to leptin. Steyn et al. (2009) confirmed the 
regulatory effect of adiponectin on GH secretion in rat pituitary somatotrophs. However, 
this study demonstrated that adiponectin stimulated GH secretion in a dose-dependent 
manner through binding to either AdipoR1 or AdipoR2. Although these results are 
conflicting, they demonstrate interaction between adiponectin, GH, and their receptors at 
the central and peripheral level. The terms of this interaction needs to be further elucidated 
by both in vitro and in vivo experiments. 
 
To conclude, adiponectin is a very interesting molecule but research has been mostly 
conducted in humans and rodents. There is only limited evidence for a role of adiponectin 
in nutrient partitioning, reproductive performance, and milk yield in dairy cattle. Thus, the 
interplay of adiponectin with other bovine hormonal and metabolic stimuli must be 
investigated further. 
 
 
2.5.Workinghypothesesandobjectives
 
The literature review strongly suggested that reproductive performance of lactating dairy 
cows interacts with nutrition and BCS at calving and that the related hormonal and 
metabolic profile plays a role in cow fertility. This was the main hypothesis of the present 
thesis. This hypothesis has been developed in Chapter 3 in this PhD project, and has been 
tested in a series of specific objectives. More specifically the objectives were to: 
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 Examine the effect of two dietary treatments (high starch versus high fat diet) on 
metabolic profile and reproduction (Chapter 3). 
 Explore the effect of BCS at calving on metabolic profile and reproductive performance 
(Chapter 3). 
 Define optimum plasma insulin concentration in terms of reproduction, and address its 
impact on pregnancy rate and milk progesterone profile (Chapter 3). 
 
The second hypothesis was that different BCS at calving, diets, milk yield potential and 
physiological stages will affect circulating and milk adiponectin values, and production 
traits, metabolic hormones and metabolites, and their relationships. This hypothesis has 
been developed in Chapter 4 in this PhD project, and has been broken down into more 
specific objectives. More specifically the objectives were to: 
 
 Measure circulating adiponectin and milk adiponectin in dairy cows (Chapter 4). 
 Investigate the effects of diet and BCS at calving on circulating adiponectin (Chapter 4). 
 Demonstrate the effect of stage of lactation on circulating adiponectin (Chapter 4). 
 Investigate associations between leptin, adiponectin, production traits, and metabolic 
and hormonal signals (Chapter 4). 
 Assess the association of circulating adiponectin with DMI in lactating dairy cows 
(Chapter 4). 
 
The third hypothesis was that high yielding cows have lower circulating adiponectin than 
low yielding cows due to increased circulating GH and its antagonistic relationship with 
adiponectin. This hypothesis has been developed in Chapter 4 in this PhD project. 
 
The fourth hypothesis was that animals with elevated plasma adiponectin concentrations 
(up to three times) will express different hormonal, metabolic, productive, and/or 
reproductive pattern. This hypothesis has been developed in Chapter 5 in this PhD project. 
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The fifth hypothesis was that high yielding cows will regulate glucose homeostasis 
differently to low yielding cows, and glucose homeostasis in dairy cows will be regulated 
by adiponectin. This hypothesis has been developed in Chapter 5 in this PhD project. 
 
A general discussion summarizing and integrating the results of these experiments has 
been presented in Chapter 6.  

3.Effectsofbodyconditionscoreatcalvinganddieton
circulating metabolic hormones, metabolites, and
reproductivetraitsindairycows
 
 
 
3.1.INTRODUCTION
 
 
Body condition score (BCS) is a rapid, non-invasive, inexpensive, but subjective way of 
assessing body reserves of the cow. It is easy applicable at the farm level and might give a 
more realistic view of the lipid and muscle reserves than live weight (Garnsworthy, 2006). 
In recent decades, BCS has been proved a useful management tool for assessing nutritional 
status and EB during lactation in dairy cows. Estimates of BCS are significantly correlated 
to subcutaneous fat (Garnsworthy & Topps, 1982; Domecq et al., 1995; Heuer et al., 1999; 
Garnsworthy et al., 2006). Ruegg & Milton (1995) reported that excessive loss of BCS 
during early lactation is related with metabolic diseases and Gearhart et al. (1990) 
described high BCS at parturition as a risk factor for reproductive performance in dairy 
cows. It is  well known that body condition loss and especially BCS at certain points of the 
cow cycle impacts directly on DMI, NEB, fertility, milk yield and milk composition, and 
health of high yielding cow (Butler, 2003; Garnsworthy, 2006). According to Chagas et al. 
(2007) the perfect BCS fluctuation to minimize the effects of NEB on health and 
reproduction is BCS at calving 3.0-3.5 units with a nadir BCS of 2.5-3.0 units. Mulligan et 
al. (2006b) suggested BCS targets for drying-off point; 2.75 units, BCS at calving; 3.0 
units, BCS at service  2.75 units, and nadir BCS; 2.75 units. 
 
According to Mulligan et al. (2006a, 2006b), over-fat cows at calving have a greater 
possibility of expressing fatty liver, ketosis, retained placenta, calving difficulties and milk 
fever. Butler & Smith (1989) and Villa-Godoy et al. (1990) demonstrated that when NEB 
is accompanied by excess BCS loss then the result is declined fertility. Numerous studies 
showed the negative impact of excess or inadequate BCS at calving, BCS loss and nadir 
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BCS on postpartum reproductive performance (Garnsworthy & Topps, 1982; Heuer et al., 
1999; Moreira et al., 2000; Yamada et al., 2003; Lopez-Gatius et al., 2003; Agenas et al., 
2003; Roche et al., 2007b). The main outcome from these studies was that reproductive 
indices determining the reproductive efficiency of the herd, such as calving interval, days 
to first oestrus, days to first service, first service conception rate and number of services 
were related to BCS, which is considered a key point of reproductive management. 
 
BCS has been considered an indirect measure of nutritional status (Short et al., 1990; 
Garnsworthy, 2006; Bewley & Schutz, 2008). That implies that BCS is affected by diet 
composition and DMI (Short et al., 1990; Garnsworthy, 2006). According to Short et al. 
(1990) the effect of nutrition on reproduction depends on whether nutritional differences 
exist before or after calving. In addition, BCS at calving is more important than postpartum 
BCS loss and consequently dietary and nutritional management of animals in the dry 
period is a crucial factor to ensure timely reproductive functionality after calving (Short et 
al., 1990). 
 
The interaction between nutrition and reproduction is complicated and variable (Boland et 
al., 2001).  This interaction involves both past and present nutritional status, but other 
factors such as genetic makeup, BCS, environmental influence, and physiological state are 
determinant modifiers of nutritional effects on reproductive performance (Short et al., 
1990; Garnsworthy & Webb, 1999; Lucy, 2001; Stevenson, 2001; Robinson et al., 2006). 
High fat diets with dietary total fat concentration over 50 g/kg of DM depressed plasma 
insulin concentration in cows at the onset of the breeding period (Garnsworthy et al., 
2008b). Conversely, high starch diets induced high plasma insulin concentration and 
increased the proportion of cows ovulating within 50 days of calving and reduced the 
interval from calving to first ovulation, and tended to reduce the intervals from calving to 
first service and to conception (Gong et al., 2002b). Moreover, Adamiak et al. (2005, 
2006) in heifers (beef X dairy) and Fouladi-Nashta et al. (2005) in lactating dairy cows 
demonstrated that diets designed to increase plasma insulin concentration had negative 
effects on blastocyst rate in heifers and lactating cows.  
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For the purposes of the present study, data generated by Garnsworthy et al. (2009) were re-
analysed.  Garnsworthy et al. (2009) provided evidence to support the hypothesis that 
pregnancy rate will be enhanced by feeding a diet that increased plasma insulin (HS diet) 
until cows resume ovarian cycles, and then switching to a diet (HF diet) that decreased 
plasma insulin during the mating period. In the study of Garnsworthy et al. (2009), the 
impact of BCS on reproductive performance of lactating cows was not assessed. Thus, the 
first objective of this study was to determine the effects of BCS at calving and diet on 
reproductive performance in early lactating dairy cows. It was hypothesized that different 
BCS at calving and diet would result in different metabolic profiles and reproductive 
performance. Hormonal and metabolic profiles of the cows were used to explain 
differences in reproductive traits such as days to first oestrus, pregnancy rate, and milk 
progesterone profile. Gong et al. (2002b) demonstrated that feeding a high starch diet to 
dairy cows for the first 50 days postpartum increased circulating insulin concentrations, 
and reproductive performance was enhanced. In addition, Fouladi-Nashta et al. (2007) 
reported that diets with a high fat content had beneficial effects on blastocyst rate in 
lactating dairy cows although they decreased circulating insulin. These two results taken 
together may imply that there is an optimum insulin concentration necessary for normal 
reproductive performance in lactating dairy cows. Moreover, it is known that fat cows at 
calving are more insulin resistant than thin cows at calving (Holtenius & Holtenius, 2007; 
Sinclair, 2010). In the study of Garnsworthy et al. (2009) cows fed the high starch and high 
fat diets had normal to high concentrations of circulating insulin and expressed very low 
pregnancy rate (26.7%). The second objective of the study was to test the hypothesis that 
there is an optimum insulin concentration necessary for normal reproductive performance 
in lactating dairy cows, and that is dependent on BCS at calving. 






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3.2.MATERIALSANDMETHODS
 
3.2.1. Data 
 
This study utilized data generated by the study of Garnsworthy et al. (2009). Key points of 
materials and methods, further statistical analysis, and handle of the data are presented 
hereinafter. 
  
3.2.2.ExperimentalDesign
 
Thirty high-yielding multiparous Holstein dairy cows were blocked according to calving 
date and parity, and were allocated at random to two equal dietary treatment groups (HS 
and HF, 15 cows in each). Within dietary treatment groups, cows were selected on the 
basis of BCS, and divided into FAT and THIN cows. Cows with BCS at calving greater 
than 3.25 were the FAT group (19 cows in total; HS, 9 cows; HF, 10 cows ) and cows with 
BCS at calving equal or less than 3.25 were the THIN group (11 cows in total; HS, 6 cows; 
HF, 5 cows).  Prepartum, all cows were fed on the same diet. Blood samples were taken 
from each cow from 2
nd
 week until 17
th
 week postcalving. The data were obtained from 
this experiment were panel, longitudinal or cross-sectional data. Cows were the panels, and 
dietary (DIET) and condition (CONDITION) treatments were nested within week of 
experiment (WEEK).  Two diets were formulated to have equal concentrations of DM, ME 
and CP, but to differ in starch, fat and NDF concentrations (Table A.1 in appendix). Diet 
HS was expected to induce relatively high plasma insulin concentrations because of its 
higher starch and lower fat contents; Diet HF was expected to induce relatively low insulin 
concentrations because of its lower starch and higher fat contents. These diets were 
equivalent to the high and low insulin diets used by Gong et al. (2002), Fouladi-Nashta et 
al. (2005), and Garnsworthy et al. (2009). Milk progesterone was measured twice each 
week (either Monday and Thursday or Tuesday and Friday mornings) and a rise in 
progesterone was defined as above 3 ng/ml for two consecutive samples (Lamming & 
Darwash, 1998; Garnsworthy et al., 2009). 
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3.2.3.Feedingandmilking
 
Cows were housed as one group in a freestall barn throughout the experiment, and were 
fed individually via electronic feeders (Roughage Intake Control feeders, Fullwood Ltd, 
Ellesmere, UK) that recorded feed intake automatically. Cows were milked by an 
automatic (robotic) milking system (AMS; Merlin, Fullwood Ltd.), which they entered 
voluntarily and were milked on average 2.65±0.09 times per day. In order to encourage 
cows to use the AMS, 4 kg fresh weight of each cow’s daily concentrate allocation was 
dispensed automatically in the AMS during milking (Garnsworthy et al., 2009). 
 
3.2.4.Reproductivemanagement
 
Cows were artificially inseminated at the first or second oestrus. Insemination was 
repeated at any subsequent oestrus until the end of the experiment at 120 days post partum. 
Oestrus was detected using a combination of behavioural observations, pedometer activity 
monitoring and milk progesterone profiles. Milk progesterone was monitored daily from 4 
days before expected oestrus until signs of oestrus were detected; monitoring then returned 
to twice weekly until 4 days before the next expected oestrus (21 days later). Progesterone 
profiles were used subsequently to classify oestrous cycles as normal or abnormal (DOV1, 
DOV2, PCL1 or PCL2), following the definitions of Lamming & Darwash (1998) (Table 
A.2 in appendix). 
 
3.2.5.Recording,samplingandanalysis
 
Milk yield and feed intake were recorded daily throughout the experiment. Live weight and 
BCS (units; 1 to 5) were recorded weekly. Milk samples were taken twice each week and 
analyzed for progesterone by ELISA (Ridgeway Scientific, Alvington, UK). Feed samples 
were taken weekly and pooled on a monthly basis for analysis of DM, CP, NDF, starch, 
sugars, fat and ME, as detailed in Garnsworthy et al.  (2008b). Blood samples were taken 
every Wednesday at 09:30 h throughout of the sampling period for measurement of 
hormones and metabolites. Blood samples were analyzed for the following hormones: 
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insulin, GH, IGF1, glucagon, and leptin, as detailed in Garnsworthy et al.  (2009). Blood 
samples were analyzed for the following metabolites on a Bayer opera autoanalyzer (Bayer 
UK Ltd): urea-N, glucose, BOHB, and NEFA as detailed in Garnsworthy et al.  (2009). All 
instances of ill health and veterinary treatments were recorded. The ultimate fate of each 
cow (subsequent calving or culling) was recorded to allow calculation of calving interval. 
For cows that were pregnant when culled, subsequent calving date was estimated as date of 
successful insemination plus 282 days; cows that were not pregnant when culled were 
omitted from statistical analysis of calving interval (Garnsworthy et al., 2009).  
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3.3.STATISTICALANALYSIS
 
All data were analyzed using PASW
©
 18 Edition (SPSS Inc., Chicago, USA). Generalized 
Linear models (GLM) and Generalized Estimating Equations (GEE) were used to test the 
specific hypotheses (Lindsey, 1997; McCullagh & Nelder, 1989; Dobson, 2002; Horton & 
Lipsitz, 1999). Family distribution and link function were selected by running a null model 
including only the dependent variable and various combinations of family distribution and 
link function (Lindsey, 1997; McCullagh & Nelder, 1989; Dobson, 2002; Horton & 
Lipsitz, 1999). Models were compared in terms of values of Akaike's information criterion 
(AIC) criterion and the one with the lowest AIC value was chosen (Lindsey, 1997; 
McCullagh & Nelder, 1989; Dobson, 2002; Horton & Lipsitz, 1999). AIC is a statistical 
model fit index, defined as AIC= -2Lm + 2m where Lm is the maximized log-likelihood and 
m is the number of parameters in the model. Lower values of AIC indicate better fit of the 
model. 
 
The biological validity of each model was tested at the post-prediction level and the 
appropriate model was selected by using AIC and the quasi-likelihood under the 
independence model criterion (QIC) for choosing the best correlation structure. QIC is 
adaptation of AIC for repeated measures, where quasi log likelihood is used instead of log 
likelihood of AIC for better model fit. As with AIC, smaller values of QIC indicate better 
model fit (Dobson, 2002). Moreover, the GEE models were selected based on this simple 
principle; working correlation matrix (R matrix) must at least in part reflect the real 
correlation structure of the data (Horton & Lipsitz, 1999). 
 
Missing or incomplete data are inherent in studies where repeated measurements are 
obtained from animals (because of ill health, culling, and funding limitation (planned 
missing data) some animals are excluded from the study) (Little & Rubin, 1987; Allison, 
2001; Frees, 2004) and this was the greatest limitation of the present study. On the one 
hand, exclusion of missing data from analysis may result in inconsistent parameter 
estimates and possible loss of statistical power (considerable reduction of the sample and 
estimation of unacceptably large standard errors) (Frees, 2004). Alternatively, inclusion of 
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missing data in the analysis may lead to biased results (Allison, 2001). However, missing 
data in panel studies can be handled by the methods of maximum likelihood (ML), 
restricted maximum likelihood (REML), and multiple imputation estimation (MI) (Allison, 
2001; Schafer, 1997; Frees 2004). According to Allison (2001) ML estimation is proven to 
be an excellent method for handling panel missing data if the data are missing at random 
(MAR). According to Enders (2010) patterns of data missingness are not that important 
and ML is well suited for any type of missing data. ML was the method of choice to deal 
with the missing values in the present study. Common repeated measurements ANOVA 
(Albert, 1999; Davis, 2002) and Mixed Linear Models (Cnaan et al., 1997; Littell et al., 
1998; Littell, 2002; Wang & Goonewardene, 2004; Gueorguieva & Krystal, 2004), which 
are alternatives for panel data analysis, were not the preferred method for analyzing the 
data, mainly because the data were nonparametric and unbalanced. Generalized linear 
models (GLM), generalized estimating equations (GEE), and log-linear Poisson models 
utilize ML to calculate parameter estimates and were the choice for analyzing the data in 
the present study (McCullagh & Nelder, 1989; Lindsey, 1997; Dobson, 2002).  GEEs use 
quasi likelihood estimation and developed to extend the GLM to repeated measurements 
(Davis, 2002). GEE models were selected based on the principle that the working 
correlation (R matrix) must at least in part reflect the real correlation structure of the data 
(Dobson, 2002). Also, inclusion of robust estimator of covariance matrix in GEE models 
may provide more accurate parameter estimates (Zorn, 2000; Harden, 2011). Finally, GEE 
and GLM  do not assume normality, but allow the choice of error distribution and link 
function that better fit the data, leading possibly to more efficient parameter estimates 
(McCullagh & Nelder, 1989; Lindsey, 1997). 
  
Models selected to test the effects of BCS at calving (CONDITION) and diet on 
reproductive and production traits and hormonal and metabolic profile are described in 
Tables 3.1 to 3.3. 
 
Milk progesterone profile variable (Normal; 16 cows, DOV1; 3 cows, DOV2; 5 cows, 
PCL2; 5 cows, and PCL1; 1 cow) was transformed to a binominal variable with two levels 
(NORMAL; 16 cows and ABNORMAL; 14 cows); pregnancy rate is a binomial variable 
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with two categories (PREGNANT; 8 cows and NON PREGNANT; 22 cows). Milk 
progesterone profile and pregnancy rate were used as binomial response variables in 
Generalized linear models to ascertain if BCS at calving and diet affected them (Table 3.1). 
 
The output of generalized logistic regression and common logistic regression models are 
presented as probabilities, unstandardized beta (b) coefficients, and odds ratio (exp (b)) 
with 95% confidence intervals (Peng et al., 2002). In common logistic regression models, 
Hosmer & Lemeshow goodness of fit test and Likelihood Ratio test (LR) were carried out. 
The LR test compared the selected model with the null model (a model which included 
only the intercept) and significant P values (P<0.05) indicated the superiority of the 
selected model. The Hosmer & Lemeshow test was used to examine the fitness of selected 
models to the actual data and non-significant P values (P>0.05) indicated better fit of the 
model (Agresti, 1996; Hosmer & Lemeshow, 2000). 
 
Receiver Operating Characteristic (ROC) analysis was conducted to evaluate the 
performance and the accuracy of logistic regression models (Hand, 2010; Zou et al., 2007). 
ROC curve is the plot of model sensitivity (true positive) versus model 1-specificity 
(=false positive) (Liu & Li, 2005). Area under the ROC curve (AUCROC), which is an 
overall statistic summary of model accuracy and ranges from zero to one, was calculated. 
AUCROC equals 0.5 when the ROC curve corresponds to random chance and 1 for perfect 
accuracy (Zou et al., 2007). According to Hosmer & Lemeshow (2000) AUCROC=0.5 
corresponds to a model with bad performance and accuracy, whereas 0.7 < AUCROC < 0.8, 
0.8 < AUCROC < 0.9, and AUCROC  0.9 are considered as acceptable, excellent, and 
outstanding performance and accuracy of the model, respectively. AUCROC is presented as 
mean± SE. 
 
Non-random associations between two categorical variables in 2X2 contingency tables 
(e.g. BCS at calving X Diet) were tested by Fishers exact test. P value equal or less than 
0.05 (P0.05) indicated statistically significant association between the two categorical 
variables. 
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The effect of BCS at calving and diet on time from calving to pregnancy was examined by 
survival analysis (Klein & Moeschberger, 2005; Selvin, 2008). Cows not pregnant at the 
end of the experiment were censored at 120 days postpartum and KaplanMeier estimates 
of the survivor function were compared for FAT and THIN cows, and cows fed high starch 
(HS) and high fat (HF) diets by using Log-rank test (Landau & Everitt, 2004; Jenkins, 
2005; Guo, 2010). The models selected for survival analysis are described in Table 3.4. 
 
Parameter estimates of GEE models are presented as marginal means plus/minus standard 
error of the difference (SED) in tables. Estimated marginal means, SEs and SEDs were 
obtained by using Least Significant Difference (LSD) adjustment for multiple comparisons 
in PASW
©
 18 statistical program. P values were calculated by Newton-Raphson Maximum 
Likelihood (ML) method and effects were considered statistically significant when P value 
was less than 0.05 (P<0.05). 


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Table3.1:Selectedmodelsforanalysisofreproductivetraits
REPRODUCTIVETRAIT
(RESPONSEVARIABLE:Y)
TYPEOF
MODEL
PREDICTORS
(X)
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX STATISTICS
”MilkP4Profile(binomial
variablewithtwolevels;
0=Normal
1=Abnormal)
Multiple
Logistic
regression
”CONDITION
”DIET
Insulin
IGF ?I
Glucose
Parity

Bernoulli
(Binomial) Logit Robust
n=29;AIC=35;LR( Ȥ2 =13.79, 
df=6, P=0.032)
”MilkP4Profile(binomial
variablewithtwolevels;
0=Normal
1=Abnormal)
GLM ”CONDITION”DIET PARITY
Bernoulli
(Binomial) Logit Robust
n=30;AIC=36;LR(ʖ2=10,
df=3,P=0.018)
”Pregnancy(binomial
variablewithtwolevels;0=
nonpregnant
1=pregnant)
GLM ”CONDITION”DIET PARITY
Bernoulli
(Binomial) Logit Robust

n=30;AIC=35;LR(ʖ2=6.2,
df=2,P=0.045)

”Pregnancy(binomial
variablewithtwolevels;0=
nonpregnant
1=pregnant)
GLM ”MILKP4
PROFILE  ?
Bernoulli
(Binomial)

Logit Robust

n=30;AIC=33;LR(ʖ2=3.89,df=1,
P=0.048)

”Pregnancy(binomial
variablewithtwolevels;0=
nonpregnant
1=pregnant)
Multiple
Logistic
regression
”CONDITION
”DIET
Insulin
PARITY
Bernoulli
(Binomial) Logit Robust
n=30;AIC=33;LR(ʖ2=16.56,
df=4,P=0.002)
”DaystoOestrus GLM ”CONDITION”DIET PARITY Poisson Log ModelBased
n=28;AIC=267;LR(ʖ2=4,df=3,
P=0.26)

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Table3.2:Selectedmodelsforanalysisofplasmametabolichormonesandmetabolites
Hormone
(RESPONSE
VARIABLE:Y)
TYPEOF
MODEL
PREDICTORS
(X)
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX
WORKING
CORRELATION
MATRIX
STATISTICS
”Insulin
”Leptin
”IGF ?I
”Glucagon
GEE
”CONDITION
”DIET
”WEEK
PARITY Gaussian
(Normal) Identity(ID) Robust Exchangeable
n=427;QIC=66
n=424;QIC=395
n=224;QIC=424,623
n=234;QIC=116,230
  
”GH GEE
”CONDITION
”DIET
”WEEK
PARITY InverseGaussian Log Robust Exchangeable n=222;QIC=67
”Glucose
”Urea

GEE
”CONDITION
”DIET
”WEEK
PARITY Gaussian
(Normal) Identity(ID) Robust Exchangeable
n=225;QIC=100
n=231;QIC=131

”BOHB
”NEFA GEE
”CONDITION
”DIET
”WEEK
PARITY InverseGaussian Log Robust Exchangeable
n=233;QIC=134
n=233;QIC=204

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Table3.3:Selectedmodelsforanalysisofproductiontraits
PRODUCTIVE
TRAIT
(RESPONSE
VARIABLE:Y)
TYPEOF
MODEL
PREDICTORS
(X)
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX
WORKING
CORRELATION
MATRIX
STATISTICS
”DMI
”MilkYield
”LWT
”BCS
GEE
”CONDITION
”DIET
”WEEK
PARITY Gaussian
(Normal) Identity(ID) Robust Exchangeable
n=460;QIC=4,306
n=460;QIC=29,954
n=460;QIC=271,156
n=473;QIC=135
      
”NadirBCS
”NadirWeek
”ȴBCS
GLM ”CONDITION”DIET PARITY
Gaussian
(Normal) Identity(ID) Robust  ? ?
n=30;AIC=24;LR(ʖ2=6.4,df=3,P=0.09)
n=30;AIC=24;LR(ʖ2=10.2,df=3,P=0.017)
n=30;AIC=42;LR(ʖ2=12,df=3,P=0.01)

Table3.4:Selectedmodelsforsurvivalanalysis(KaplanǦMeiermodels)ofintervalfromcalvingtoconception
TIME
VARIABLE
(Survivaltime)
TYPEOF
MODEL
STATUS
VARIABLE(Event
variable)
FACTORS
(Groupvariables)
SURVIVAL
FUNCTIONS
COMPARISONTEST
OBSERVATIONS RIGHTCENSORED
OBSERVATIONS
UNCENSORED
OBSERVATIONS
Dayspost
partum
(0 ?120)
Kaplan ?
Meier
Pregnancy
(binomialvariable
withtwolevels;
0=nonpregnant
1=event=pregnant)
”CONDITION
”DIET

Log ?Rank
(Mantel ?Cox) 30 22 8

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3.4.RESULTS


3.4.1.ConsistencyofBCSatcalvingtretments
 
There was no association between BCS at calving and diet, and thus the retrospective 
classification of cows as FAT and THIN was not biased by the original dietary treatments 
(Fishers exact test, n=30, P=1.0, twosided)(Table 3.5). 
 
 
3.4.2.Effectofmilkprogesteroneprofileonpregnancyrate
 
Cows with NORMAL milk progesterone profile had higher probability to be pregnant 
(44% versus 7%, AUCROC=0.74±0.08) than cows with ABNORMAL milk progesterone 
profile (P<0.05) (Table 3.6). 
 
 
3.4.3.EffectsofBCSatcalvinganddietonreproductiveperformance 
 
THIN cows at calving had higher probability to be pregnant (52% versus 14%, 
AUCROC=0.79±0.09) than FAT cows at calving (P<0.05) (Table 3.7). THIN cows at 
calving had lower probability to express ABNORMAL milk progesterone profile (18% 
versus 62%, AUCROC=0.85±0.07) than FAT cows at calving (P<0.05) (Table 3.7). There 
was no effect of diet on probability of cows to be pregnant within 120 days postpartum 
(Table 3.9). Cows fed the HS diet had higher probability to express ABNORMAL milk 
progesterone profile (65% versus 29%, AUCROC=0.85±0.07) than cows fed the HF diet 
(P<0.05) (Table 3.8). There was no effect of BCS at calving and diet on days to first 
oestrus (Table 3.9). Survival analysis showed that FAT cows had a shorter interval from 
calving to conception than THIN cows, but FAT cows had a lower probability to be 
pregnant within 120 days postpartum than THIN cows (P<0.05) (Figure 3.1). However, 
survival analysis demonstrated that there was no effect of diet on probability of cows to be 
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pregnant within 120 days postpartum and cows fed the HS diet did not have significantly 
different interval from calving to conception compared to cows fed the HS diet (Figure 
3.2). 
 
 
3.4.4.EffectsofBCSatcalvinganddietoncirculatingmetabolichormones
 
THIN cows at calving had higher circulating IGF-I (147.5±10.12 ng/ml versus 104.9±9.30 
ng/ml) than FAT cows at calving (P<0.05) (Table 3.10). There was no effect of BCS at 
calving on circulating insulin, leptin, glucagon, and GH (Table 3.10). Cows fed the HS diet 
had higher circulating insulin (0.49±0.03 ng/ml versus 0.41±0.03 ng/ml) than cows fed the 
HF diet (P<0.05) (Table 3.11). There was no effect of diet on circulating IGF-I, leptin, 
glucagon, and GH (Table 3.11). 
 
 
3.4.5.EffectsofBCSatcalvinganddietoncirculatingmetabolites
 
THIN cows at calving had lower circulating NEFA (0.32±0.03 mmol/l versus 0.41±0.03 
mmol/l) than FAT cows at calving (P<0.05) (Table 3.12). There was no effect of BCS at 
calving on circulating glucose, BOHB, and urea (Table 3.12). Cows fed the HS diet had 
higher circulating urea (2.83±0.14 mmol/l versus 2.32±0.14 mmol/l) than cows fed the HF 
diet (P<0.05) (Table 3.13). Circulating BOHB was lower (P<0.05) for cows fed the HS 
diet (0.485±0.040 mmol/l) than for cows fed the HF diet (0.650±0.040 mmol/l) (Table 
3.13). There was no effect of diet on circulating glucose and NEFA (Table 3.13). 
 
 
3.4.6.EffectsofBCSatcalvinganddietonproductiontraits
 
THIN cows at calving had lower milk yield (40.5±2.5 kg/d versus 47.7±1.6 kg/d) than FAT 
cows at calving (P<0.05) (Table 3.15). There was no effect of BCS at calving on LWT and 
DMI (Table 3.14). THIN cows at calving had lower BCS (2.36±0.06 units versus 
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2.66±0.08 units), ǻBCS (0.47±0.11 units versus 0.82±0.09 units) and nadir BCS 
(2.02±0.06 units versus 2.30±0.09 units), and shorter nadir week (4.5±0.8 weeks versus 
6.5±0.8 weeks) than FAT cows at calving (P<0.05) (Table 3.14). 
 
There was no effect of diet on LWT, DMI, milk yield, BCS, ǻBCS, nadir week, and nadir 
BCS (Table 3.15). 


3.4.7.Effectofinsulinonpregnancyrate
 
Multiple logistic regression analysis examined the effects of insulin, BCS at calving, diet, 
and parity on pregnancy rate. Insulin had a strong negative effect (OR=1.11*10
-07
~0, 95% 
CI for OR (0, 0.03), b=-16.01) on the odds of cows to be pregnant (P=0.012), holding the 
other predictors of the model at a fixed value. Dietary treatments (OR=0.73, 95% CI for 
OR (0.10, 5.33), b=-0.31) had no effect on the odds of cows to be pregnant (P=0.76). BCS 
at calving (categorical variable with two levels; 0=FAT, 1=THIN) (OR=52.32, 95% CI for 
OR (5.79, 472.38), b=3.96, P=0.001) and parity (OR=0.21, 95% CI for OR (0.05, 0.85), 
b=-1.54, P=0.03) had a negative effect on the odds of cows to be pregnant, holding the 
other predictors of the model at a fixed value (Table 3.16). 
 
The output of this model was expressed as probability of cows to be pregnant. The 
negative association of circulating insulin concentrations with the probability of cows to be 
pregnant is illustrated in Figure 3.3. This graph presents that the optimum insulin 
concentration that maximized the probability of cows to be pregnant ranged from 0.2 to 0.3 
ng/ml, whereas insulin greater than 0.6 ng/ml tended to zero the probability of cows to be 
pregnant.  Probability of cows to be pregnant was adjusted for different condition status at 
calving (FAT versus THIN), dietary treatments (HS versus HF), and circulating insulin 
concentrations (Figure 3.4, Figure 3.5, and Figure 3.6). According to Figure 3.4, THIN 
cows at calving had higher probability to be pregnant than FAT cows at calving (P<0.05), 
when insulin ranged from 0.3 to 0.6 ng/ml. Moreover, there was no effect of diet on 
probability of cows to be pregnant (P>0.05), when the animals had approximately the same 
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insulin concentration and insulin concentration ranged from 0.1 to 1.2 ng/ml (Figure 3.5). 
Also, there was no effect of (BCS at calving*diet) on probability of cows to be pregnant 
(P>0.05) (Figure 3.6). 
 
 
3.4.8.Effectsofinsulin,IGFǦI,glucose,andparityonmilkprogesteroneprofile
 
Multiple logistic regression analysis examined the effects of insulin, IGF-I, glucose, and 
parity on milk progesterone profile. Each exponentiated coefficient in this model is the 
change in odds for a unit increase in the corresponding predictor variable holding other 
variables at certain value. Odds ratio (OR) for insulin was very high and that means strong 
positive effect of insulin on the odds for cows to express abnormal milk progesterone 
profile (P<0.05) (Table 3.17). OR for circulating glucose was very low and that means 
strong negative effect of circulating glucose on the odds for cows to express abnormal milk 
progesterone profile (P<0.05) (Table 3.5). OR for parity was 8.59 (P<0.05) (Table 3.17). 
So holding insulin, IGF-I, BCS at calving, diet, and glucose at a fixed value, an increase of 
parity by 1 will increase the odds for cows to express atypical milk progesterone profile by 
759 %. IGF-I (OR=0.97) also tended to have negative influence on the odds for cows to 
express abnormal milk progesterone profile (P 0.1), holding the other predictors of the 
model at a fixed value (Table 3.17). 
  
The output of this model was expressed as probability for cows to express abnormal milk 
progesterone profile. The positive association of circulating insulin concentrations with the 
probability for cows to express abnormal milk progesterone profile is illustrated in Figure 
3.7. This graph presents that the optimum insulin concentration that minimized the 
probability for cows to express abnormal milk progesterone profile ranged from 0.1 to 0.3 
ng/ml, whereas insulin greater than 0.5 to 0.6 ng/ml tended to maximize the probability for 
cows to express abnormal milk progesterone profile. Probability for cows to express 
atypical milk progesterone profile was adjusted for different condition status at calving 
(FAT versus THIN), dietary treatments (HS versus HF), and circulating insulin 
concentrations (Figure 3.8, Figure 3.9, and Figure 3.10). According to Figure 3.8, THIN 
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cows at calving had lower probability to to express abnormal milk progesterone profile 
than FAT cows at calving (P<0.05), when the animals had approximately the same insulin 
concentration and insulin concentration ranged from 0.4 to 0.9 ng/ml. Moreover, there was 
no effect of diet on probability for cows to express abnormal milk progesterone profile 
(P>0.05), when the animals had approximately the same insulin concentration and insulin 
concentration ranged from 0.1 to 1.2 ng/ml (Figure 3.9). However, THIN cows at calving 
that fed the HF diet had lower probability  to express abnormal milk progesterone profile 
than THIN cows at calving that fed the HS diet (P<0.05), when the animals had 
approximately the same insulin concentration and insulin concentration ranged from 0.1 to 
0.6 ng/ml. (Figure 3.10). In addition, THIN cows at calving that fed the HF diet had lower 
probability  to express abnormal milk progesterone profile than THIN cows at calving that 
fed the HS diet (P<0.05), when  insulin concentration ranged from 0.1 to 0.3 ng/ml. 
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Table 3.5: Crosstabulation of BCS at calving with diet. Association between BCS at calving and diet was tested by 
performing Fishers exact test (n= 30, P= 1.0, twosided).  There was no association between BCS at calving and diet. 
BCS at calving 
Diet FAT THIN Total 
HS 9 6 15 
HF 10 5 15 
Total 19 11 30 
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Table3.6:Effectofmilkprogesteroneprofileonprobabilitycowstobepregnant
 
Treatment: MILK PROGESTERONE PROFILE 
 
Parameters: NORMAL

 n1 

 ABNORMAL

 n2
 
 P 
Probability for cows to be pregnant  0.44 (0.22, 0.68) 15 0.07 (0, 0.20) 15 0.049 
 Columns are means with 95 % Confidence Interval (CI). 
  n1 and n2 are the numbers of animals expressed NORNAL and ABNORMAL milk progesterone profile, respectively. 
 
Table3.7:EffectofBCSatcalving(CONDITION)onprobabilityofcowstobepregnantandtoexpressabnormalmilk
progesteroneprofiles
 
Treatment: CONDITION 
 
Parameters: FAT

 n1 

 THIN

 n2  

 P 
Probability for cows to be pregnant  0.14 (0, 0.20) 15 0.52 (0.24, 0.81) 15 0.017 
Probability for cows to express 
abnormal milk progesterone profile  
0.62 (0.43, 0.80) 15 0.18 (0, 0.38) 15 0.02 
 Columns are means with 95 % Confidence Interval (CI). 
  n1 and n2 are the numbers of animals assessed FAT and THIN at calving, respectively. 
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Figure 3.2: Calving-to-conception survival analysis curves for FAT and THIN cows at calving. The survival curve for THIN cows is
higher than the curve for FAT cows (n=30, Log-rank test P=0.022). Vertical drop in the survival curves indicates an event (a cow became
pregnant). FAT cows at calving had a shorter interval from calving to conception (55±4.9 days postpartum versus 88±15.3 days postpartum)
than THIN cows at calving. 
1
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Figure 3.2: Calving-to-conception survival analysis curves for cows fed the high starch (HS) and the high fat (HF) diet. There are no
differences in the survival curves for cows fed with HS and HF diet (n=30, Log-rank test P=0.40). Vertical drop in the survival curves indicates
an event (a cow became pregnant). Cows fed the HS diet did not have significantly different interval from calving to conception (74±16.5 days
postpartum versus 59±7.5 days postpartum) compared to cows fed the HS diet. 
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Table3.9:EffectofdietandBCSatcalving(CONDITION)ondaystofirstoestrus
 
Treatments: DIET CONDITION 
Parameters: HS

 n1 

 HF

 n2 

 P FAT

 n3 
‡ THIN

 n4 
‡ P 
           
Days to first 
oestrus 
(days 
postpartum) 
58.2 (50.2, 66.2) 13 51.2 (44.5, 57.9) 15 0. 19 53.3 (46.7, 59.9) 13 56.1 (47.6, 64.7) 15 0.26 
 Columns are means with 95 % Confidence Interval (CI). 
   n1 and n2 are the numbers of animals fed with HS and HF diets, respectively. 
‡  n3 and n4 are the numbers of animals assessed FAT and THIN at calving, respectively. 
Table3.8:Effectofdietonprobabilityofcowstobepregnantandtoexpressabnormalmilkprogesteroneprofiles
 
Treatment: DIET 
 
Parameters: HS

 n1 

 HF

 n2 

 P 
Probability for cows to be pregnant  0.23  (0.07, 0.40) 15 0.31  (0.08, 0.53) 15 0.59 
Probability for cows to express 
abnormal milk progesterone profile  
0.65 (0.47, 0.86) 15 0.27 (0.09, 0.45) 15 0.03 
 Columns are means with 95 % Confidence Interval (CI). 
 n1 and n2 are the numbers of animals fed with HS and HF diets, respectively. 
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Table3.10:EffectofBCSatcalving(CONDITION)oncirculatinginsulin,glucagon,GH,IGFǦI,andleptin
    
Treatment: CONDITION 
  
Parameters: FAT

 n1 

 THIN

 n2 

 SED‡ P 
Insulin 
(ng/ml) 
0.43 274 0.47 153 0.040 0.19 
Glucagon 
(pg/ml) 
93.4 151 95.3 83 5.97 0.75 
GH 
(ng/ml) 
4.40 141 4.27 81 0.670 0.84 
IGF-I 
(ng/ml) 
104.9 142 147.5 82 9.75 0.03 
Leptin 
(ng/ml) 
1.72 272 1.41 15 0.298 0.30 
 Columns are means.  
  n1 and n2 are the repeated observations of animals assessed FAT and THIN at calving, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.11:Effectofdietoncirculatinginsulin,glucagon,GH,IGFǦI,andleptin
    
Treatment: DIET 
  
Parameters: HS

 n1 

 HF

 n2 

 SED‡ P 
Insulin 
(ng/ml) 
0.49 211 0.41 216 0.034 0.02 
Glucagon 
(pg/ml) 
99.5 116 89.6 118 5.28 0.06 
GH 
(ng/ml) 
4.54 106 4.15 116 0.650 0.54 
IGF-I 
(ng/ml) 
132.0 105 122.7 119 13.16 0.48 
Leptin 
(ng/ml) 
1.73 208 1.43 216 0.312 0.35 
 Columns are means.  
  n1 and n2 are the repeated observations of animals fed with HS and HF diets, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.12:EffectofBCSatcalving(CONDITION)oncirculatingglucose,urea,ȾǦhydroxybutyrate(BOHB),andnonǦ
esterifiedfattyacids(NEFA).
    
Treatment: CONDITION 
  
Parameters: FAT

 n1 

 THIN

 n2 

 SED‡ P 
Glucose 
(mmol/l) 
3.65 138 3.55 87 0.142 0.44 
Urea 
(mmol/l) 
2.66 145 2.49 86 0.160 0.29 
BOHB 
(mmol/l) 
0.580 146 0.583 87 0.0383 0.92 
NEFA 
(mmol/l) 
0.41 146 0.32 87 0.032 0.021 
 Columns are means.  
  n1 and n2 are the repeated observations of animals assessed FAT and THIN at calving, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.13:Effectofdietoncirculatingglucose,urea,ȾǦhydroxybutyrate(BOHB),andnonǦesterifiedfattyacids
(NEFA).
    
Treatment: DIET 
  
Parameters: HS

 n1 

 HF

 n2 

 SED

 P  
Glucose 
(mmol/l) 
3.60 115 3.61 110 0.114 0.92 
Urea 
(mmol/l) 
2.83 114 2.32 117 0.146 0.01 
BOHB 
(mmol/l) 
0.485 115 0.650 118 0.0404 0.01 
NEFA 
(mmol/l) 
0.306 115 0.309 118 0.0262 0.90 
 Columns are means.  
  n1 and n2 are the repeated observations of animals fed with HS and HF diets, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.14:EffectofBCSatcalving(CONDITION)ondrymatterintake(DMI),liveweight(LWT),milkyield,BCS,
nadirBCS,nadirweek,andpostpartumbodyconditionloss(ȟBCS)
    
Treatment: CONDITION 
  
Parameters: FAT

 n1 

 THIN

 n2 

 SED

 P 
DMI 
(kg/d) 
22.52 294 21.12 166 1.401 0.18 
Milk Yield 
(kg/d) 
47.7 294 40.5 166 2.06 0.02 
LWT 
(kg) 
658 294 664 166 7.1 0.41 
BCS 
(units 1-5) 
2.66 304 2.36 169 0.069 0.003 
Nadir BCS 
(units 1-5) 
2.30 15 2.02 15 0.076 0.017 
Nadir Week 
(weeks) 
6.5 15 4.5 15 0.59 0.024 
ǻBCS 
(units 1-5) 
0.82 15 0.47 15 0.103 0.025 
 Columns are means.  
  n1 and n2 are the observations of animals assessed FAT and THIN at calving, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.15:Effectofdietondrymatterintake(DMI),liveweight(LWT),milkyield,BCS,nadirBCS,nadirweek,and
postpartumbodyconditionloss(ȟBCS)
    
Treatment: DIET 
  
Parameters: HS

 n1 

 HF

 n2 

 SED

 P 
DMI 
(kg/d) 
21.50 228 22.15 232 0.957 0.50 
Milk Yield 
(kg/d) 
45.4 228 42.8 232 2.56 0.31 
LWT 
(kg) 
658 228 664 232 7.2 0.37 
BCS 
(units 1-5) 
2.44 240 2.58 233 0.099 0.17 
Nadir BCS 
(units 1-5) 
2.11 15 2.27 15 0.084 0.19 
Nadir Week 
(weeks) 
4.9 15 6.6 15 0.74 0.12 
ǻBCS 
(units 1-5) 
0.76 15 0.63 15 0.112 0.43 
 Columns are means.  
  n1 and n2 are the observations of animals fed with HS and HF diets, respectively. 
 SED = standard error of the difference between treatment means. 
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Table3.16:Effectsofinsulin,parity,BCSatcalving,anddieton probability of cows to be pregnant
  95% CI for exp (b)   
Parameters in the model: exp (b)

 Lower Upper 
Beta (b) 
coefficient 
P  
Constant    8.13 0.01 
Insulin 0 0 0.03 -16.01 0.01 
Parity 0.21 0.05 0.85 -1.54 0.03 
BCS at calving 

 52.32 5.79 472.38 3.96 0.001 
Diet - 0.73 0.10 5.34 -0.31 0.76 
Likelihood ratio test (  Ȥ2=16.56, df=4, P=0.002);  Hosmer & Lemeshow test for fitness (  Ȥ2=5.97, df=8, P=0.65);   AUCROC=0.85±0.08 
 exp (b) is the odds ratio  BCS at calving  is a  variable with two levels; 0= FAT and 1= THIN 
- Diet  is a  variable with two levels; 0= HS and 1= HF 
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Figure 3.3: Effect of circulating insulin on probability of cows to be pregnant (n= 30, P=0.01, AUCROC=0.85±0.08, LR (Ȥ2=16.56, df=4, 
P=0.002), Hosmer & Lemeshow test for fitness (Ȥ2=5.97, df=8, P=0.65), multiple logistic regression model with Bernoulli error distribution, 
logit link function, and robust standard error estimation). In this model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) 
whereas insulin and parity were added as continuous covariates, and BCS at calving and diet as factors. Red solid line represents the estimated 
probability whereas blue and purple dashed lines show the upper and lower 95 % Confidence Interval (CI). Optimum insulin concentration that 
maximized the probability of cows to be pregnant ranged from 0.2 to 0.3 ng/ml, whereas insulin greater than 0.6 ng/ml tended to zero the 
probability of cows to be pregnant. Model parameter estimates are presented in Table 3.16.  
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Figure 3.4: Probability of cows to be pregnant adjusted for different condition status at calving (FAT versus THIN) and circulating 
insulin concentrations (n= 30, P=0.01, AUCROC=0.85±0.08, LR (Ȥ2=16.56, df=4, P=0.002), Hosmer & Lemeshow test for fitness (Ȥ2=5.97, 
df=8, P=0.65), multiple logistic regression model with Bernoulli error distribution, logit link function, and robust standard error estimation). In 
this model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) whereas insulin and parity were added as continuous covariates, 
and BCS at calving and diet as factors. Red triangles (r) represent marginal means ± SE for THIN cows at calving, whereas purple dots (”) 
are marginal means ± SE for FAT cows at calving. THIN cows at calving had higher probability to be pregnant than FAT cows at calving
(P<0.05), when the animals had approximately the same insulin concentration and insulin concentration ranged from 0.3 to 0.6 ng/ml. Model 
parameter estimates are presented in Table 3.16.
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Figure 3.5: Probability of cows to be pregnant adjusted for different dietary treatments (HS versus HF) and circulating insulin
concentrations (n= 30, P=0.76, AUCROC=0.85±0.08, LR (Ȥ2=16.56, df=4, P=0.002), Hosmer & Lemeshow test for fitness (Ȥ2=5.97, df=8,
P=0.65), multiple logistic regression model with Bernoulli error distribution, logit link function, and robust standard error estimation). In this
model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) whereas insulin and parity were added as continuous covariates, and
BCS at calving and diet as factors. Purple triangles (r) represent marginal means ± SE for cows fed the HF diet, whereas red rectangles (̈) are
marginal means ± SE for cows fed the HS diet. There is no effect of diet on probability of cows to be pregnant (P>0.05), when the animals had
approximately the same insulin concentration and insulin concentration ranged from 0.1 to 1.2 ng/ml. Model parameter estimates are presented
in Table 3.16.
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Figure 3.6: Probability of cows to be pregnant adjusted for different condition status at calving (FAT versus THIN), diets (HS versus
HF), and circulating insulin concentrations (n= 30, P=0.76, AUCROC=0.85±0.08, LR (Ȥ2=16.56, df=4, P=0.002), Hosmer & Lemeshow test 
for fitness (Ȥ2=5.97, df=8, P=0.65), multiple logistic regression model with Bernoulli error distribution, logit link function, and robust standard 
error estimation). In this model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) whereas insulin and parity were added as 
continuous covariates, and BCS at calving, diet, and interaction (BCS at calving*diet) as factors. Red diamonds (Æ) are marginal means ± SE 
for THIN cows fed the HS diet. Blue dots (”) are marginal means ± SE for FAT cows fed the HS diet. Green triangles (r) represent marginal 
means ± SE for FAT cows fed the HF diet. Purple rectangles (̈) are marginal means ± SE for THIN cows fed the HS diet. There was no effect 
of (BCS at calving*diet) on probability of cows to be pregnant (P>0.05).  
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Table3.17:Effectsofinsulin,IGFǦI,glucose,parity,BCSatcalving,anddietonmilkprogesteroneprofile
  95% CI for exp (b)   
Parameters in the model: exp (b)

 Lower Upper 
Beta (b) 
coefficient 
P  
Constant    13.67 0.057 
Insulin 30,517 1.30 ~+(1.04*109) 10.32 0.044 
IGF-I 0.97 0.937 1.004 -0.03 0.087 
Glucose 0.007 0.0001 0.311 -5.02 0.011 
Parity 8.59 1.49 49.44 2.15 0.016 
BCS at calving 

 0.014 0.0007 0.284 -4.23 0.005 
Diet - 0.079 0.004 1.778 -2.53 0.110 
Likelihood ratio test ( Ȥ2 =13.79, df=6, P=0.032);  Hosmer & Lemeshow test for fitness ( Ȥ2=3, df=8, P =0.934);  AUCROC=0.91±0.05 
 exp (b) is the odds ratio  BCS at calving  is a  variable with two levels; 0= FAT, 1= THIN 
- Diet  is a  variable with two levels; 0= HS, 1= HF 
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Figure 3.7: Effect of circulating insulin on probability for cows to express abnormal milk progesterone profile (n=30, P=0.044,
AUCROC=0.91±0.05, LR (Ȥ2 =13.79, df=6, P=0.032), Hosmer & Lemeshow test for fitness (Ȥ2=3, df=8, P =0.934), multiple logistic regression 
model with Bernoulli error distribution, logit link function, and robust standard error estimation). In this model, dependent variable was milk 
progesterone profile (0= normal, 1= abnormal) whereas insulin, IGF-I, glucose, and parity were added as covariates, and BCS at calving and 
diet as factors. Red solid line represents the estimated probability whereas blue and purple dashed lines show the upper and lower 95 %
Confidence Interval (CI). Optimum insulin concentration that minimized the probability for cows to express abnormal milk progesterone
profile ranged from 0.1 to 0.3 ng/ml, whereas insulin greater than 0.5 to 0.6 ng/ml tended to maximize the probability for cows to express 
abnormal milk progesterone profile. Model parameter estimates are presented in Table 3.17. 
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Figure 3.8: Probability for cows to express abnormal milk progesterone profile adjusted for different condition status at calving (FAT
versus THIN) and circulating insulin concentrations (n=30, P=0.014, AUCROC=0.91±0.05, LR (Ȥ2 =13.79, df=6, P=0.032), Hosmer & 
Lemeshow test for fitness (Ȥ2=3, df=8, P =0.934), multiple logistic regression model with Bernoulli error distribution, logit link function, and 
robust standard error estimation). In this model, dependent variable was milk progesterone profile (0= normal, 1= abnormal) whereas insulin, 
IGF-I, glucose, and parity were added as covariates, and BCS at calving and diet as factors. Green triangles (r) represent marginal means ± SE 
for THIN cows at calving, whereas red dots (”) are marginal means ± SE for FAT cows at calving. THIN cows at calving had lower 
probability  to express abnormal milk progesterone profile than FAT cows at calving (P<0.05), when the animals had approximately the same 
insulin concentration and insulin concentration ranged from 0.4 to 0.9 ng/ml. Model parameter estimates are presented in Table 3.17. 
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Figure 3.9: Probability for cows to express abnormal milk progesterone profile adjusted for different dietary treatments (HS versus
HF) and circulating insulin concentrations (n=30, AUCROC=0.91±0.05, LR (Ȥ2 =13.79, df=6, P=0.032), Hosmer & Lemeshow test for fitness
(Ȥ2=3, df=8, P =0.934), multiple logistic regression model with Bernoulli error distribution, logit link function, and robust standard error 
estimation). In this model, dependent variable was milk progesterone profile (0= normal, 1= abnormal) whereas insulin, IGF-I, glucose, and 
parity were added as covariates, and BCS at calving and diet as factors. Purple triangles (r) represent marginal means ± SE for cows fed the 
HF diet, whereas red rectangles (̈) are marginal means ± SE for cows fed the HS diet. There is no effect of diet on probability for cows to 
express abnormal milk progesterone profile (P>0.05), when the animals had approximately the same insulin concentration and insulin 
concentration ranged from 0.1 to 1.2 ng/ml. Model parameter estimates are presented in Table 3.17.
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Figure 3.10: Probability for cows to express abnormal milk progesterone profile adjusted for different condition status at calving (FAT
versus THIN), diets (HS versus HF), and circulating insulin concentrations (n=30, AUCROC=0.91±0.05, LR (Ȥ2 =13.79, df=6, P=0.032), 
Hosmer & Lemeshow test for fitness (Ȥ2=3, df=8, P =0.934), multiple logistic regression model with Bernoulli error distribution, logit link 
function, and robust standard error estimation). In this model, dependent variable was milk progesterone profile (0= normal, 1= abnormal) 
whereas insulin, IGF-I, glucose, and parity were added as covariates, and BCS at calving, diet, and interaction (BCS at calving*diet) as factors.
Red diamonds (Æ) are marginal means ± SE for THIN cows fed the HS diet. Blue dots (”) are marginal means ± SE for FAT cows fed the HS 
diet. Green triangles (r) represent marginal means ± SE for FAT cows fed the HF diet. Purple rectangles (̈) are marginal means ± SE for 
THIN cows fed the HS diet. THIN cows at calving that fed the HF diet had lower probability  to express abnormal milk progesterone profile
than THIN cows at calving that fed the HS diet (P<0.05), when the animals had approximately the same insulin concentration and insulin 
concentration ranged from 0.1 to 0.6 ng/ml. Moreover, THIN cows at calving that fed the HF diet had lower probability to express abnormal 
milk progesterone profile than THIN cows at calving that fed the HS diet (P<0.05), when  insulin concentration ranged from 0.1 to 0.3 ng/ml. 
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3.5.DISCUSSION
 
3.5.1.EffectofBCSatcalvingoncirculatingmetabolichormones,metabolites,
andreproductivetraitsindairycows

The present study utilized data generated by the study of Garnsworthy et al. (2009). 
Because the animals retrospectively allocated to BCS at calving groups, analysis 
performed to assess the consistency of BCS at calving treatments. This analysis clearly 
demonstrated that the retrospective classification of cows as FAT and THIN was not 
biased by the original dietary treatments (Table 3.5). 

The present study showed that there was no effect of BCS at calving on days to first 
oestrus. In agreement with this result, Pedron et al. (1993), Ruegg et al. (1992b), and 
Ruegg & Milton (1995) did not find any influence of BCS at calving on days to first 
oestrus in dairy cows. Grainger et al. (1982) found that increasing BCS at calving resulted 
in fewer days to first oestrus in dairy cows. Also, Garnsworthy & Topps (1982) 
demonstrated that dairy cows calving at a medium BCS (2.5-3.0; 1-5 units) had 
significantly fewer days to first oestrus than cows with high or low BCS at calving. These 
latter results are not in line with the present study. 
 
The present study showed that FAT cows at calving had shorter interval from calving to 
conception than THIN cows at calving. Primiparous fat dairy cows (BCS at calving3.0; 1-
5 units) had a shorter interval from calving to conception than primiparous lean dairy cows 
(BCS at calving<3.0; 1-5 units) in the study of Meikle et al. (2004), which is in line with 
the current study. In contrast, other studies have failed to find any relationship between 
BCS at calving and calving interval (Garnsworthy & Jones, 1988; Ruegg & Milton, 1995; 
Pedron et al., 1993). 
 
The present study found that FAT cows at calving had lower probability to be pregnant 
within 120 days postpartum than THIN cows at calving. According to Buckley et al. 
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(2003) cows with precalving BCS>3.0 (1-5 units) had lower probability of pregnancy after 
42 day of breeding, which is in agreement with the present study. 
 
 
According to Lamming & Darwash (1998), cows with abnormal patterns in milk 
progesterone profile showed a significant deterioration in postpartum reproductive 
performance. Also, dairy cows with abnormal oestrous cycles had lower pregnancy rate 
compared to cows with normal oestrous cycles in the study of Garnsworthy et al. (2009) 
and postpartum BCS loss of Holstein cows was risk factor for a prolonged luteal phase in 
the study of Ledoux et al. (2011).  The present study found that cows with normal milk 
progesterone profile had higher probability to be pregnant than cows with abnormal milk 
progesterone profile, and FAT cows had higher probability to express abnormal milk 
progesterone profile than THIN cows. Moreover, FAT cows had lower IGF-I than THIN 
cows and IGF-I had a negative impact (tendency) on the odds for cows to express 
abnormal milk progesterone profile. This finding may explain why FAT cows had higher 
probability to express abnormal milk progesterone profile than THIN cows. Finally, these 
results taken together may explain why in the present study FAT cows were found to have 
lower probability to be pregnant within 120 days postpartum than THIN cows. 
 
In the present study, components of postpartum reproductive performance (probability for 
cows to be pregnant or express abnormal milk progesterone profile, and interval from 
calving to conception) were influenced by BCS at calving. Only days to first oestrus was 
unaffected by BCS at calving. This suggests that BCS at calving is a determinant factor for 
postpartum reproductive performance of dairy cows. Looking for the underlying 
explanation for the influence of BCS at calving on reproduction, the present study 
examined the effect of BCS at calving on metabolic hormones and metabolites, and 
productive traits. Of the metabolic hormones measured, only IGF-I was affected by BCS at 
calving. In agreement with this result, Meikle et al. (2004) and Lake et al. (2006)  found 
that circulating insulin was unaffected by BCS at calving. Meikle et al. (2004) reported 
that circulating leptin was statistically higher in fat cows (BCS at calving 3; 1-5 units) 
than in thin cows (BCS at calving <3; 1-5 units), which is not in agreement with the 
present study. A likely reason for these discrepancies between studies is that cows in the 
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present study were over-conditioned at calving compared with the cows in the studies of 
Lake et al. (2006) and Meikle et al. (2004). Another explanation could be variation in 
breeds, diets, and production systems. It is known that circulating insulin and glucagon are 
modulated mostly by dietary starch intake and its interaction with blood sugar (Brockman 
1978, 1979; Marieb & Hoehn, 2007; Aronoff et al. 2004), and that is possibly the reason 
for no effect of animal condition in this experiment. Circulating GH and leptin may be 
associated with BCS at parturition (Garnsworthy et al., 2008a), but this is only when 
differences of BCS at calving are great (Ryan et al., 1994). In the present study condition 
differences at calving were minimal, which could account for the lack of influence of 
condition at parturition on circulating GH and leptin. According to Hill (2004) the 
correlation between leptin and body condition appears to weaken postpartum when many 
other physiological influences are in action, and this is possibly an extra reason for no 
effect of BCS at parturition on circulating leptin. 
 
FAT cows at calving had lower circulating IGF-I than THIN cows at calving throughout 
the experimental period, which could also explain why THIN cows showed superior 
reproductive performance compared with FAT cows. Lake et al. (2006) found that serum 
IGF-I was greater in fat cows (BCS at calving: 6.0; 1-10 units) than in thin cows (BCS at 
calving: 4.0; 1-10 units) and Meikle et al. (2004) noted that lean dairy cows at calving 
(BCS<3; 1-5 units) had lower circulating IGF-I than fat cows (BCS3; 1-5 units). These 
two results appear to contradict the finding of the present study. However, the majority of 
cows in the present study were over-conditioned at calving (BCS=3.38±0.2); and THIN 
cows at calving (BCS=3.00±0.08) were actually fat to moderate fat whereas FAT cows at 
calving (BCS=3.59±0.03) were over-fat. Therefore, the results of Lake et al. (2006) and 
Meikle et al. (2004) are, at least in part, in agreement with the result of the present study. 
 
Of the metabolites examined in this experiment, only circulating NEFA was affected by 
BCS at calving. Busato et al. (2002) found that circulating NEFA was higher in fat cows 
(BCS one week ante partum 3.25; 1-5 units) that lost greater than 0.75 units of BCS 
throughout the experimental period. Furthermore, the same study showed that circulating 
glucose and insulin were not influenced by BCS one week ante partum combined with 
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different levels of BCS loss.  In the study of Lake et al. (2006), circulating glucose and 
BOHB was not affected by BCS at calving, which is in agreement with the current study; 
however, they observed a trend for circulating NEFA to be higher in fat cows compared to 
thin cows, in contrast to the current results. Also, Meikle et al. (2004) in agreement with 
the current results did not find any effect of BCS at calving on circulating BOHB but there 
was a trend for circulating NEFA to be higher in fat cows. Pedron et al. (1993) noted that 
circulating glucose was unchanged among classes of cows with different BCS at calving, 
but circulating FFA tended to be higher only in over-conditioned cows at parturition 
(BCS=4; 1-5 units). 
 
The present study showed that there was no effect of BCS at calving on DMI and LWT, 
but milk yield, BCS, ǻBCS, nadir BCS, and nadir week were higher in FAT than THIN 
cows at calving. In line with these results, Meikle et al. (2004) found that lean cows at 
calving (BCS<3.0) had lower mean BCS during the experimental period, and fat cows at 
calving (BCS 3.0) tended to lose more BCS. Also, Lake et al. (2005) demonstrated that 
thin beef cows at parturition maintained condition over the course of the study, whereas fat 
beef cows lost condition, but without any effect of BCS at parturition on milk yield. In 
agreement with the results of the present study Ruegg & Milton (1995) showed that 
duration and magnitude of condition loss depended primarily on BCS at calving and was 
greater for cows that calved with higher BCS. Pedron et al. (1993) found that class of BCS 
at parturition (BCS at calving; 3.0, 3.5, and 4.0; 1-5 units) did not influence milk yield, but 
Waltner et al. (1993) showed exactly the opposite. According to Garnsworthy & Jones 
(1987) quality of diet postcalving may influence the association between BCS at calving 
and milk production, and it is likely to be a reason for the variation in the results reported 
from different studies. Many studies demonstrated that higher postpartum BCS loss 
(ǻBCS) accompanied higher milk production (Ruegg & Milton, 1995; Domecq et al., 
1997), in agreement with results of the current study. 
 
In the present study, FAT cows at calving showed higher nadir BCS, longer nadir week, 
and smaller BCS change. Roche et al. (2007c, 2009) proposed that the greater the calving 
and nadir BCS, and the smaller the BCS loss between calving and nadir, the shorter the 
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postpartum anoestrous interval. According to Houghton et al. (1990) fatter beef cows at 
calving exhibited a shorter postpartum anoestrous interval. In line with these results FAT 
cows at calving in the present study had shorter interval from calving to conception than 
THIN cows at calving. 
 
It is known that postpartum DMI decreases with increasing BCS at calving (Broster & 
Broster, 1998; Garnsworthy, 2006). In the current study, however, DMI was unaffected by 
BCS at calving. It could be that the differences in BCS at calving between THIN and FAT 
cows were not large enough and the majority of the cows were over-conditioned at calving 
(mean BCS at calving=3.38±0.20). Thus, the difference in DMI between FAT and THIN 
cows at calving was smaller. 
 
The results of the present study clearly indicate that THIN cows at calving (BCS3.25) had 
better reproductive performance than FAT cows at calving (BCS>3.25). However, BCS at 
calving had no effect on days to first oestrus and FAT cows at calving showed shorter 
interval from calving to conception than THIN cows at calving. Although, reproductive 
hormones were not measured by the present study, metabolic hormones, metabolites, and 
productive traits convincingly explain why THIN cows at calving expressed better 
reproductive performance than FAT cows at calving. Circulating NEFA was higher in FAT 
cows at calving. NEFA are used as an alternative energy source by the liver to preserve 
glucose (Hayirli, 2006), and the majority of circulating glucose is used preferentially by 
the mammary gland to form lactose (Bauman & Currie, 1980). In the present study, FAT 
cows at calving lost more condition to support milk production and without increasing 
DMI. The depressed DMI in FAT cows at calving could be the direct effect of elevated 
circulating NEFA on hypothalamic neural centres controlling feeding behaviour 
(Ingvartsen & Andersen, 2000; Krasnow & Steiner, 2006). Also, elevated circulating 
NEFA may detrimentally affect follicular growth and development by acting directly on 
follicle cells (Leroy et al., 2008, 2010), which may explain the inferior reproductive 
performance of FAT cows at calving. Circulating IGF-I was higher in THIN cows at 
calving. The IGF-system plays an important role in follicle growth and development by 
acting directly on ovarian cells (Webb et al., 2004). Moreover, low circulating IGF-I 
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negatively influences postpartum reproductive performance (Butler et al., 2000; 
Huszenicza et al., 2001; Meikle et al., 2004). To conclude, the present study demonstrated 
that THIN cows at calving (BCS3.25), which lost less than 0.5 units of BCS (ǻBCS) 
during the first 4 months of lactation, had superior reproductive performance, and that was 
because of increased circulating IGF-I and decreased circulating NEFA. However, further 
work is required to determine the effects of BCS at calving on fertility. 
 
 
3.5.2 Effect of diet on circulating metabolic hormones, metabolites, and
reproductivetraitsindairycows
 
A secondary objective of the present study was to determine whether feeding a HS diet 
(designed to induce increasing circulating insulin) or a HF (designed to reduce circulating 
insulin) for the first 4 months postpartum could result in changing reproductive 
performance of dairy cows. The present study showed that cows fed HS diet had higher 
probability to express abnormal milk progesterone profile than cows fed HF diet, but there 
was no effect of diet on the probability of cows to be pregnant, days to first oestrus, and 
interval from calving to conception. Additionally, high circulating insulin was associated 
with higher odds for cows to express abnormal milk progesterone profile, and that may 
explain why cows fed the HS diet had higher probability to express abnormal milk 
progesterone profile than cows fed the HF diet. Moreover, cows fed the HS diet had insulin 
concentrations tended to be 0.5 ng/ml, whereas cows fed the HF diet had insulin 
concentrations tended to be 0.4 ng/ml in the present study (Table 3.11). This difference in 
insulin concentrations between animals fed the HS and HF diet may explain why cows fed 
the HS diet had higher probability to express abnormal milk progesterone profile than 
cows fed the HF diet (Table 3.8 and Figure 3.7). 
 
Cows fed the HS diet had higher circulating insulin  than cows fed the HF diet, but there 
was no effect of diet on circulating GH, leptin, and IGF-I. This finding is in agreement 
with the results of Gong et al. (2002b) and Garnsworthy et al. (2008b). According to 
Garnsworthy et al. (2008a) and Lucy (2000),  circulating  GH and IGF-I are associated 
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more to productive traits (such as milk yield, live weight and energy balance) than to diet 
composition, whereas leptin is mainly linked with BCS (Hill, 2004), and it is conflicting if 
it can be affected by diet (Chilliard et al., 2005). Also, glucose and insulin seem to play a 
key role in regulating leptin expression in ruminants (Chilliard et al., 2005). Milk yield, 
BCS, ǻBCS, LWT, and circulating glucose were not affected by diet in this experiment 
and maybe that is why circulating GH, leptin, and IGF-I were not influenced by diet. 
Failure of diet to influence circulating metabolic hormones (except insulin), may explain 
why reproductive performance was the same for the two dietary treatments, as it is known 
that circulating GH, leptin, and IGF-I directly affect reproductive performance 
(Garnsworthy et al., 2008a). 
 
The study of Gong et al. (2002b) used similar diets to the current study, but for a period of 
50 days postpartum. Their study clearly demonstrated a beneficial effect of cows fed HS 
diet on early reproductive indices (i.e. increased proportion of cows ovulating within 50 
days postpartum, decreased intervals from calving to first ovulation, and decreased 
intervals from calving to first service and to conception).  However, in the study of Gong et 
al. (2002b) the subsequent fertility parameters (i.e. conception rate to first service and 
number of services required per conception) were not affected by diet and that finding is at 
least in part in agreement with the current study. Moreover, this finding may suggest that 
the beneficial effect of HS diet on cow fertility is constrained to the first 50 days 
postpartum. In general, the results of the present study concerning early reproductive 
indices are not in line with those of the study of Gong et al. (2002b). Cows fed the HS diet 
did not show shorter days to first oestrus or intervals from calving to conception and they 
had higher probability to express abnormal milk progesterone profile than cows fed HF 
diet. This latter result combined with the finding that cows with normal milk progesterone 
profile had higher probability to be pregnant than cows with abnormal milk progesterone 
profile  may indicate that cows fed the HS diet are likely to have lower probability to be 
pregnant than cows fed the HF diet. However, this latter conclusion was not confirmed by 
the present study as diet had no effect on the probability cows to be pregnant. An 
explanation for the discrepancies between the two studies could be that in the present study 
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the animals were dietary manipulated for longer (up to 2 times) than the animals of the 
study of Gong et al. (2002b).  
 
In the study of Gong et al. (2002b) circulating insulin was 0.32 ± 0.015 ng/ml and 0.21 ± 
0.011 ng/ml for the high yielding cows fed HS and HF diets, respectively. In the present 
study, mean insulin was 0.44±0.02 ng/ml and animals fed the HS diet had higher mean 
circulating insulin (0.49±0.03 ng/ml) than cows fed the HF diet 0.41±0.03 ng/ml. 
According to Kaneko et al. (2008b), reference range of circulating insulin for cows varies 
from zero (undetectable) to 0.23 ng/ml. Moreover, basal circulating insulin varied from 
0.14±0.02 ng/ml to 0.15±0.03 ng/ml, independently from diet and genetic merit for milk 
yield in the study of Chagas et al. (2009). That means circulating insulin was 
approximately two times higher than the reference range in the current study (or about 
three times higher than the mean insulin in the study of Chagas et al. (2009)), 
independently from the dietary treatments. Thus, the animals in the present study exceeded 
an optimum insulin concentration which was not surpassed by the animals in the study of  
Gong et al. (2002b), and this is another explanation for the discrepancies between the two 
studies. 
 
Butler (2000) reported that increased circulating urea may lead to impaired fertility of 
cows as high plasma urea concentrations interfere with the normal inductive actions of 
progesterone on the microenvironment of the uterus, and therefore cause suboptimal 
conditions for supporting embryo development. Sinclair et al. (2000) suggested that 
exposure of oocytes in antral follicles to high levels of ammonia, prevents cleavage and 
blastocyst formation. In the current study, cows fed the HS diet had higher circulating urea 
than cows fed the HF diet and this may explain the higher probability to express abnormal 
milk progesterone profile observed in cows fed the HS diet. 
 
BOHB was influenced by diet in the present study, and cows fed the HS diet had lower 
circulating BOHB than cows fed the HF diet.  Increased BOHB is associated with NEB 
(Bell, 1995; Grummer, 1995), but there was no effect of diet on other metabolites or 
productive traits (milk yield, BCS, ǻBCS, and nadir BCS) to indicate higher body fat 
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mobilization of cows fed the HF diet in this experiment. The reason why circulating 
BOHB was elevated in this study is not known.  BOHB has no direct effect in reproductive 
performance (Leroy et al., 2008), and its higher concentration in cows fed HF diet cannot 
explain why these cows had lower probability to express ABNORMAL milk progesterone 
profile. 
 
To conclude, the present study demonstrated that feeding dairy cows with a HS diet or a 
HF diet for the first 4 months of lactation would not result in changing reproductive 
performance (probability of cows to be pregnant, interval from calving to conception, and 
days to first oestrus were not affected by dietary treatment). This was mainly because 
important metabolic hormones (i.e. leptin, IGF-I, and GH), productive traits (milk yield, 
BCS, ǻBCS, nadir week, and nadir BCS), and metabolites (i.e. NEFA and glucose) were 
not influenced by diet.  In addition, long-term moderately elevated insulin concentration 
induced by feeding dairy cows the HS diet might account for the higher probability to 
express abnormal milk progesterone profile. However, further work is required to 
determine the effects of HS and HF diets on fertility, and especially the association of 
chronic moderately elevated insulin concentration with reproductive performance. 


3.5.3Reproductiveperformanceandoptimuminsulinconcentration
 
The present study showed that pregnancy rate was negatively affected by insulin (Figure 
3.3) but this effect was dependent on BCS at calving (Figure 3.4). Also, cows with high 
insulin had higher probabilities to express abnormal milk progesterone profile (Figure 3.7) 
and this effect was dependent on BCS at calving (Figure 3.8). These two results taken 
together may imply that there was an optimum insulin concentration necessary for normal 
reproductive performance in lactating dairy cows which was dependent on BCS at calving. 
According to Garnsworthy et al. (2009) there is a minimum insulin concentration (from 
0.21 to 0.32 ng/ml) that is necessary for commencement of normal ovarian activity in early 
lactating cows. In accordance with this observation, the present study presented that; (1) 
optimum insulin concentration that maximized the probability of cows to be pregnant 
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varied from 0.2 to 0.3 ng/ml, whereas insulin greater than 0.6 ng/ml tended to zero the 
probability of cows to be pregnant (Figure 3.3); and (2) optimum insulin concentration that 
minimized the probability for cows to express abnormal milk progesterone profile varied 
from 0.1 to 0.3 ng/ml, whereas insulin greater than 0.4 to 0.6 ng/ml tended to maximize the 
probability for cows to express abnormal milk progesterone profile (Figure 3.7). Thus, 
insulin concentration that optimized fertility in lactating cows varied from 0.2 to 0.3 ng/ml 
while insulin concentration greater than 0.6 ng/ml impaired reproductive performance in 
lactating dairy cows. Moreover, the current study found that BCS at calving was a critical 
modulator of fertility in lactating dairy cows (Figure 3.4 and Figure 3.8), whereas 
reproductive performance (pregnancy rate and milk progesterone profile) of dairy cows 
was not affected by dietary treatments (Figure 3.5 and Figure 3.9) when insulin 
concentrations were about the same. Therefore, achieving a BCS of less than 3.25 units at 
calving is essential to ensure optimum cow fertility.  
 
In the present study, mean insulin was 0.44±0.02 ng/ml whereas the actual percentage of 
pregnant cows was 26.7% and the actual percentage of cows expressed irregular oestrous 
cycles was 46.7%. According to Figure 3.3 and Figure 3.7, the model estimated percentage 
of pregnant cows and the model estimated percentage of cows expressed irregular oestrous 
cycles was (25.5±5) % and (49.9±6) %, respectively. Thus, the low percentage of pregnant 
cows and the high percentage of irregular oestrous cycles in the animals of the present 
study were due to insulin concentration exceeded the optimum (0.2-0.3 ng/ml) in terms of 
reproduction. 
 
Another finding of the present study was that THIN cows at calving that fed the HF diet 
had lower probability to express abnormal milk progesterone profile than THIN cows at 
calving that fed the HS diet, when insulin concentration ranged from 0.1 to 0.6 ng/ml 
(Figure 3.10). Therefore, HF diet must be the preferable feeding strategy to maximaze 
reproductive performance of dairy cows when insulin concentration ranges from 0.1 to 0.6 
ng/ml and BCS at calving is equal or lower than 3.25 units. Moreover, because THIN cows 
at calving had lower probability to express abnormal milk progesterone profile than FAT 
cows at calving when circulating insulin was relatively high (0.4 to 0.9 ng/ml) (Figure 3.8), 
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body condition management must be aimed at a BCS of less than 3.25 units at calving. 
Alternatively, if the animals are FAT at calving, the best feeding strategy to ensure 
optimum fertility is the animals to be fed a diet that induces an optimum circulating insulin 
concentration (0.2 - 0.3 ng/ml). However, this approach is not easy to be achieved in the 
long term, and consequently obtaining a BCS of less than 3.25 units at calving must be 
considered the most realistic strategy. Thus, BCS at calving management has greater 
impact on cow fertility than postpartum dietary treatments such as HS and HF diets. This 
latter may imply that prepartum feeding strategy and BCS management are essential for 
optimal reproduction performance in lactating dairy cows. 
 
 
3.5.4.Conclusions
In conclusion, results of this study support the concept that BCS at calving is a critical 
modulator of fertility in lactating dairy cows. THIN cows at calving (BCS3.25), which 
lost less than 0.5 units of BCS (ǻBCS) during the first 4 months of lactation, had superior 
reproductive performance, and that was because of increased circulating IGF-I and 
decreased circulating NEFA. Moreover, this study clearly shows that there is an optimum 
insulin concentration (0.2 - 0.3 ng/ml) necessary for normal reproductive performance, 
while insulin concentration greater than 0.6 ng/ml impairs reproductive performance in 
lactating dairy cows. The results strongly suggest that optimal reproductive performance of 
dairy cow is dependent on insulin concentration and BCS at calving. Cow fertility was not 
affected by dietary treatments, mainly because optimum insulin concentration was 
exceeded by the animals of the present study. However, HF diet must be the preferable 
feeding strategy to maximize reproductive performance of dairy cows when insulin 
concentration ranges from 0.1 to 0.3 ng/ml and BCS at calving is equal or lower than 3.25 
units. Finally, moderately elevated insulin concentration that exceeded optimum insulin 
concentration may explain the low percentage of pregnant cows and the high percentage of 
cows expressed abnormal oestrous cycles in this experiment. However, these results need 
to be investigated further. 
 

4.Measurementofplasmaandmilkadiponectin,andthe
impact of lactation stage, diet, and body condition at
calving on plasma adiponectin concentrations in dairy
cows
 
 
4.1.INTRODUCTION
 
Adiponectin, also known as Acrp30, apM1, and AdipoQ, is an adipokine mainly secreted 
by adipocytes (Berg et al., 2002; Kadowaki & Yamauchi, 2005; Shetty et al., 2009). 
Adipokines are highly bioactive molecules and may be implicated in regulation of energy 
expenditure and homeostasis, immunity, and reproduction (Yokota et al., 2000; Mitchell et 
al., 2005; Antuna-Puente et al., 2008; Guzic et al., 2006; Kamada et al., 2008; Dridi & 
Taouis, 2009). Although leptin and adiponectin are the main adipokines expressed in 
adipose tissue (Guzic et al., 2006; Ahima, 2006), adiponectin concentration in plasma is 
two to three times higher than other hormones (Ahima, 2006). Circulating adiponectin 
varies in different species (human; 3-30 ȝg/ml, rat; 10-30 ȝg/ml, horses; 1.3-4.8 ȝg/ml, dog; 
20-40 ȝg/ml, cats; 1-4 ng/ml) (Kamada et al., 2008; Mousavinasab et al., 2005; Combs et 
al., 2004;  Goldstein & Scalia, 2007; Ishioka et al., 2006; Kearns et al.,  2006; Radin et al., 
2009; Hoenig et al., 2007 ). 
 
It is known that periparturient cows enter a period of negative energy balance accompanied 
by decreased insulin sensitivity (Bell, 1995; Veerkamp et al., 2003; Hayirli, 2006), and 
adiponectin is implicated in murine and human insulin resistance (Kadowaki & Yamauchi, 
2005). Lemor et al. (2009) reported that AdipoR1 and AdipoR2 mRNA abundance in 
adipose tissue decreased as high yielding cows moved from pregnancy to lactation. 
Raddatz et al., (2008) reported that plasma adiponectin concentration varied from 8.3±1.4 
ng/ml to 16.0±2.7 ng/ml in early lactating cows and circulating adiponectin was 
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significantly increased from week 1 to week 4 post partum, and declined to remain at 12-
13 ng/ml until week 11 postpartum. Komatsu et al. (2007) showed that adiponectin mRNA 
expression in adipose tissue was higher in non-lactating cows than peak-lactation cows, but 
it was similar in early-lactation and late-lactation cows. The pattern of change of 
circulating adiponectin throughout the lactation cycle of dairy cows has not yet been 
determined. 
 
Contrary to what happens for most adipokines, circulating values of adiponectin are higher 
in lean than in obese individuals (Berg et al., 2002; Matsuzawa et al., 2004; Kadowaki & 
Yamauchi, 2005; Kadowaki et al., 2006; Shetty et al., 2009; Goldstain & Scalia, 2007). 
Kearns et al. (2006) reported that adiponectin is inversely proportional to adiposity in 
horses. According to Ishioka et al. (2006) obese dogs showed low circulating adiponectin. 
Raddatz et al. (2008) proposed that circulating adiponectin is not correlated with BCS in 
early lactating cows. Circulating adiponectin was negatively correlated with body weight, 
body mass index, and insulin in humans (Berg et al , 2002; Matsuzawa et al., 2004; Guzic 
et al., 2006; Ahima, 2006), but the association of circulating adiponectin with body weight, 
BCS at calving, and metabolic profile in cattle or other ruminants have not yet been 
investigated. 
 
Dietary factors may modulate circulating adiponectin (Reis et al., 2010). High 
consumption of magnesium (Qi et al., 2005; Cassidy et al., 2009), caffeine (Williams et 
al., 2008), n-3 PUFA (Duda et al., 2007), and dietary salt (Lely et al., 2007) are associated 
in humans with higher circulating adiponectin. According to Barnea et al. (2006) mice fed 
a High Fat diet exhibited elevated insulin resistance, although circulating adiponectin 
remained unchanged compared to controls. Jones et al. (2009) demonstrated that a high-fat 
diet increased maternal adiposity and circulating maternal leptin, but murine serum 
adiponectin was decreased from a period around the mating and throughout gestation. 
Pischon et al. (2005) showed that circulating adiponectin was negatively related to 
glycaemic load in men. It is known that ruminants regulate glucose homeostasis and lipid 
metabolism in different ways than other monogastric animals (Allen et al., 2005; Nafikov 
& Beitz, 2007). For example, many ruminant tissues preferentially utilize acetate rather 
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than glucose, and VFA are the main products of organic matter fermentation (Lewis & Hill 
1983; Nafikov & Beitz, 2007). The effect of dietary components on circulating adiponectin 
has not yet been demonstrated for any ruminant. 
 
Adiponectin is assessed in human milk (Weyermann et al., 2006; Martin et al., 2006; 
Bronsky et al., 2006), and bovine mammary epithelial cells are expressed AdipoR1 
(Ohtani et al., 2011). However, the presence of adiponectin in bovine milk has not yet been 
reported. 
 
In this project, circulating and milk adiponectin were measured by using a commercially 
available human adiponectin kit (HADP-61 HK, Linco Research, Millipore, St. Charles, 
MO, USA). The presence of adiponectin in bovine milk was confirmed for first time. The 
main objective of the study was to test the hypothesis that as physiological state of cow 
dramatically changes by moving from pregnancy to calving and lactation, major 
physiological changes occur, which may be partially reflected in circulating adiponectin. 
Additionally, the influences of BCS at calving and diet on circulating adiponectin, and the 
relationships of circulating adiponectin with other metabolic hormones, metabolites, and 
productive traits were investigated. Kubota et al., (2007) showed that adiponectin stimulate 
food intake in mouse. A second hypothesis was that circulating adiponectin would be 
associated with DMI in lactating dairy cows. Evidence may indicate that the relationship 
between GH and adiponectin is negative in human and rat (Lam et al., 2004; Nilsson et al.,  
2005; Rodriguez-Pacheco et al., 2007). It is known that genetic selection for milk yield led 
to higher circulating GH in dairy cows (Veerkamp et al., 2003). A third hypothesis was 
that high yielding cows would have lower circulating adiponectin than low yielding cows 
due to increased circulating GH and its antagonistic relationship with adiponectin. 
 
 
 
 
 
 
”Chapter4Measurementofplasma&milkadiponectin


102

4.2.MATERIALSANDMETHODS
 
 
4.2.1.Measurementofadiponectininbovinemilk(Experiment1)
 
Milk samples were collected from 6 cows fed on the same diet, but at different stages of 
lactation (from 5 to 50 days post partum). Cows were milked through a robotic milking 
system (AMS; Merlin, Fullwood Ltd.). All milk samples were collected between 15:00 and 
17:00 in the afternoon and left in the fridge (0 to 4 °C) overnight. Because lipids interfere 
with radioimmunoassays (RIA), skim milk was used (Martin et al., 2006). Milk samples 
(4ml) were mixed by vortex and skim milk (aqueous phase) was prepared by centrifugation 
(1500 ×g, 20 min, 4 °C) and removal of the fat layer. Adiponectin was determined in 
duplicate by using a commercial RIA kit (Linco Research, St Charles, MO, USA), as 
described in the protocol (A.4 in appendix). 
 
 
4.2.2.Measurementofcirculatingadiponectin(Experiment2)
4.2.2.1.Data
 
This study utilized the dataset generated by the study of Garnsworthy et al. (2009). In the 
current study, circulating adiponectin values were measured and added. Key points of 
materials and methods, further statistical analysis, and handling of the data are presented 
hereinafter. 
4.2.2.2.Experimentaldesign 
 
Sixty high-yielding multiparous Holstein dairy cows were blocked according to calving 
date and parity, and were allocated at random to two dietary treatment groups (HS and HF, 
30 cows in each). Two diets were formulated to have equal concentrations of DM, ME and 
CP, but to differ in starch, fat and NDF concentrations (Table A.1 in appendix). Diet HS 
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had higher starch content and was expected to induce relatively high plasma insulin 
concentrations; Diet HF had a higher fat content and was expected to induce relatively low 
plasma insulin concentrations. These diets were equivalent to the high and low insulin diets 
used by Gong et al. (2002b), Fouladi-Nashta et al. (2005), and Garnsworthy et al. (2009). 
 
Within dietary treatment groups, cows were allocated on the basis of BCS at calving into 
FAT (BCS >3.25 units) and THIN (BCS 3.25 units) cows. The FAT group comprised 40 
cows (19 HS; 21 HF); the THIN group comprised 20 cows (11 HS; 9 HF).  Prepartum, all 
cows were fed on the same diet. 
 
 
4.2.2.3.Feedingandmilking
 
These are described in § 3.2.3. 
 
 
4.2.2.4.Recording,samplingandanalysis
 
Milk yield and feed intake were recorded daily throughout the experiment. Previous milk 
yield (PMY) was obtained by dairy records while aggregated milk yield (AMY) was 
calculated by summarizing the milk yield for each cow at the end of the experiment. Live 
weight and BCS (units; 1 to 5) were recorded weekly. Milk samples were taken twice in a 
week (for the weeks; +2, +4, +6, +8, +12, + 15 postpartum) and analyzed for fat, protein 
and lactose contents by infrared analysis at the National Milk Records Laboratory, 
Harrogate, UK, using AOAC reference method No. 972.16 (AOAC, 1990). Metabolizable 
energy balance was calculated for each cow from LWT, milk energy output, and 
metabolizable energy intake, using UPWin software (AGM Systems, Exeter, UK) and 
Feed Into Milk equations (Thomas et al., 2004). 
 
Blood samples were taken every Wednesday at 09:30 h from weeks -2 prepartum and +2, 
+4, +6, +8, +12, + 15 postpartum for measurement of hormones and metabolites. Blood 
”Chapter4Measurementofplasma&milkadiponectin


104

samples were analyzed for the following hormones: insulin, GH, glucagon, adiponectin, 
and leptin, as detailed in Garnsworthy et al.  (2009). Circulating and milk adiponectin were 
measured by using a commercially available human adiponectin kit (HADP-61 HK, Linco 
Research, Millipore, St. Charles, MO, USA) as described in the protocol (A.3 in appendix). 
The sensitivity of the method (expressed as ED80) was 2.33 ng/ml. Blood samples were 
analyzed for the following metabolites on a Bayer opera autoanalyzer (Bayer UK Ltd): 
urea-N, glucose, BOHB and NEFA, as detailed in Garnsworthy et al.  (2009). All instances 
of ill health and veterinary treatments were recorded. All analytical methods used to 
measure metabolites, and metabolic hormones are described in the appendices. 
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4.3.STATISTICALANALYSIS
 
4.3.1.Adiponectininbovinemilk(Experiment1)
 
Cows were divided into two groups according to daily milk yield; cows yielding >30 kg/d 
were the HIGH group (3 cows); cows yielding <30 kg/d were the LOW group (3 cows). 
The difference between groups in milk adiponectin concentration was tested by using 
Students t-test within the PASW
©
 18 Edition (SPSS Inc., Chicago, USA) statistical 
software package. 
 
 
4.3.2.Circulatingadiponectin(Experiment2)
 
All data were analyzed using PASW
©
 18 Edition (SPSS Inc., Chicago, USA). Generalized 
Estimating Equations (GEE) were used to test specific hypotheses (Lindsey, 1997; 
McCullagh & Nelder, 1989; Dobson, 2002; Horton & Lipsitz, 1999) because adiponectin 
values were not normally distributed (Shapiro-Wilk W value=0.847, Shapiro-Wilk  P 
value=0.001), and all known transformations failed to normalize the data. Family 
distribution and link function were selected as detailed in § 3.3. Selection of GEE models 
was performed based on QIC criterion, as detailed in § 3.3.  
 
Models selected to test effects of lactational stage (WEEK), BCS at calving 
(CONDITION) and diet on production traits and hormonal and metabolic profile are 
illustrated in Table 4.1 and 4.2. 
 
Parameter estimates of GEE models are presented as marginal means plus/minus standard 
error of the difference (SED) in tables. Estimated marginal means, SEs and SEDs were 
obtained by using Least Significant Difference (LSD) adjustment for multiple comparisons 
in PASW
©
 18 statistical program. P values were calculated by Newton-Raphson Maximum 
Likelihood (ML) method and effects were considered statistically significant when P value 
was less than 0.05 (P<0.05). 
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Shapiro-Wilk test was used to assess whether the distribution of variables followed a 
normal distribution. Linear relationships between quantitative variables were assessed with 
the Spearman correlation coefficients for nonparametric data. Spearman correlation 
coefficients (rho) were calculated and considered statistically significant when P value was 
less than 0.05 (P<0.05) whereas P value equal or less than 0.1 (P  0.1) were considered as 
a trend. 
 
Regression analysis was performed for DMI, adiponectin, leptin, glucose, milk yield, and 
MEBAL in FAT and THIN cows at calving (Table 4.3). In this way, two regression models 
for DMI were constructed. The model fitness was inspected by graphing observed values 
of DMI against predicted values of DMI and R-squared coefficient.  Raw residuals and 
Pearson residuals were calculated, and the validity and the stability of the models were 
examined by exploring their normality. Beta (unstandardized) coefficients were estimated 
and they were used to build up regression equations to predict DMI. Beta coefficients were 
considered statistically significant and entered in the regression equations when P value 
was less than 0.1 (P<0.1). 
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Table4.1:Selectedmodelsforanalysisoftheeffectoflactationalstageoncirculatingadiponectin,metabolites,metabolic
hormones,andproductiontraits
RESPONSE
VARIABLES(Y)
TYPEOF
MODEL
PREDICTORS
(X)
SUBJECT(ID)
VARIABLE
WITHIN ?
SUBJECT
VARIABLE
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE 
MATRIX
WORKING
CORRELATION
MATRIX
STATISTICS
”Adiponectin
 GEE ”WEEK
COW
(60) WEEK PARITY Gamma log Robust Exchangeable n=378;QIC=230
”Insulin
”Leptin
”Glucagon
”Glucose
”Urea
”DMI
”Milkyield
”LWT
”BCS
”MEBAL
GEE ”WEEK COW
(60) WEEK PARITY
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable
n=377;QIC=28
n=378;QIC=474
n=216;QIC=123,651
n=246;QIC=75
n=249;QIC=130
n=352;QIC=3,242
n=352;QIC=23,775
n=352;QIC=228,742
n=418;QIC=79
n=352;QIC=50,678
”GH
”BOHB
”NEFA
GEE ”WEEK COW
(60) WEEK PARITY
Inverse
Gaussian

Log Robust Exchangeable
n=206;QIC=37
n=248;QIC=122
n=249;QIC=224
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
Table4.2:SelectedmodelsforanalysisoftheeffectsofdietandBCSatcalving(CONDITION)oncirculatingadiponectin,
metabolites,metabolichormones,andproductiontraits
RESPONSE
VARIABLES(Y)
TYPEOF
MODEL
PREDICTORS
(X)
SUBJ.
VAR.
WITHIN ?
SUBJECT
VARIABLE
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE 
MATRIX
WORKING
CORRELATION
MATRIX
STATISTICS
”Adiponectin
 GEE
”CONDITION
”DIET*
COW
(60) WEEK PARITY Gamma log Robust Exchangeable n=342;QIC=214
”Insulin
”Leptin
”Glucagon
”Glucose
”Urea
”DMI
”Milkyield
”LWT
”BCS
”MEBAL
GEE ”CONDITION”DIET*
COW
(60) WEEK PARITY
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable
n=33O;QIC=21
n=332;QIC=356
n=216;QIC=121,477
n=202;QIC=69
n=205;QIC=114
n=352;QIC=3,969
n=352;QIC=26,606
n=352;QIC=256,097
n=358;QIC=72
n=352;QIC=86,330
”ȴBCS GLM ”CONDITION”DIET  ?  ? PARITY
Gaussian
(Normal)
Identity
(ID) Robust Independent
n=59;AIC=77;LR(
ʖ2=8.81,df=2,P=0.032)
”GH
”BOHB
”NEFA
GEE ”CONDITION”DIET*
COW
(60) WEEK PARITY
Inverse
Gaussian

Log Robust Exchangeable
n=206;QIC=41
n=205;QIC=93
n=205;QIC=273
* Precalving data were excluded from the analysis 
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Table4.3:SelectedmodelforregressionanalysisofDMI
RESPONSE
VARIABLES(Y)
TYPE
OF
MODEL
PREDICTORS
(X)
SUBJECT
(ID)
VARIABLE
WITHIN ?
SUBJECT
VARIABLE
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX
WORKING
CORRELATION
MATRIX
OBSERVATIONS

”DMI*

GEE  ? COW
(60cows) WEEK
Adiponectin
Milkyield
Glucose
Leptin
MEBAL
Gaussian
(Normal)
Identity
(ID)
Robust
Estimator Exchangeable
111
(eachtime)*
*The same model was run twice, for FAT and THIN cows at calving. 
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4.4.RESULTS
 
 
4.4.1.Adiponectininbovinemilk(Experiment1)
 
Mean milk adiponectin concentration was 11.5 ±3.49 ng/ml. Milk adiponectin varied with 
day in milk, from low (<5 ng/ml; 10 and 46 day in milk) to moderate (10 ng/ml; 6 day in 
milk) and high (20-25 ng/ml; 15-36 day in milk). Cows with HIGH daily milk yield did not 
have higher (P= 0.31) milk adiponectin (8. 8±4.01 ng/ml versus 17.0± 6.40 ng/ml) than 
cows with LOW daily milk yield. 
 
 
4.4.2.Circulatingadiponectin(Experiment2)
 
Mean circulating adiponectin was 8.6 ±0.33 ng/ml and this was greater than the mean of 
other metabolic hormone (insulin; 0.4±0.01 ng/ml, leptin; 1.7±0.06 ng/ml, GH; 4.6±0.22 
ng/ml, glucagon; 95.9±0.63 pg/ml). Circulating adiponectin values showed high correlation 
(average correlation; ȡ= 0.844) by week of experiment. They were not normally 
distributed (Shapiro-Wilk W value=0.847, Shapiro-Wilk P value=0.001), left skewed 
(median=7.21; skewness=1.80), and highly peaked (leptokurtotic probability distribution; 
kurtosis=7.49). Individual cows showed consistently high or normal circulating 
adiponectin values throughout the experimental period (Figure 4.1). 
 
 
4.4.2.1.Lactationalstage
 
There was an effect of lactational stage on circulating adiponectin, insulin, leptin, and GH 
(P<0.01) (Table 4.4). Circulating adiponectin was elevated 2 weeks prepartum (11.1 ±1.06 
ng/ml), decreased to week 2 postpartum (7.1±0.90 ng/ml), increased to week 4 postpartum 
(8.9±0.76 ng/ml), remained stable until week 12 postpartum (9.1±0.86 ng/ml), and then 
declined to 6.5±0.75 ng/ml at the end of the study (Figure 4.2). Circulating insulin 
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decreased from week 2 prepartum (0.4±0.03 ng/ml) to week 2 postpartum (0.3±0.02 
ng/ml), and then increased constantly between 0.33 and 0.54 ng/ml for the remainder of the 
study. Circulating leptin was elevated 2 weeks prepartum (2.2±0.24 ng/ml), decreased until 
week 2 postpartum (1.5±0.10 ng/ml), remained at 1.4- 1.64 ng/ml until the end of week 8 
postpartum, and then increased constantly for the remainder of the study (Table 4.4). 
Circulating GH was elevated 2 weeks postpartum (6.9±0.53 ng/ml), decreased steadily 
until week 12 (3.2±0.53 ng/ml), and remained unchanged after week 12 postpartum (Table 
4.4). There was no effect of lactational stage on circulating glucagon (Table 4.4). 
 
There was an effect of lactational stage on circulating glucose, NEFA, and urea (P< 0.01) 
(Table 4.5).  Circulating glucose was (3.0±0.07 mmol/l) in week 2 prepartum  and week 2 
postpartum, increased rapidly to week 8 postpartum (3.6±0.08), and then remained at the 
same level until the end of the experiment (Table 4.5). NEFA increased from 2 weeks 
prepartum (0.4±0.05 mmol/l) to week 2 postpartum (0.9±0.16 mmol/l), then declined 
substantially and remained between 0.54 and 0.24 mmol/l for the remainder of the study 
(Table 4.5). Circulating urea was lowest 2 weeks prepartum (1.6±0.10 mmol/l) and 
increased steadily throughout the study. There was no effect of lactational stage on 
circulating BOHB (Table 4.5). 
 
There was an effect of lactational stage on DMI, LWT, milk yield, BCS, and MEBAL 
(P<0.01) (Table 4.6). DMI (17.9±0.23 kg/d) and milk yield (35.1±0.52 kg/d) were low 2 
weeks postpartum, increased until week 8 postpartum (DMI 22.8 ±0.23 kg/d; milk yield 
46.8 ±0.52 kg/d) and decreased after this point to be 22.3±0.23 kg/d and 41.1±0.51 kg/d 
respectively, at the end of the study (Table 4.6). BCS was high 2 weeks postpartum 
(2.9±0.04) and decreased rapidly until week 6 postpartum (2.4±0.04). After week 6 
postpartum, cows gained condition for the remainder of the study (Table 4.6). 
Metabolizable energy balance (MEBAL) was negative from week 2 to week 6 postpartum 
and remained positive after week 8. LWT remained between 650 and 654 kg from week 2 
to week 6 postpartum and then increased steadily to reach 669 kg at the end of the study 
(Table 4.6). 
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4.4.2.2.DietandBCSatcalving
 
Circulating adiponectin was not different (P>0.05) for cows fed the HS diet (8.3±0.68 
ng/ml) than for cows fed the HF diet (8.8±0.81 ng/ml). Cows fed the HS diet had higher 
circulating insulin, NEFA, and BOHB (P<0.05) than cows fed the HF diet (Tables 4.7 & 
4.8). There was no effect of DIET on DMI, LWT, milk yield, BCS, ǻBCS, and MEBAL 
(Table 4.9). 
 
Circulating adiponectin was not different (P>0.05) for FAT cows at calving (8.3±0.87 
ng/ml) than for THIN cows at calving (8.91.39 ng/ml) (Table 4.7). There was no effect of 
BCS at calving on circulating insulin, leptin, GH, glucagon, glucose, NEFA, BOHB, and 
urea (Tables 4.7 & 4.8). FAT cows at calving had higher DMI, milk yield, BCS, and ǻBCS 
than THIN cows at calving (P<0.05). There was no effect of BCS at calving on LWT and 
MEBAL (Table 4.9). 
 
 
4.4.2.3. Associations of circulating adiponectin with circulating metabolites,
metabolichormones,andproductiontraits
 
Plasma adiponectin was negatively correlated with GH concentration (rho= -0.144, 
P=0.042) and tended to be correlated negatively with plasma glucose (rho= -0.110, 
P=0.10). Circulating GH was correlated negatively with circulating insulin (rho = -0.287, 
P=0.001) and leptin (rho= -0.319, P=0.001). Circulating insulin was correlated negatively 
with ǻBCS (rho= -0.158, P=0.002) 
 
Circulating adiponectin was correlated negatively with previous milk yield (PMY; rho= -
0.256, P=0.001) and aggregated milk yield (AMY; rho= -0.119, P=0.02). AMY was 
correlated positively with PMY (rho= 0.430, P=0.001). GH was correlated positively with 
AMY (rho= 0.216, P=0.002) and PMY (rho= 0.127, P=0.05). Leptin was correlated 
negatively with PMY (rho= -0.122, P=0.018) and positively with circulating insulin (rho= 
0.356, P=0.001). 
”Chapter4Measurementofplasma&milkadiponectin


113

 
Adiponectin concentration was correlated negatively with ǻBCS (rho= -0.173, P=0.001). 
ǻBCS was correlated positively with GH (rho=0.253, P=0.001), and negatively with 
circulating leptin (rho= -0.261, P=0.001). ǻBCS was correlated positively with PMY 
(rho= 0.281, P=0.001), AMY (rho= 0.434, P=0.001), milk yield (rho= 0.388, P=0.001), 
DMI (rho= 0.382, P=0.001) and BOHB (rho= -0.193, P=0.002). 
 
Milk yield was correlated positively with PMY (rho= 0.473, P=0.001) and AMY (rho= 
0.753, P=0.001). AMY was correlated positively with PMY (rho= 0.513, P=0.001) and 
DMI (rho=0.595, P=0.001). PMY was correlated positively with DMI (rho= 0.365, 
P=0.001). 
 
 
4.4.2.4.RelationshipsbetweenDMIandcirculatingadiponectin,glucose,leptin,
MEBAL,andmilkyieldinFATandTHINcowsatcalving
 
DMI for THIN cows at calving can be predicted, with high precision (R
2
= 0.88), by the 
regression equation; DMI=0.318 * MY (kg/d) + 0.057 * MEBAL (MJ/d) - 0.043 * ADIPO 
(ng/ml)+ 8.74, whereas DMI for FAT cows at calving can be predicted   by the regression 
equation; DMI=0.293 * MY (kg/d) + 0.055 * MEBAL (MJ/d) + 0.047*ADIPO (ng/ml)- 
0.54* GLU (mmol/l) +10.71 (R
2
= 0.78) (Figure 4.3). Adiponectin beta coefficient in the 
regression equation for THIN cows was negative (-0.043), whereas it was positive (0.047) 
for FAT cows at calving (Table 4.10 & 4.11). Glucose featured only in the model for FAT 
cows at calving and its beta coefficient was negative (-0.54) (Table 4.11).
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Figure 4.1: Box Whisker plot of circulating adiponectin values (n= 387). Box shows median value of circulating adiponectin, and the size
of the first and third quartile. Outliers appear as individual points » or æ outside the box (marked by cow id number). The » outlier values
are known as outside values, and the æ outlier values as far outside values. Outliers are at the upper range of the data (above the box); the
mean value is above the median (the centre line in the box); the median line does not evenly divide the box; and the upper tail of the box plot
is longer than the lower tail; thus, the population distribution from which the data were sampled is skewed to the right. Interestingly, outlier
values come consistently from 6 cows (id; 57, 94, 146, 219, 330, and 331) which showed the same trend for higher adiponectin values
throughout the experiment. 

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Figure 4.2: Effect of lactational stage (WEEK) on circulating adiponectin (n = 387, P value = 0.001). GEE model with Gamma error
distribution, log link function, and exchangeable R matrix structure with robust estimator of covariance matrix. Dependent variable was
adiponectin, subject variable was cows (60 cows), and within subject variable was WEEK (7 weeks).WEEK was added as factorial
independent, and parity as continuous covariate in the model). Red dots (”) represent marginal means ± SE. -2 point in x-axis represents two
weeks prepartum whereas 15 is fifteen week postpartum. Means marked with different letters are significant different (P<0.05).
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Table4.4:Effectoflactationalstage(WEEK)oncirculatingmetabolichormones
 
Factors: WEEK   Contrasts- P val. 
Parameters: -2

 2

 4

 6

 8

 12

 15

 SED
‡
 n
 
 c1 c2 c3 c4 c5 c6 
Adiponectin 
(ng/ml) 
11.19 7.01 8.83 8.90 9.09 8.82 6.48 0.842 387 <0.01 <0.01 NS
*
 NS NS <0.01 
Insulin 
 (ng/ml) 
0.36 0.26 0.33 0.40 0.45 0.48 0.54 0.026 377 <0.01 NS <0.01 <0.01 <0.01 <0.01 
GH  
(ng/ml) 
- 6.9 5.1 4.1 3.9 3.2 3.7 0.53 206 - <0.01 <0.01 <0.01 <0.01 NS 
Leptin 
 (ng/ml) 
2.21 1.46 1.43 1.50 1.65 1.84 2.15 0.110 378 <0.01 NS NS <0.05 NS <0.05 
Glucagon 
 (pg/ml) 
- 96.3 93.5 91.7 92.1 96.5 100.4 4.30 216 NS NS NS NS NS NS 
 Columns are means.  
  SED = standard error of the difference between treatment means. 
-  c1 (-2 week versus 2 week); c2 (2 week versus 4 week); c3 (4 week versus 6 week); c4 (6 week versus 8 week); c5 (8 week versus 12 week); c6 (12 week versus 15 
week). 
 n is  the total repeated observations of animals 
* NS = non-significant 
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Table4.5:Effectoflactationalstage(WEEK)oncirculatingmetabolites
 
Factors: WEEK   Contrasts- P val. 
Parameters: -2

 2

 4

 6

 8

 12

 15

 SED

 n
 
 c1 c2 c3 c4 c5 c6 
Glucose  
(mmol/l) 
3.03 3.07 3.27 3.44 3.60 3.74 3.75 0.090 246 NS
*
 <0.05 <0.05 <0.05 NS NS 
BOHB  
(mmol/l) 
0.70 0.73 0.68 0.59 0.60 0.61 0.62 0.074 248 NS NS NS NS NS NS 
NEFA  
(mmol/l) 
0.45 0.88 0.54 0.47 0.28 0.24 0.23 0.085 249 <0.01 <0.05 NS <0.05 NS NS 
Urea  
(mmol/l) 
1.63 2.11 2.26 2.51 2.67 2.71 2.90 0.124 249 <0.01 NS <0.05 NS NS NS 
 Columns are means.  
  SED = standard error of the difference between treatment means. 
-  c1 (-2 week versus 2 week); c2 (2 week versus 4 week); c3 (4 week versus 6 week); c4 (6 week versus 8 week); c5 (8 week versus 12 week); c6 (12 week versus 15 
week). 
 n is  the total repeated observations of animals 
* NS = non-significant 
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Table4.6:Effectoflactationalstage(WEEK)onproductivetraits
 
Factors: WEEK   Contrasts- P val. 
Parameters: 2

 4

 6

 8

 12

 15 SED

 n
 
 c2 c3 c4 c5 c6 
DMI  
(kg/d) 
17.9 20.8 22.2 22.8 22.7 22.3 0.23 352 <0.01 <0.01 <0.01 NS NS 
LWT  
(kg) 
654.7 645.2 650.0 657.4 667.6 669.3 3.00 352 <0.01 NS
*
 <0.01 <0.01 NS 
Milk yield  
(kg/d) 
35.1 43.2 45.9 46.9 45.6 44.1 0.51 352 <0.01 <0.01 <0.05 <0.05 <0.01 
BCS  
(units 1-5) 
2.95 2.60 2.45 2.51 2.64 2.77 0.037 418 <0.01 <0.01 <0.05 <0.01 <0.01 
MEBAL  
(MJ/d) 
-24.3 -12.6 -5.4 1.1 5.7 2.7 1.70 352 <0.01 <0.01 <0.01 <0.05 NS 
 Columns are means.  
  SED = standard error of the difference between treatment means. 
-  Contrasts: c2 (2 week versus 4 week); c3 (4 week versus 6 week); c4 (6 week versus 8 week); c5 (8 week versus 12 week); c6 (12 week   versus 15 week).  
 n is  the total repeated observations of animals 
 * NS = non-significant 
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Table4.7:EffectofdietandBCSatcalving(CONDITION)oncirculatingmetabolichormones
 
Factors: DIET  CONDITION  
Parameters: HS

 n1
- HF n2 - SED

 P  FAT

 n3 

 THIN

 n4 

 SED

 P  
Adiponectin 
(ng/ml) 
8.29 170 8.77 172 0.745 0.23 8.34 229 8.92 113 1.130 0.73 
Insulin 
 (ng/ml) 
0.46 168 0.38 162 0.027 0.01 0.40 223 0.43 107 0.029 0.37 
GH 
 (ng/ml) 
4.7 94 4.2 112 0.32 0.31 4.7 126 4.2 80 0.54 0.30 
Leptin  
(ng/ml) 
1.75 165 1.67 167 0.183 0.66 1.59 224 1.82 108 0.265 0.41 
Glucagon  
(pg/ml) 
96.6 105 93.0 111 2.61 0.16 96.8 140 92.8 76 5.41 0.46 
 Means for high-starch (HS) and high-fat (HF) diet groups, and FAT (>3.25) and THIN (3.25) BCS at calving groups. 
-  n1 and n2 are the repeated observations of animals fed with HS and HF diets, respectively. 
  
  n3 and n4 are the repeated observations of animals assessed FAT and THIN at calving, respectively. 
 SED = standard error of the difference between treatment means. 
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Table4.8:EffectofdietandBCSatcalving(CONDITION)oncirculatingmetabolites
 
Factors: DIET  CONDITION  
Parameters: HS

 n1
- HF n2 - SED

 P  FAT

n3 

 THIN

n4 

 SED P  
Glucose  
(mmol/l) 
3.56 98 3.44 104 0.096 0.20 3.44 117 3.56 85 0.113 0.28 
BOHB  
(mmol/l) 
0.54 98 0.70 107 0.051 0.002 0.66 120 0.58 85 0.052 0.13 
NEFA  
(mmol/l) 
0.36 98 0.49 107 0.065 0.044 0.48 123 0.37 82 0.066 0.08 
Urea  
(mmol/l) 
2.65 96 2.41 109 0.119 0.047 2.63 121 2.44 84 0.163 0.23 
  Means for high-starch (HS) and high-fat (HF) diet groups, and FAT (>3.25) and THIN (3.25) BCS at calving groups.  
-  n1 and n2 are the repeated observations of animals fed with HS and HF diets, respectively. 
  
  n3 and n4 are the repeated observations of animals assessed FAT and THIN at calving, respectively. 
  SED = standard error of the difference between treatment means. 
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Table4.9:EffectofdietandBCSatcalving(CONDITION)onproductiontraits
 
Factors: DIET  CONDITION  
Parameters: HS

 n1
- HF n2 - SED

 P FAT

 n3 

 THIN

 n4 

 SED

 P 
DMI  
(kg/d) 
21.0 176 21.4 176 0.35 0.23 22.1 237 20.3 115 0.72 0.02 
LWT 
 (kg) 
657.7 176 657.6 176 4.21 0.99 656.5 237 658.2 115 5.53 0.68 
Milk yield  
(kg/d) 
42.8 176 42.5 176 0.80 0.75 45.4 237 39.9 115 1.99 0.01 
BCS  
(units 1-5) 
2.61 180 2.60 178 0.046 0.92 2.75 240 2.47 118 0.075 0.01 
ǻBCS  
(units 1-5) 
0.60 30 0.58 29 0.083 0.81 0.77 40 0.41 19 0.122 0.01 
MEBAL  
(MJ/d) 
-4.7 176 -6.2 176 2.05 0.46 -5.6 237 -5.3 115 1.59 0.87 
 Means for high-starch (HS) and high-fat (HF) diet groups, and FAT (>3.25) and THIN (3.25) BCS at calving groups. 
-  n1 and n2 are the repeated observations of animals fed with HS and HF diets, respectively. 
 
   n3 and n4 are the repeated observations of animals assessed FAT and THIN at calving, respectively. 
 SED = standard error of the difference between treatment means. 
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Figure 4.3: Relationships among DMI and circulating adiponectin, glucose, leptin, MEBAL, and milk yield in FAT and THIN cows at
calving. GEE regression was performed for FAT and THIN cows (Table 4.3). In this model, DMI was the dependent variable and
adiponectin, glucose, leptin, MEBAL, and milk yield were independent. Parameter estimates for regression models are presented in Table
4.10 for THIN cows at calving and Table 4.11 for FAT cows at calving. Model fitness, regression equations to predict DMI, and R-squared
coefficients were presented to (A) for THIN cows at calving and (B) for FAT cows at calving. 
(A) THIN cows at calving (B) FAT cows at calving 
”DMI=0.318*MY + 0.057*MEBAL - 0.043*ADP + 8.74             
 
                                      (R2 = 0.88) 
”DMI=0.293*MY + 0.055*MEBAL + 0.047*ADP - 0.54* 
GLU+10.71            
  
 
(R
2 = 0.78) 
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Table4.10:Regressionparameterestimatesforprediction
ofDMIinTHINcowsatcalving  Table4.11:RegressionparameterestimatesforpredictionofDMIinFATcowsatcalving
Parameters in the model 
Beta (b) 
Coefficient 
SE

 P   Parameters in the model 
Beta (b) 
Coefficient 
SE

 P  
Constant 8.74 1.24 0.001  Constant 10.71 1.32 0.001 
Adiponectin (ADP) -.043 0.010 0.001  Adiponectin (ADP) .047 0.028 0.097 
Milk yield (MY) .318 0.022 0.001  Milk yield (MY) .291 0.020 0.001 
MEBAL .057 0.011 0.001  MEBAL .055 0.011 0.001 
Leptin .031 0.086 0.72  Leptin .014 0.145 0.92 
Glucose (GLU) -.156 0.271 0.56  Glucose (GLU) -.539 0.299 0.07 

Standard error of beta coefficient   

Standard error of beta coefficient 
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4.5.DISCUSSION
 
 
 
Transition from late pregnancy to early lactation is accompanied by substantial 
homeostatic and homeorhetic adaptations in energy and nutrient partitioning (Bauman & 
Currie, 1980; Beever, 2006).  In early lactating cows, increased circulating GH, PRL, 
NEFA, BOHB, and glucocorticoids (GC) and decreased circulating insulin and leptin,  
induce metabolic adaptations in liver and insulin dependent tissues that prioritise glucose 
partitioning to the mammary gland (Jorritsma et al., 2003; Leroy et al., 2008; Leroy et al., 
2010). Adiponectin, because of its insulin sensitising actions (Berg et al., 2002; Matsuzawa 
et al., 2004; Kadowaki & Yamauchi, 2005), could be another putative regulator of 
metabolism during the transition from pregnancy to lactation (Mazaki-Tovi et al., 2005; 
Mitchell et al., 2005) . The purposes of this study were to measure circulating and milk 
adiponectin and to assess the impact of diet and body condition at calving on circulating 
adiponectin values in dairy cows. 
 
 
4.5.1.Measurementofplasmaandmilkadiponectin
 
Circulating and milk adiponectin were measured in this study by using a commercially 
available human adiponectin kit. There is no validated RIA kit for measuring bovine 
adiponectin, but the Linco kit has been used for cows (Raddatz et al., 2008), horses 
(Gordon & McKeever, 2005; Gordon et al., 2006; Kearns et. al, 2006; Pratt et al., 2005), 
and dogs (Gayet et al., 2007; Brunson et al., 2007). Bovine adiponectin protein sequence 
shares about 91% homology with mouse, and murine adiponectin protein sequence is 
similar up to 85% with human, rat, and monkey adiponectin protein sequences (Berg et al., 
2002). This high conservation and homology of adiponectin molecule among species and 
the fact that Linco kit measured both bovine circulating adiponectin and milk adiponectin 
in this study, plasma adiponectin in another experiment (Raddatz et al., 2008), and 
circulating adiponectin in other species (Gordon & McKeever, 2005; Gordon et al., 2006; 
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Kearns et. al, 2006; Pratt et al., 2005; Gayet et al., 2007; Brunson et al., 2007), suggest 
that Linco kit can be used to assess bovine adiponectin. 
  
In this experiment, mean plasma adiponectin varied from 6.5±0.75 ng/ml to 11.1±1.06 
ng/ml, and some cows had constantly elevated plasma adiponectin throughout the 
experiment. Raddatz et al., (2008) reported that plasma adiponectin values varied from 
8.3±1.4 ng/ml to 16.0±2.7 ng/ml in early lactating cows and individual cows had 
consistently high or low adiponectin levels throughout the sampling period, in agreement 
with the present study. Circulating adiponectin values were not normally distributed, but 
were left skewed and highly peaked; this agrees with distributions reported for plasma 
adiponectin by Cassidy et al. (2009) and Pischon et al. (2005) in humans and Barnea et al. 
(2006) in mice. Adiponectin concentration in plasma has been reported to be two to three 
times higher than other hormones (Ahima, 2006); in the present study, mean circulating 
adiponectin was significantly greater than the mean of insulin, leptin, GH and glucagon. 
The high autocorrelation of circulating adiponectin values might indicate that plasma 
adiponectin concentration was tightly genetically controlled and other factors had only 
minimal impact, but this needs to be further elucidated.  
  
Mean plasma adiponectin was 8.6±0.33 ng/ml whereas milk adiponectin was 11.5±2.60 
ng/ml. Adiponectin concentrations in human breast milk ranged from 3.9 to 30.4 ng/ml 
(Bronsky et al., 2006), and from 4.2 to 87.9 ng/ml (Martin et al., 2006).  Ahima (2006) 
reported that normal concentrations in human serum ranged from 5 to 30 ȝg/ml. No study 
directly compared circulating and milk adiponectin. In the present study, milk and plasma 
adiponectin concentrations were similar, which may imply that milk adiponectin is 
excreted at concentrations similar to blood, but this hypothesis needs to be investigated 
further.  
 
In mice and human milk, adiponectin decreases over the course of lactation. Human milk 
adiponectin concentrations decrease approximately 5% – 6% with each month of lactation 
(Newburg et al., 2010; Savino & Liguori, 2008). In the present study, milk adiponectin 
concentrations did not show the same trend, although samples were collected only for the 
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first two months of lactation; nevertheless, adiponectin varied with day in milk and the 
pattern needs to be investigated further. Another finding of this study was that milk 
adiponectin was not different for cows with high or low milk yield, which also needs to be 
investigated further.   
 
 
4.5.2.Theimpactoflactationalstageoncirculatingadiponectin
 
This study showed that, as in humans (Asai-Sato et al., 2006; Ritterath et al., 2008), the 
transition from pregnancy to lactation in dairy cows is associated with a reduction in the 
plasma concentration of adiponectin. The same pattern of decreased AdipoR1 and 
AdipoR2 mRNA expression in subcutaneous fat tissue during transition from pregnancy (1 
week precalving) to lactation (3 weeks postcalving) was reported by Lemor et al. (2009) in 
high yielding dairy cows. The result of this study is generally in agreement with Komatsu 
et al. (2007) who reported that adiponectin mRNA expression in adipose tissue was higher 
in non-lactating cows (dried-off for 3–10 weeks) than cows at peak lactation (8–11 weeks 
after parturition). The present study generally agrees with Ohtani et al. (2011) who 
reported that mammary gland adiponectin mRNA expression was lower in early and late 
lactation compared with non-pregnant or dry cows. Moreover, the present study found that 
after the 4
th
 week postpartum circulating adiponectin is significantly increased and remains 
at the same level until the 12
th
 week postpartum. Another study measured circulating 
adiponectin in cows by using the same RIA kit (Raddatz et al., 2008) reported that 
circulating adiponectin was significantly increased from (8.3 ± 1.4 ng/ml) in the first week 
to (16.0 ± 2.7 ng/ml) at week 4 postpartum and then declined to remain at 12-13 ng/ml 
until the 11
th
 week postpartum. This pattern of circulating adiponectin is also in agreement 
with the pattern found in the present study. Furthermore, this study suggests that after 12
th
 
week postpartum there is a significant reduction in circulating adiponectin, whereas plasma 
adiponectin values do not change during the period from 4 to 12 week postpartum. In the 
study of Komatsu et al. (2007), adiponectin mRNA expression in adipose tissue from four 
cows in early lactation (8–11 weeks after parturition) did not differ from that of four cows 
in late lactation (40–50 weeks after parturition). This result does not directly contradict the 
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finding of the present study because Komatsu et al.  (2007) measured expression of mRNA 
in adipose tissue at a much later stage of lactation. 
 
In the present study, stage of lactation affected the majority of circulating metabolic 
hormones, metabolites, and production traits, but circulating adiponectin showed 
correlations only with circulating GH and ǻBCS, although there was a weak negative 
association between plasma adiponectin and glucose. The weekly changing pattern of 
circulating adiponectin can be partially explained by the negative relationship between GH 
and adiponectin; GH was elevated 2 weeks postpartum and adiponectin reached a nadir at 
the same point of time. Subsequently, GH decreased steadily until week 12 and then 
increased slightly, while adiponectin increased until week 4 and then remained stable until 
week 12and then decreased. ǻBCS was correlated negatively with plasma adiponectin and 
positively with circulating GH, and cows gained BCS after week 8 postpartum in this 
experiment, which might be another reason for the decrease in adiponectin between weeks 
12 and 15. This is the first study to demonstrate a negative relationship between GH and 
adiponectin in dairy cows. However, this relationship needs to be investigated further.  
 
In the present study, milk yield was correlated positively with GH and negatively with 
adiponectin. This may indicate that GH is the major regulator of circulating adiponectin 
postpartum in dairy cows. It is known that genetic selection for milk yield led to higher 
circulating GH in dairy cows (Veerkamp et al., 2003), which makes the dairy cow the most 
suitable animal model to study relations between GH and adiponectin. Lam et al. (2004) 
reported that circulating adiponectin was low in patients who suffered from acromegaly, 
and that circulating adiponectin increased after GH-lowering therapies. Nilsson et al.  
(2005) demonstrated that gene expressions of AdipoR1 and AdipoR2 in human adipose 
tissue are differentially regulated by PRL and GH. Also, PRL and GH reduced adiponectin 
secretion by human adipose tissue in vitro and in vivo in mice. Rodriguez-Pacheco et al. 
(2007) investigated if adiponectin plays a central role, similar to leptin, in regulating 
somatotroph and gonadotroph function. They showed that short-term Adiponectin 
exposure abolishes both basal and stimulated (by Ghrelin and GnRH) secretion of GH and 
LH by rat pituitary cells in vitro. According toLópez-Siguero et al. (2010) GH deficient 
”Chapter4Measurementofplasma&milkadiponectin


128

children had higher circulating adiponectin than healthy controls. These studies are in line 
with the result of the present study as they imply negative correlation between circulating 
GH and adiponectin. 
 
Other hormonal signals may be associated with changes in circulating adiponectin by 
week. According to Asai-Sato et al. (2006) circulating adiponectin declined slightly as 
pregnancy advanced and reached its lowest level during lactation, possibly because PRL 
affects regulation of maternal metabolism through suppression of adiponectin. Shi et al. 
(2010) demonstrated that GC decreased adiponectin in rat. TNF-Į is another adipokine 
which is potent negative regulator of systemic insulin sensitivity, which has also been 
demonstrated to stimulate leptin (Zumbach et al., 1997) but inhibits adiponectin production 
(Fasshauer et al., 2002; Ruan et al., 2002). It is possibly that elevated GH, PRL, and TNF-
Į, and GC could account for diminished circulating adiponectin 2 weeks postpartum, 
although TNF-Į, PRL and Glucocorticoids were not measured in the present study. 
 
The role of adiponectin is closely connected to glucose metabolism through enhancing 
insulin sensitivity and increasing glucose uptake via the GLUT4 transporter (Dridis & 
Taouis, 2009). Adiponectin increases insulin sensitivity in isolated primary hepatocytes, 
resulting in decreased glucose production (Berg et al., 2001). NEFA and glucose are 
negatively correlated with circulating adiponectin in rodents and humans (Fruebis et al., 
2001; Yang et al., 2004; Pischon et al., 2005; Qi et al., 2005; Cassidy et al., 2008) but, in 
the present study, although circulating adiponectin tended to be negatively correlated with 
circulating glucose, adiponectin was not correlated with NEFA. 
 
 
4.5.3.TheimpactofdietandBCSatcalvingoncirculatingadiponectin
 
There was no effect of diet and BCS at calving on circulating adiponectin, even though 
cows fed on the HS diet had higher insulin but lower BOHB and NEFA than cows fed on 
the HF diet. Also, diet had no effect on production traits. Circulating insulin, BOHB, and 
NEFA were not correlated with adiponectin. Yang et al. (2004) observed that rats fed on a 
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HF diet showed significant increases in postprandial serum triglycerides, FFA, and insulin 
but no change in serum glucose and adiponectin. Xu et al. (2007) explored the effect of 
dietary supplementation of cysteamine on expression of adiponectin and adiponectin 
receptors in various tissues of rat. They observed no significant change in adiponectin 
mRNA expression in adipose tissue whereas circulating GH remained unchanged and 
insulin was higher in the treatment group than in the control. Muhlhausler et al. (2007) 
reported that maternal plasma glucose and insulin and foetal plasma glucose and insulin 
were significantly increased in well-fed ewes and their foetuses when compared with 
control ewes and their foetuses, and this rise was followed by significantly increased 
circulating adiponectin in both maternal and foetal plasma of well-fed animals. These three 
studies may suggest that plasma adiponectin concentrations change only when circulating 
GH or/and glucose are changed, in agreement with the present study. Circulating GH and 
glucose were not altered by dietary treatments in this experiment, which was possibly the 
reason diet had no effect on circulating adiponectin.  
 
Body condition score at calving had no effect on metabolic hormones and metabolites, 
which could be the reason it did not influence circulating adiponectin in this experiment. 
Plasma GH and glucose concentrations were not different in THIN and FAT cows at 
calving. Thus, it is possible that circulating adiponectin was unchanged by BCS at calving 
because this treatment did not influence circulating GH and glucose which affect 
circulating adiponectin. However, DMI, milk yield, and ǻBCS were higher in FAT cows at 
calving than THIN cows at calving. ǻBCS was correlated positively with GH and 
negatively with plasma adiponectin concentrations in this experiment. This means that 
FAT cows at calving should have had lower circulating adiponectin and higher circulating 
GH than THIN cows at calving. Unfortunately, this was not the case in the present study. 
GH was substantially reduced in human obesity (Williams et al., 1984), but in dairy cows 
genetic improvement has led to animals with higher BCS and circulating GH (Veerkamp et 
al., 2003). In the present study, BCS at calving was generally high in both condition 
groups, so the groups consisted of fat to over-fat cows, which might explain the lack of 
effect on circulating GH. 
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A metabolic explanation why in the present study BCS at calving and BCS did not 
influence adiponectin could be the following.  The present study was carried out in 
pregnant and lactating animals. It is known that pregnancy and lactation require 
considerable energy uptake and mobilization by the mother (Bauman, 2000). Furthermore, 
the first half of pregnancy is associated with acute fat mass deposition to ensure proper 
embryonic development, and the second half of pregnancy and early lactation involve the 
development of an insulin-resistant state in the mother in order to increase hepatic 
gluconeogenesis and decrease glucose uptake in maternal muscle and adipose tissue 
(Bauman & Currie, 1980; Leroy et al., 2010). This latter adaptation results in maximum 
supply of maternal glucose to the foetus (in late pregnancy) or mammary gland (in early 
lactation) and adiponectin, due to its insulin sensitizing effects, will preferably channel 
nutrients to maternal tissues rather than to foetus or mammary gland. So, it is possible that 
mammals have developed an alternative mechanism that results in uncoupling of maternal 
body condition with circulating adiponectin levels. In humans, there is a negative 
relationship between circulating adiponectin and pre-gestational BMI (Lopez-Bermejo et 
al., 2004; Retnakaran et al., 2004; Williams et al., 2004), but adiponectin levels throughout 
pregnancy are not correlated with maternal BMI (Mazaki-Tovi et al., 2005; Jansson et al., 
2008). According to Mazaki-Tovi et al. (2005) the disruption of the negative correlation 
between adiponectin and maternal weight can result from several factors, but dramatic 
hormonal changes during pregnancy, such as increased levels of oestrogen, prolactin, 
cortisol, and testosterone that characterize normal human pregnancy, must be the main 
reason. Moreover, circulating adiponectin showed a strong negative relationship with 
visceral body fat and visceral body fat is strongly related with BMI in humans (Matsubara 
et al., 2002; Cnop et al., 2003; Lara-Castro et al., 2006). It is doubtful if BCS is related to 
visceral body fat of the cow, except for a possible negative correlation in thin cows 
(Garnsworthy, 2006), and that is possibly another reason why circulating adiponectin was 
not influenced by BCS at calving. Lemor et al. (2010) showed that mRNAs of both 
adiponectin receptors were more highly expressed in ovine visceral than in ovine 
subcutaneous fat tissue, whereas mRNA of adiponectin did not differ. The other adipokine, 
leptin, measured in the present study was also not affected by BCS at calving, which 
supports the above suggestion. Also, according to Mousavinasab et al. (2005) only in 
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severely obese cases (BMI30 kg/m2) with more than 10% decrease in BMI circulating 
adiponectin tended to increase in humans, although not statistically significantly.  
 
In the present study, circulating insulin, glucagon, leptin, NEFA, BOHB, and urea were not 
correlated with circulating adiponectin. Some studies suggest that the relationship between 
adiponectin and leptin is negative (Matsubara et al., 2002; Huypens, 2007). However, 
other studies reported positive correlation between leptin and adiponectin (Pardo et al., 
2004; Rossi et al., 2005) or no correlation (Park et al., 2004) which was the case in this 
experiment. In line with this study, Giahi et al. (2008) in overweight diabetic and non-
diabetic men and Raddatz et al., (2008) in dairy cows showed that circulating insulin was 
not correlated with circulating adiponectin. Yamauchi et al. (2001) showed that 
adiponectin is a putative stimulator of protein synthesis and inhibitor of protein 
degradation through activation of the insulin signalling pathway, but circulating 
adiponectin was uncorrelated with plasma urea in this experiment. Also, BCS, milk yield, 
MEBAL, and LWT were not correlated with circulating adiponectin in this experiment. 
Raddatz et al. (2008) found no correlation of BCS, insulin, milk yield, DMI, and energy 
corrected milk yield with adiponectin, in agreement with the present study.  
 
It has been demonstrated that AMPK activation and deactivation in hypothalamic neural 
cells play a key role in monitoring energy status and regulating food intake (Andersson et 
al., 2004; Minokoshi et al., 2004; Claret et al., 2007; Lim et al., 2010). Leptin and 
adiponectin control AMPK with leptin to deactivate (Minokoshi et al., 2008) and 
adiponectin to activate it (Kubota et al., 2007) in hypothalamic neurons. Receptors of 
leptin and adiponectin have been found in various hypothalamic regions and presence of 
leptin and adiponectin have been ascertained in cerebrospinal fluid (Steinberg & Kemp, 
2007). Also, other stimuli, such as insulin and glucose, deactivate AMPK (Claret et al., 
2007). Kubota et al., (2007) showed that adiponectin enhances AMPK activity in the 
murine arcuate hypothalamus through its receptor AdipoR1 to stimulate food intake. In the 
present study, regression analysis demonstrated that adiponectin is likely to be related with 
DMI in dairy cows, but this relation is minimal and dependent on BCS at calving. The 
equations predict a negative relationship between circulating adiponectin and DMI for 
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THIN cows at calving, but a positive relationship for FAT cows at calving. In both 
equations, adiponectin beta coefficients are small compared with beta coefficients of other 
terms in the models, which suggests a minimal influence of circulating adiponectin on feed 
intake. Removal of adiponectin from the model reduced R
2
 by 1% for THIN cows at 
calving and 0.2% for FAT cows. Thus, adiponectin has only a marginal positive or 
negative effect on DMI depending on BCS at calving. However, this finding needs to be 
investigated further.  
 
AMY (aggregated milk yield at the end of the experiment) and PMY (previous milk yield) 
positively correlated with milk yield (AMY; rho= 0.753, PMY; rho= 0.473), DMI (AMY; 
rho= 0.595, PMY; rho= 0.365), and ǻBCS (AMY; rho= 0.434, PMY; rho= 0.281) Also, 
AMY positively correlated with PMY (rho= 0.513). Thus, milk yield, DMI, and ǻBCS 
were all correlated positively in the present study. This means that high yielding cows gave 
more milk, eat more feed, and lost more condition than low yielding cows. Moreover, 
ǻBCS negatively correlated with circulating adiponectin (rho= -0.173) and leptin (rho= -
0.261). Therefore, high yielding cows had lower circulating adiponectin and leptin than 
low yielding cows. In support of this, AMY (rho= -0.117) and PMY (rho= -0.256) 
negatively correlated with circulating adiponectin, whereas PMY negatively correlated 
with circulating leptin (rho= -0.122). ǻBCS positively correlated with circulating GH 
(rho= 0.253) in this study. This means that high yielding cows lost more condition 
postpartum, and they had higher circulating GH but lower circulating adiponectin and 
leptin than low yielding cows. In congruence with this, circulating adiponectin (rho= -
0.144) and leptin (rho= -0.319) were negatively correlated with circulating GH. 
Furthermore, ǻBCS positively correlated with milk yield (rho= 0.388), DMI (rho=0.382), 
and negatively correlated with circulating insulin (rho= -0.158). Additionaly, insulin 
positively correlated with leptin (rho= 0.356) and negatively correlated with circulating 
GH (rho= -0.287) in the present study. To sum up, high yielding cows in this experiment 
lost more condition postpartum, ate more feed and had higher circulating GH, milk yield 
and DMI but lower circulating adiponectin, leptin, and insulin than low yielding cows. It is 
known that selection for a higher yield increases DMI, GH, and BOHB (Veerkamp et al., 
2003; Leroy et al., 2010) and this is in agreement with the findings of this study. 
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Moreover, high yielding cows lose more condition postpartum than low yielding cows 
(Roche et al., 2009) and that is in line with the results. Leifers et al. (2005) suggested that 
leptin expression in adipose tissue is possibly regulated in early lactating cows by the 
double impact of insulin (positive) and GH (negative), which might be the case in the 
present study. This is the first study to suggest that due to increased circulating GH and its 
antagonistic relationship with adiponectin (and leptin), high yielding cows may have lower 
circulating leptin and adiponectin than low yielding cows. However, this result needs to be 
elucidated further.  
 
 
4.5.4.Conclusions
 
To conclude, circulating adiponectin and milk adiponectin were measured in dairy cows in 
the present study. Milk adiponectin varied by day in milk and it was unaffected by average 
daily milk yield. Circulating adiponectin was influenced by lactational stage, but was not 
influenced by diet and BCS at calving. The negative correlation between circulating GH 
and adiponectin may explain the effect of lactational stage on plasma adiponectin 
concentrations. Diet and BCS at calving did not influence circulating adiponectin values, 
mainly because they did not change circulating GH. ǻBCS was correlated negatively with 
leptin and adiponectin and may be a useful tool to study circulating adipokines in 
periparturient and early lactating cows. Regression analysis showed that adiponectin is 
likely to be related with DMI in dairy cows, but this relationship is minimal and dependent 
on BCS at calving. High yielding cows may have lower circulating leptin and adiponectin, 
and higher circulating GH than low yielding cows. However, these results need to be 
investigated further.  

 
 
 
 

5. Interrelationship of adiponectin with glucose
homeostasis,andtheeffectofcirculatingadiponectinlevels
onreproductiveperformanceindairycows



5.1.INTRODUCTION
 
Adiponectin is an adipokine secreted by adipose tissue, which improves the ratio of 
glucose to FFA and consequently has insulin sensitizing activity (Kadowaki & Yamauchi, 
2005; Ahima, 2006). In the liver, adiponectin decreases glucose output, increases FFA 
oxidation, and increases influx of NEFA. In muscle tissue, adiponectin increases FFA 
utilization and stimulates glucose usage (Kadowaki & Yamauchi, 2005; Garaulet et al., 
2007; Shetty et al., 2009). 

Lam et al. (2004) reported that circulating adiponectin was low in patients suffered from 
acromegaly and circulating adiponectin increased after GH-lowering therapies. Nilsson et 
al.  (2005) demonstrated that GH declined adiponectin secretion by human adipose tissue 
in vitro and in vivo in mice. Rodriguez-Pacheco et al. (2007) presented that short-term 
adiponectin exposure abolished both basal and stimulated (by Ghrelin and GnRH) 
secretion of GH by rat pituitary cells in vitro. According toLópez-Siguero et al. (2010) GH 
deficient children had higher circulating adiponectin than healthy controls. It is known that 
genetic selection for milk yield led to higher circulating GH in dairy cows (Veerkamp et 
al., 2003) and that makes dairy cow a suitable animal model to study relations between GH 
and adiponectin. However, the relationship between GH and adiponectin in dairy cows has 
not yet been investigated. 

Adiponectin and its receptors are present in theca and granulosa cells, oocytes and the 
corpus luteum (Lord et al., 2005; Ledoux et al., 2006; Ramachandran et al., 2007; 
Chabrolle et al., 2007a, 2007b). In sows, adiponectin is also present in follicular fluid at a 
concentration that is estimated to be 80–90% of the concentration in serum (Ledoux et al., 
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2006). Adiponectin may influence steroidogenesis but contradictory results were reported 
(Ledoux  et al., 2006; Lagaly et al., 2008; Chabrolle et al., 2009; Gutman et al., 2009; 
Pierre et al., 2009; Maillard et al., 2010). It has been hypothesized that adiponectin effects 
on the ovary are mediated through its insulin-sensitizing traits (Mitchell et al., 2005) and 
through its effect on the action of IGF-I (Dupont et al., 2008; Michalakis & Segars, 2010). 

The present study utilized the data generated by the previous experiment (data generated 
by Garnsworthy et al. (2009), in which circulating adiponectin values were measured and 
added in the working dataset as detailed in Chapter 4). In this dataset, some cows had 
persistently elevated plasma adiponectin concentrations throughout the experimental 
period. In line with this, Raddatz et al., (2008) measured circulating adiponectin in twenty-
six (26) lactating Holstein cows for the first 11 weeks of lactation, and they reported that 
individual cows had consistently high or low adiponectin levels throughout the sampling 
period. In the present study, cows were categorized according to high or low circulating 
adiponectin level. The main hypothesis was that elevated plasma adiponectin 
concentrations (up to three times) may result in changes in hormonal and metabolic profile, 
and/or reproductive performance. This hypothesis has not previously been tested in dairy 
cows. Also, using a multivariate approach, the association of circulating adiponectin with 
other metabolic hormones and metabolites, and glucose homeostasis were explored in high 
yielding and low yielding cows. The interrelationships of adiponectin with the metabolic 
and hormonal components of glucose homeostasis have not been examined previously in 
dairy cows.  
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5.2.MATERIALSANDMETHODS
5.2.1.Data
 
This study utilized the dataset generated by the study of Garnsworthy et al. (2009). In the 
current study, circulating adiponectin values were measured and added (Chapter 4). Key 
points of materials and methods, further statistical analysis, and handling of the data are 
presented hereinafter. 
 
 
5.2.2.Experimentaldesign
 
Data generated by the previous experiment (Chapter 4) were used in the present study. In 
this dataset, diet and BCS at calving had no effect on circulating adiponectin, whereas 
lactational stage affected plasma adiponectin concentrations. Moreover, some cows had 
persistently elevated plasma adiponectin concentrations (up to 3 times the average) 
throughout the experimental period. Scatter plot graphical representation of circulating 
adiponectin values (Figure 5.1) illustrated that cows with elevated plasma adiponectin 
concentrations had a tendency to express characteristic peaks of circulating adiponectin for 
more than two weeks throughout the experimental period. Based on this observation, cows 
were grouped into a HIGH adiponectin subgroup (6 cows; 57, 94, 146, 219, 330, and 331, 
average circulating adiponectin; 21.2±1.32 ng/ml) and a NORMAL subgroup (54 cows, 
average circulating adiponectin; 7.1±0.23 ng/ml). Thus, the main factor studied in this 
experiment was ADIPONECTIN LEVEL (HIGH versus NORMAL).  
 
The experimental design was a retrospective case-control epidemiological study. This 
design is highly susceptible to bias error, sources of which are not always obvious. 
However, there are occasions in which this design is the best choice in practice. This is 
where the examined trait is rare or takes a long time to develop (Woodward, 1999). 
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Multivariate analysis was performed to examine the associations of adiponectin with other 
metabolic hormones and metabolites, and central glucose homeostasis. This analysis and 
data arrangement are explained in § 5.3.2. 
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 Figure 5.1: Scatter plot graphical representation of circulating adiponectin values (n= 387) by week of experiment. Outlier
adiponectin values came consistently from 6 cows (id; 57, 94, 146, 219, 330, and 331) which showed the same trend (more than two weeks
throughout the experimental period) for higher adiponectin values.
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5.2.3.Feedingandmilking
 
These are described in § 3.2.3.  
 
 
5.2.4.Reproductivemanagement
 
Cows were artificially inseminated at the first or second oestrus. Insemination was 
repeated at any subsequent oestrus until the end of the experiment at 120 days post partum. 
Oestrus was detected using a combination of behavioural observations, pedometer activity 
monitoring and milk progesterone profiles. Milk progesterone was monitored daily from 4 
days before expected oestrus until signs of oestrus were detected; monitoring then returned 
to twice in a week until 4 days before the next expected oestrus (21 days later). 
Progesterone profiles were used subsequently to classify oestrous cycles as normal or 
abnormal (DOV1, DOV2, PCL1 or PCL2), following the definitions of Lamming & 
Darwash (1998) (Table A.2 in appendix). 
 
Cows that had not been inseminated, or were not cycling normally, by 90 days post partum 
were scanned by trans-rectal ultrasound (Aloka SSD-500 scanner equipped with a 5-MHz 
linear array transducer, Aloka Co., Ltd., Tokyo, Japan) to investigate the existence of 
cystic body. 
 
5.2.5.Recording,samplingandanalysis
 
Milk yield and feed intake were recorded daily throughout the experiment whereas 
previous milk yield obtained from dairy records. Live weight and BCS (units; 0-5) were 
recorded weekly whereas ǻBCS calculated as BCS at calving minus BCS at 15 week 
postpartum. Collection and preparation of the samples, and all methods and approaches 
were used to measure animal productive traits, metabolites, and metabolic hormones are 
analytically described in the appendices and § 4.2.2.4. 
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5.3.STATISTICALANALYSIS
 
 
5.3.1 Effect of Adiponectin levels on metabolic and hormonal profiles, and
reproductiveperformance
 
Data were analyzed by using PASW
©
 18 Edition (SPSS Inc., Chicago, USA). Generalized 
Estimating Equations (GEE) and Generalized Linear Models (GLM) were used to test 
specific hypotheses (Lindsey, 1997; McCullagh & Nelder, 1989; Dobson, 2002; Horton & 
Lipsitz, 1999). 
 
Family distribution and link function were selected as detailed in § 3.3. Selection of GLM 
and GEE models was performed based on AIC and QIC criterion, as detailed in § 3.3.  
 
Parameter estimates of GEE models are presented as marginal means plus/minus standard 
error of the difference (SED) in tables. Estimated marginal means, SEs and SEDs were 
obtained by using Least Significant Difference (LSD) adjustment for multiple comparisons 
in PASW
©
 18 statistical program. P values were calculated by Newton-Raphson Maximum 
Likelihood (ML) method and effects were considered statistically significant when P value 
was less than 0.05. P values equal or less than 0.1 were considered to show a trend. 
 
The GEE and GLM models selected to test the effects of ADIPONECTIN LEVEL on 
productive traits, reproductive performance, and hormonal and metabolic profile are 
illustrated by Tables 5.1, 5.2, & 5.3. The effects of ADIPONECTIN LEVEL and leptin on 
days to first oestrus (days to oestrus were count data and in such data Poisson distribution 
function with log link function fits better) were assessed by fitting GLMs (Tables 5.1 & 
5.2). The effect of ADIPONECTIN LEVEL on the probability for cows to be pregnant was 
examined by fitting a generalized logistic regression model (Table 5.2). Cows non 
pregnant at the end of the experiment were censored at 120 days post partum and Kaplan
Meier estimates of the survivor function were compared for cows with HIGH and 
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NORMAL adiponectin levels by using Log-rank test (Landau & Everitt, 2004; Jenkins, 
2005; Guo, 2010). The models selected for survival analysis are illustrated in Table 5.4. 
 
Data from milk progesterone profiles were pooled into two groups; cows with NORMAL 
milk progesterone profile (37 cows) and cows with ABNORMAL milk progesterone 
profile (23 cows; 5cows with DOV1, 8 cows with DOV2, 1 cow with PCL1, and 9 cows 
PCL2). In this way, milk progesterone profile was transformed to a binary variable, and 
causal effects of other continuous and binary variables on it were examined by common 
logistic regression (Table 5.3). Presence of a follicular cyst at day 90 (CYSTIC BODY) 
was binary output (8 cows were found with follicular cysts at 90 days postpartum; the 
remaining 52 cows had no cyst) and causal effects were examined by multiple logistic 
regression models (Table 5.3). The outputs of generalized logistic regression and multiple 
logistic regression models are presented as probabilities, unstandardized beta (b) 
coefficients, and odds ratio (exp (b)) with 95% confidence intervals. Fitness of multiple 
logistic regression models was assessed as detailed in § 3.3. 
 
Receiver Operating Characteristic (ROC) analysis was conducted to evaluate the 
performance and the accuracy of logistic regression models, as detailed in § 3.3.  
 
A Shapiro-Wilk test was used to assess whether the distribution of variables was normal. 
Non-random association between two categorical variables was tested by cross-tabulation 
and Fischer’s exact test. P values equal or less than 0.05 were considered statistically 
significant whereas P values equal or less than 0.1 were considered to show a trend. 
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Table5.1:Selectedmodelsforanalysisoftheeffectofcirculatingadiponectinlevelsonmetabolites,metabolic
hormones,andproductiontraits
RESPONSE
VARIABLE(Y)
TYPEOF
MODEL
PREDICTORS
(X)
SUBJECT(ID)
VARIABLE
WITHIN ?
SUBJECT
VARIABLE
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX
WORKING
CORRELATION
MATRIX
STATISTICS
”Insulin
”Glucagon
”Urea
”DMI
”Milkyield
”LW
”MEBAL
GEE ”ADP
LEVELS
COW
(60) WEEK PARITY
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable
n=377;QIC=23
n=216;QIC=126,067
n=249;QIC=167
n=352;QIC=4,041
n=352;QIC=27,836
n=352;QIC=255,866
n=352;QIC=85,754
”Adiponectin GEE ”ADP
LEVELS
COW
(60) WEEK PARITY Gamma log Robust Exchangeable n=387;QIC=166

”Leptin

GEE ”ADP
LEVELS
COW
(60) WEEK
PARITY
GH
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable n=204;QIC=232
”ȴBCS
”BCSat
calving
GLM ”ADP
LEVELS  ?  ? PARITY
Gaussian
(Normal)
Identity
(ID) Robust  ?
n=59;AIC=69; LR(
ʖ2=5.9,df=1,P=0.01)
n=60;AIC=35;LR(
ʖ2=4.1,df=1,P=0.04)
”IGF ?I GEE ”ADP
LEVELS
COW
(60) WEEK PARITY
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable n=197;;QIC=516,092
”Glucose
 GEE
”ADP
LEVELS
COW
(60) WEEK
PARITY
GH
Leptin
Gaussian
(Normal)
Identity
(ID) Robust Exchangeable
n=188;QIC=64

”GH
”BOHB
”NEFA
GEE ”ADP
LEVELS
COW
(60) WEEK PARITY
Inverse
Gaussian

Log Robust Exchangeable
n=206;QIC=35
n=248;QIC=113
n=249;QIC=333
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Table5.2:Selectedmodelsforanalysisofreproductivetraits
RESPONSEVARIABLE(Y) TYPEOF
MODEL
PREDICTORS
(X)
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX STATISTICS
”Pregnancy(binomialvariable;
0=nonpregnant,1=pregnant) GLM ”ADPLEVELS PARITY
Bernoulli
(Binomial) Logit Robust
n=60;AIC=75;LR(ʖ2=4.7,
df=1,P=0.03)

”Pregnancy(binomialvariable;
0=nonpregnant,1=pregnant) GLM ”ȴBCS PARITY
Bernoulli
(Binomial) Logit Robust
n=59;AIC=73; LR( ʖ2=10.9,
df=2,P=0.004)

”Pregnancy(binomialvariable;
0=nonpregnant,1=pregnant) GLM ”IGF ?I PARITY
Bernoulli
(Binomial) Logit Robust
n=60;AIC=73; LR( ʖ2=4.9,
df=1,P=0.02)

”Pregnancy(binomialvariable;
0=nonpregnant,1=pregnant) GLM ”MilkP4Profile PARITY
Bernoulli
(Binomial) Logit Robust
n=60;AIC=75; LR( ʖ2=7.5,
df=2,P=0.024)

”Pregnancy(binomialvariable;
0=nonpregnant,1=pregnant) GLM ”MilkYield PARITY
Bernoulli
(Binomial) Logit Robust
n=60;AIC=78;LR(ʖ2=4.3,
df=1,P=0.038)

”Daystofirstoestrus GLM ”Leptin PARITY Poisson log Modelbased n=58;AIC=587;LR(ʖ
2
=29.3,
df=2,P=0.001)
”Daystofirstoestrus GLM ”ȴBCS PARITY Poisson log Robust n=57;AIC=571;LR(ʖ
2
=11.2,
df=2,P=0.003)
”Daystofirstoestrus GLM ”ADPLEVELS PARITY Poisson log Modelbased
n=58;AIC=595; LR( ʖ2=21.1,
df=2,P=0.001)

”Daystoconception GLM  ?
Insulin
Milkyield
IGF ?I
Poisson log Robust
n=21;AIC=207; LR( ʖ2=31.5,
df=3,P=0.001)

”Daystoconception GLM ”Daystofirst
oestrus PARITY Poisson log Robust
n=21;AIC=213; LR( ʖ2=8.5,
df=2,P=0.01)
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Table5.3:Selectedmodelsforanalysisofmilkprogesteroneprofileandcysticbody
RESPONSEVARIABLE(Y) TYPEOF
MODEL
PREDICTORS
(X)
CONTINUOUS
COVARIATES
ERROR
DISTRIBUTION
FUNCTION
LINK
FUNCTION
COVARIANCE
MATRIX STATISTICS
”MILKP4 PROFILE(binomial
variable;0=NORMAL,1=
ABNORMAL)
GLM ”Daystooestrus PARITY Bernoulli
(Binomial) Logit Robust
n=58;AIC=74;LR(ʖ2=9.4,
df=2,P=0.01)
”MILKP4PROFILE(binomial
variable;0=NORMAL,1=
ABNORMAL)
GLM ”Adiponectin PARITY Bernoulli
(Binomial) Logit Robust
n=60;AIC=74;LR(ʖ2=6,
df=2,P=0.05)
”MILKP4 PROFILE(binomial
variable;0=NORMAL,1=
ABNORMAL)
Multiple
logistic
regression
”Milkyield
”DMI
”GH
PARITY Bernoulli
(Binomial) Logit Robust
n=59;AIC=78;LR(ʖ2=10.6,
df=4,P=0.031)
”CYSTICBODY(binomial
variable;0=nocyst,
1=follicularcyst)
GLM ”Daystooestrus PARITY Bernoulli
(Binomial) Logit Robust
n=58;AIC=45;LR(ʖ2=7.1,
df=2,P=0.03)
”CYSTICBODY(binomial
variable;0=nocyst,
1=follicularcyst)
Multiple
logistic
regression
”Insulin
”GH
”Glucose
”NEFA
PARITY Bernoulli
(Binomial) Logit Robust
n=57;AIC=32;LR(ʖ2=25.3,
df=5,P=0.001)
Table5.4:Selectedmodelsforsurvivalanalysis(KaplanǦMeiermodels)ofintervalfromcalvingtoconception
TIME
VARIABLE
(Survivaltime)
TYPEOF
MODEL
STATUS
VARIABLE(Event
variable)
FACTORS
(Groupvariables)
SURVIVAL
FUNCTIONS
COMPARISONTEST
OBSERVATIONS RIGHT
CENCORED
OBSERVATIONS
UNCENCORED
OBSERVATIONS
Dayspost
partum(0 ?120
dayspost
partum)
Kaplan ?
Meier
Pregnancy
(binomialvariable;
0=nonpregnant
1=event=pregnant)
”ADPLEVELS Log ?Rank(Mantel ?Cox) 60 39 21
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5.3.2Explorationofadiponectininterrelationshipswithglucose,BCS,metabolic
hormones,andmetabolites:amultivariateapproach
 
 
Data were analyzed by using AMOS
©
 (AMOS Development Corporation, Spring House, 
PA, USA). AMOS
©
 incorporates structural equation modelling (SEM) and path diagrams 
analysis (PDA). AMOS
©
 is a relatively new graphical SEM analysis tool that can fit 
multiple models in a single analysis by constraining parameters within the models 
(Cunningham & Wang, 2005; Arbuckle, 2007). SEM and PDA enable researchers to 
answer a set of interrelated research questions in a single, systematic, and comprehensive 
analysis by modelling the relationships among multiple independent and dependent 
variables simultaneously (Gefen et al., 2000; Ahn, 2002; Kline, 2005). The SEM approach 
is asymptotically the same as classical regression when its assumptions are satisfied. 
Regression works by minimizing variance but SEM is based on methods of maximization 
of likelihood (Gefen et al., 2000). The main assumption of SEM is achievement of 
multivariate normality, but deviations from multivariate normality may or may not affect 
the result of analysis (Kline, 2005; Cunningham & Wang, 2005; Arbuckle, 2007). 
 
The data used for this analysis were averaged by cow for each measured trait, metabolite, 
and metabolic hormone (i.e. one value per cow for adiponectin, leptin, etc) across the 
whole experimental period. Using this “main data set”, a basic model was constructed for 
circulating glucose and its interrelationships with adiponectin, insulin, leptin, glucagon, 
GH, BOHB, NEFA, and BCS. The fitness of this basic model was ascertained by using fit 
indices and chi-square statistics and the data were imputed by using Bayesian imputation 
(MCMC algorithm, for 10,000 observations assuming 0.1 autocorrelation) (Jackman, 2004; 
Dunson et al., 2005; Carter, 2006; Arbuckle, 2007). In this way, ten complete data sets 
plus the original were generated. The data sets were appended to the main data set and 
averaged by cow. Finally, a complete data set was created, containing one value for each 
measured trait, metabolite, and metabolic hormone for each individual cow. In this 
complete data set, the validity of the basic model was tested again using fit indices and chi-
square statistics and a 1,000 samples Bollen-Stine bootstrap for nonparametric data. For 
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non-normal data, Bollen-Stine bootstrap can provide the correct P values for the chi-square 
statistic to assess overall model fit. Bollen-Stine bootstrap uses the same chi-square 
hypothesis structure, at the conventional significance level of 0.05, to test the fitness of the 
model. If the P value is larger than 0.05 the model is accepted, and thus conclude that the 
model fits the data well, whereas the model is rejected if P value is smaller than 0.05 
(Arbuckle, 2007). The basic model showed excellent fitness to the data, so it was used as 
the source model for constructing further models. 
 
Cows were classified according to milk yield in the previous lactation (PMY) with a cut-
off point between high and low yielding cows of 10,000 kg/cow/lactation. PMY was 
modelled as a factor with two levels; LOW yielders (30 cows, 8,044 ±395 kg/lactation) and 
HIGH yielders (30 cows, 12,726±366 kg/lactation). DMI, milk yield, ǻBCS, and BCS at 
calving were assessed by multivariate analysis of variance (MANOVA) for statistically 
significant differences between PMY groups in the present lactation. Wilks lambda (Ȝ) test 
was used to examine the overall significance of the model. When the overall model was 
significant (P<0.05), then simultaneous effects of the independent variables on the 
dependent variable existed. Boxs test was used to test the equality of covariance between 
the groups with insignificant P values (P0.05) to denote that covariance matrices of the 
dependent variable were equal across groups. Levenes test examined whether or not the 
variance between independent variable groups was equal.  Non-significant P values 
(P0.05) of Levenes test denoted equal variance between groups. Power was the 
probability of correctly accepting or rejecting hypotheses based on the results of the test 
(Field, 2005; PASW
©
 18 Users guide, 2009).Differences in parity between PMY groups 
were assessed by Student’s t-test (two-sided). This analysis was performed to confirm 
LOW PMY cows and HIGH PMY cows were low yielding and high yielding cows, 
respectively, in the present lactation. Because the animals retrospectively allocated to PMY 
groups, a Fishers exact test performed to assess if PMY blocking of animals was biased 
by the original dietary treatments. 
 
Glucose interrelationships with adiponectin, metabolites, and metabolic hormones in cows 
with HIGH and LOW previous milk yield were examined by applying and modifying the 
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basic model in the “main data set”, so that the maximum fitness to be achieved, and under 
the condition that previous milk yield was HIGH or LOW. The validity and the fit of the 
models derived from the basic model were tested by model fit indices (Table 5.5) and 
comparison of the original correlation matrices with the model-based correlation matrices 
(Schreiber et al., 2006; Arbuckle, 2007). Also, models were run by Bayesian Estimation 
method and the Deviance Information Criterion (DIC) was used to determine the fit of the 
models to the data. 
 
Model parameter estimates (mean±SE) are illustrated in Table B.1 in appendix. 
 
Table5.5:Modelfitcriteriaandacceptablefitinterpretation
Model Fit Criterion Acceptable level Interpretation 
”Chi-square statistics 
(Ȥ2) P>0.05 indicates good fit 
Compares obtained chi-square 
value with table value 
for given degrees of freedom 
”Bollen-Stine 
nonparametric bootstrap 
P>0.05 indicates good fit 
Provide the correct P value for 
chi-square statistic when data 
are non-normal. 
”Comparative fitness 
index (CFI) 
0 (no fit) to 1 (perfect fit) 
Value close to 0.95 reflects a 
good model fit 
Normed fit index (NFI) 0 (no fit) to 1 ( perfect fit) 
Value close to 0.95 reflects a 
good model fit 
”Root-mean-square 
error of approximation 
(RMSEA) 
<0.05 ( good fit model) 
>1.0 ( not acceptable) 
Value less than 0.05 or  0.08 
indicates a good model fit 
Value more than 1.0 indicates 
the model is not 
acceptable 
”Akaikes information 
criterion(AIC) 
The smaller value is the 
better 
Compares values in alternative 
models 
”Deviance Information 
Criterion (DIC) 
Posterior predictive P 
value should be near 0.5 
for a correct model, with 
values toward the extremes 
of 0 or 1 indicating that a 
model is not plausible 
DIC is for comparing the fit of 
alternative models, with smaller 
values being better. DIC cannot 
be used to evaluate a single 
model in absolute terms. 
Source: Arbuckle, 2007; Kline, 2005; Bollen & Curran, 2006 
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5.4.RESULTS
 
 
5.4.1.The effectof circulating adiponectin levelsonmetabolicandhormonal
profile,productiontraits,andreproduction
 
 
5.4.1.1.Reproductiveperformance
 
Interval from calving to conception between cows with HIGH adiponectin levels and cows 
with NORMAL adiponectin levels were not statistically significant different (Figure 5.2). 
Cows with NORMAL milk progesterone profiles were more likely to become pregnant 
(48% versus 10%, AUCROC=0.73±0.06) during the experimental period than cows with 
ABNORMAL milk progesterone profiles (P<0.05) (Table 5.6). Cows with HIGH 
adiponectin levels had a higher probability to be pregnant (83% versus 30%, 
AUCROC=0.67±0.07) during the experimental period than cows with NORMAL 
adiponectin levels (P<0.05) (Table 5.7). Cows with HIGH adiponectin levels had lower 
days to first oestrus (43.1 versus 56) than cows with NORMAL adiponectin levels 
(P<0.05) (Table 5.7). There was a tendency for non-random association between cows 
with HIGH adiponectin levels and cows with NORMAL milk progesterone profile (P<0.1) 
because no cow with HIGH adiponectin had ABNORMAL profiles (Table 5.8). There was 
no association between adiponectin level and presence of follicular cysts at day 90 of 
lactation (Table 5.9).  
 
Logistic regression analysis showed a significant association between change in BCS 
(ǻBCS) and the probability for a cow to be pregnant. Cows losing 0.25 units of BCS or 
less were more likely to become pregnant (56% versus 30%, AUCROC=0.72±0.06) than 
cows losing 0.70 units of BCS or more (Figure 5.3). The association between circulating 
IGF-I and probability to be pregnant was significant. Cows with average circulating IGF-I 
equal or greater than 155 ng/ml were more likely to be pregnant (46% versus 33%, 
AUCROC=0.70±0.07) than cows with average circulating IGF-I equal or less than 120 ng/ml 
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throughout the experimental period (Figure 5.4). Days to first oestrus were significantly 
associated with the probability of cows to express ABNORMAL milk progesterone 
profiles. Cows with average 43.1 days to first oestrus were less likely (25% versus 36%, 
AUCROC=0.72±0.07) to express ABNORMAL milk progesterone profiles than cows with 
average 56 days to first oestrus (Figure 5.5), whereas days to first oestrus were 
significantly associated with the probability for cows to express cystic body at day 90 
postpartum (Figure 5.6). Moreover, ǻBCS significantly associated with days to first 
oestrus (Figure 5.7) and days to first oestrus positively associated with days to conception 
(Figure 5.8). Circulating adiponectin was significantly associated with the probability for 
cows to express ABNORMAL milk progesterone profiles (Figure 5.9), whereas circulating 
leptin was significantly associated with the days to first oestrus (Figure 5.10). Milk yield 
was significantly associated with the probability of cows to be pregnant (Figure 5.11). 
 
Multiple logistic regression analysis examined the effects of milk yield, DMI, GH, and 
parity on milk progesterone profile. Each exponentiated coefficient in this model is the 
change in odds for a unit increase in the corresponding predictor variable holding other 
variables at certain value.  Odds ratio (exp (b)) for milk yield was 1.21 (P<0.05) (Table 
5.10). So holding GH, DMI and parity at a fixed value, an increase of milk yield by 1 kg/d  
will increase the odds for cows to express ABNORMAL milk progesterone profile by 
21%. GH and DMI tended to influence milk progesterone profile (P<0.1). GH odds ratio 
was 1.31 (P=0.07); DMI odds ratio was 0.68 (P =0.07) (Table 5.10). The odds ratio for GH 
and DMI say that, holding the other predictors of the model at a fixed value,  a one-unit 
increase in GH was expected to result in a 31% increase, and a one-unit increase in DMI a 
32% decrease, in the odds of cows to express ABNORMAL milk progesterone profiles. 
Parity also tended to influence milk progesterone profile (P<0.1). The odds ratio for parity 
says that, holding the other predictors of the model at a fixed value, an increase of parity 
by one year resulting in an 86% rise in the odds of cows to express ABNORMAL milk 
progesterone profiles. 
 
Multiple logistic regression analysis examined the effects of insulin, glucose, GH, NEFA, 
and parity on presence of follicular cysts at 90 days postpartum (Table 5.11). Odds ratios 
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for insulin and glucose were close to zero and that means strong negative effects on 
follicular cyst formation (P<0.05). Odds ratios for GH and NEFA were 2.1 and 201.6 
respectively, indicating high positive effects of GH and NEFA on follicular cyst formation 
(P<0.05). Parity had no effect on follicular cyst formation. 
 
Multiple poisson regression analysis examined the effects of insulin, milk yield, and IGF-I 
on days to conception (Table 5.12). Insulin, milk yield, and IGF-I beta coefficients were 
0.98, 0.014, and -0.002, respectively (P<0.05). Beta coefficient of insulin is bigger than the 
beta coefficients of milk yield and IGF-I and that means the insulin effect on days to 
conception is bigger than the effect of milk yield and IGF-I. Insulin concentration greater 
than 0.7 ng/ml resulted in calving to conception interval greater than 100 days, whereas 
animals with insulin concentration within the range 0.2-0.3 ng/ml had a calving to 
conception interval of less than 70 days (Table 5.13). 
 
 
5.4.1.2.Metabolicprofile,hormonalprofile,andproductivetraits
 
Cows with HIGH adiponectin levels had higher circulating adiponectin and IGF-I, but 
lower circulating GH and glucose than cows with NORMAL adiponectin levels (P<0.05) 
(Table 5.14). Cows with HIGH adiponectin levels showed a tendency for higher plasma 
concentrations of leptin, but lower circulating BOHB than cows with NORMAL 
adiponectin levels (P<0.1). Adiponectin levels had no effect on plasma concentrations of 
insulin, glucagon, NEFA, and blood urea (Table 5.14). 
 
Cows with HIGH adiponectin levels had lower DMI, milk yield, BCS at calving, and 
ǻBCS than cows with NORMAL adiponectin levels (P<0.05) (Table 5.15). Adiponectin 
levels had no effect on LWT and MEBAL (Table 5.15). 
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5.4.2. Adiponectin interrelationshipswith glucose, BCS,metabolic hormones,
andmetabolites
 
There was no association between PMY and diet, and thus the retrospective classification 
of cows as PMY LOW and PMY HIGH was not biased by the original dietary treatments 
(Fishers exact test, n=60, P=0.325, twosided). 
 
Multivariate analysis revealed that glucose balance in dairy cows was regulated by the 
negative influences of circulating adiponectin (-0.26, P=0.014), BOHB (-0.36, P=0.001), 
and glucagon (-0.23, P=0.036) on circulating glucose, and the positive influence of 
circulating insulin (0.24, P=0.036) on circulating glucose (Figure 5.12). GH, NEFA, leptin, 
and BCS had no direct effect on circulating glucose, but GH was negatively correlated 
with adiponectin (-0.24, P=0.042) and leptin (-0.35, P=0.001) whereas leptin was 
positively correlated with insulin (0.34, P=0.012) (Figure 5.12). 
 
In low yielding cows, glucose balance was regulated by the negative influences of 
circulating adiponectin (-0.31, P=0.041) and glucagon (-0.31, P=0.043) on circulating 
glucose, and the positive influence of circulating insulin (0.44, P=0.008) on circulating 
glucose (Figure 5.13). GH, NEFA, leptin, and BCS had no direct effect on circulating 
glucose, but leptin was positively correlated with insulin (0.42, P=0.022). 
 
In high yielding cows, glucose balance was regulated by the negative influences of BCS (-
0.51, P=0.01) and BOHB (-0.48, P=0.001), and the positive influence of circulating insulin 
(0.45, P=0.035) on circulating glucose (Figure 5.14). GH, NEFA, leptin, and glucagon had 
no direct effect on circulating glucose. However, a multitude of interrelations between 
metabolites and hormones was revealed. Glucagon was positively correlated with leptin 
(0.48, P=0.004), but negatively correlated with BCS (-0.28, P=0.049). Adiponectin was 
positively correlated with BCS (0.34, P=0.031), but negatively correlated with GH (-0.34, 
P=0.031). GH was negatively correlated with BOHB (-0.31, P=0.05), BCS (-0.40, 
P=0.027), and leptin (-0.44, P=0.01). Leptin was positively correlated with NEFA (0.29, 
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P=0.003). Insulin was positively correlated with NEFA (0.45, P=0.02), BCS (0.58, 
P=0.027), and leptin (0.39, P=0.02). 
 
One-way MANOVA revealed a significant multivariate main effect for PMY (Wilks’ Ȝ = 
0.787, F=3.66, P=0.01, df=54, Boxs test P=0.112, Power =0.850). Given the significance 
of the overall MANOVA model, the univariate main effects were examined. High PMY 
cows had higher milk yield (47.1±1.27 kg/d versus 40.3±1.25 kg/d, F=14.4, df=57, 
P=0.001, Levenes test P=0.937, Power=0.962), DMI (22.5±0.47 kg/d versus 20.5±0.46 
kg/d, F=8.7, df=57, P=0.006, Levenes test P=0.466, Power=0.827), and BCS at calving 
(3.52±0.050 units versus 3.35±0.060 units, F=4.6, df=57, P=0.035, Levenes test P=0.005, 
Power=0.563), and a trend for higher ǻBCS (0.76±0.082 units versus 0.56±0.082 units, 
F=2.54, df=57, P=0.1, Levenes test P=0.662, Power=0.347) than low PMY cows in the 
present lactation.  
 
Parity was not statistical different for high PMY cows compared to low PMY cows 
(2.77±0.190 lactations versus 2.40±0.190 lactations, t = 1.39, df=58, P=0.17). 
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Figure 5.2: Calving-to-conception survival analysis curves for cows with HIGH and NORMAL adiponectin (ADP) levels. There was no 
difference in the survival curves for cows with HIGH and NORMAL adiponectin levels (n=60, Log-rank, P = 0.18). Vertical drop in the 
survival curves indicates an event (a cow became pregnant). Interval from calving to conception between cows with HIGH (74± 10.9 days) 
and NORMAL (78±10.0 days) adiponectin levels were not significantly different.
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Table 5.6:  Effect of milk progesterone profile on probability of cows to be pregnant 
 
Treatment: MILK PROGESTERONE PROFILE   
Parameters: NORMAL

 ABNORMAL

 n P 
Probability for cows to be pregnant  0.48 (0.32, 0.65) 0.01 (0.00, 0.27) 60 0.001 
 Columns are means with 95 % Confidence Interval (CI). 
Table 5.7:  Effect of circulating adiponectin levels (ADP LEVELS) on probability of cows to be pregnant 
 
Treatment: ADP LEVELS   
Parameters: NORMAL

 HIGH

 n P 
Days to first oestrus 
(days postpartum) 
56.0 (51.6, 60.4) 43.1 (36.8, 49.3) 56 0.001 
Probability for cows to be pregnant  0.30 (0.17, 0.42) 0.83 (0.53, 0.99) 60 0.031 
 Columns are means with 95 % Confidence Interval (CI). 
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Table 5.8: Crosstabulation of circulating adiponectin levels (ADP LEVELS) with milk progesterone profile. Association 
between ADP LEVELS and milk progesterone profile was tested by performing Fishers exact test (n= 60, P=0.073, two-sided). 
There was a tendency for non-random association between cows expressing HIGH circulating adiponectin levels and NORMAL 
milk progesterone profile, and between cows expressing NORMAL adiponectin levels and ABNORMAL milk progesterone 
profile. 
ADP LEVELS  
Milk progesterone profile NORMAL HIGH Total 
NORMAL 31 6 37 
ABNORMAL 23 0 23 
Total 54 6 60 
 
 
 
 
 
Table 5.9: Crosstabulation of circulating adiponectin levels (ADP LEVELS) with follicular cysts found at day 90 
postpartum (CYSTIC BODY). Association between ADP LEVELS and CYSTIC BODY was tested by performing Fishers 
exact test (n= 60, P= 0.585, twosided).  There was no association between adiponectin level and cystic body. 
ADP LEVELS 
CYSTIC BODY  NORMAL HIGH Total 
NO 46 6 52 
YES 8 0 8 
Total 54 0 60 
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Figure 5.3: Effect of postpartum change in body condition score (ǻBCS) on probability of cows to be pregnant (n= 59, P=0.001, exp (b) 
=0.09, CI for exp (b); [0.02, 0.37], beta coefficient (b) = -2.43, AUCROC=0.72±0.06, GLM with Bernoulli error distribution, logit link function, 
and robust standard error estimation). In this model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) whereas ǻBCS and
parity were added as continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines show the 
upper and lower 95 % Confidence Interval (CI). ǻBCS values with negative sign indicate gain of BCS whereas positive ǻBCS values denote 
loss of BCS.
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Figure 5.4: Effect of circulating IGF-I on probability of cows to be pregnant (n= 60, P=0.027, exp (b) =1.01, CI for exp (b); [1.002, 1.028], 
beta coefficient (b) = 0.015, AUCROC=0.70±0.07, GLM with Bernoulli error distribution, logit link function, and robust standard error 
estimation). In this model, dependent variable was pregnancy (0= non pregnant, 1= pregnant) whereas circulating IGF-I and parity were added 
as continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines show the upper and lower 95 
% Confidence Interval (CI). 
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Figure 5.5: Effect of days to first oestrus on probability for cows to express abnormal milk progesterone profiles (n= 56, P= 0.016,
exp (b) =1.011, CI for exp (b); [1.01, 1.09], beta coefficient (b) = 0.045, AUCROC=0.72±0.07, GLM with Bernoulli error distribution, logit
link function, and robust standard error estimation). In this model, dependent variable was progesterone profile (0= normal, 1= abnormal)
whereas days to oestrus and parity were added as continuous covariates. Red solid line represents the estimated probability whereas blue
and purple dashed lines show the upper and lower 95 % Confidence Interval (CI). 
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Figure 5.6: Effect of days to first oestrus on probability for cows to express cystic body (n= 58, P= 0.01, exp (b) =1.06, CI for exp (b); 
[1.01, 1.11], beta coefficient (b) = 0.06, AUCROC=0.76±0.09, GLM with Bernoulli error distribution, logit link function, and robust standard 
error estimation). In this model, dependent variable was cystic body (0=cystic body was not expressed, 1= cystic body was expressed) 
whereas days to oestrus and parity were added as continuous covariates. Red solid line represents the estimated probability whereas blue 
and purple dashed lines show the upper and lower 95 % Confidence Interval (CI). 
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Figure 5.7: Effect of postpartum change in body condition score (ǻBCS) on days to first oestrus (n= 57, P=0.012). GLM with Poisson
error distribution, log link function, and robust standard error estimation. In this model, dependent variable was days to first oestrus whereas
ǻBCS and parity were added as continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines 
show the upper and lower 95 % Confidence Interval (CI). ǻBCS values with negative sign indicate gain of BCS whereas positive ǻBCS values 
denote loss of BCS. 
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Figure 5.8: Effect of days to first oestrus on days to conception (n= 21, P=0.001). GLM with Poisson error distribution, log link function, 
and robust standard error estimation. In this model, dependent variable was days to conception whereas days to first oestrus and parity were 
added as continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines show the upper and 
lower 95 % Confidence Interval (CI).  
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Figure 5.9: Effect of circulating adiponectin on probability for cows to express abnormal milk progesterone profiles (n= 60, P= 
0.037, exp (b) =0.88, CI for exp (b); [0.79, 0.99], beta coefficient (b) = -0.12, AUCROC=0.71±0.07, GLM with Bernoulli error distribution, 
logit link function, and robust standard error estimation). In this model, dependent variable was progesterone profile (0= normal, 1= 
abnormal) whereas circulating adiponectin and parity were added as continuous covariates. Red solid line represents the estimated
probability whereas blue and purple dashed lines show the upper and lower 95 % Confidence Interval (CI).
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Figure 5.10: Effect of circulating leptin on days to first oestrus (n= 58, P=0.023), GLM with Poisson error distribution, log link 
function, and robust standard error estimation). In this model, dependent variable was days to first oestrus whereas circulating leptin and 
parity were added as continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines show
the upper and lower 95 % Confidence Interval (CI).
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Figure 5.11: Effect of milk yield on probability of cows to be pregnant (n= 60, P=0.024, exp (b) =0.92, CI for exp (b); [0.86, 0.98], beta 
coefficient (b) = -0.08, AUCROC=0.68±0.07, GLM with Bernoulli error distribution, logit link function, and robust standard error 
estimation). In this model, dependent variable was pregnancy (0= normal, 1= abnormal) whereas milk yield and parity were added as 
continuous covariates. Red solid line represents the estimated probability whereas blue and purple dashed lines show the upper and lower 
95 % Confidence Interval (CI). 
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Table5.11:Effectsofinsulin,glucose,GH,NEFA,andparityonfollicularcystformation
  95% CI for exp (b)   
Parameters in the model: 
exp (b)

 Lower Upper 
Beta (b) 
coefficient 
P  
Constant - - - 16.84 0.012 
Insulin  ~0 (2.4 10
-11
) 0.00 0.004 -24.43 0. 004 
Glucose 0.006 0.00 0.74 -5.06 0.035 
GH 2.10 1.06 4.21 0.75 0.044 
NEFA 201.60 1.16 34,861 5.31 0.029 
Parity 0.96 0.31 2.90 -0.04 0.944 
Likelihood ratio test ( Ȥ2=25.3, df=5, P=0.001); Hosmer & Lemeshow test for fitness ( Ȥ2 =3.5, df=8, P=0.90);  AUCROC=0.95±0.02 
 exp (b) is the odds ratio 
Table5.10:Effectsofmilkyield,DMI,GH,andparityonmilkprogesteroneprofile
  95% CI for exp (b)   
Parameters in the model: 
exp (b)

 Lower Upper 
Beta (b) 
coefficient 
P  
Constant - - - -3.18 0.251 
Milk yield 1.21 1.03 1.41 0.19 0.02
DMI 0.68 0.44 1.04 -0.39 0.07
GH 1.31 0.97 1.76 0.27 0.07
Parity 1.86 0.91 3.75 0.62 0.09
Likelihood ratio test ( Ȥ2=10.6, df=4, P=0.031); Hosmer & Lemeshow test for fitness ( Ȥ2=12.6, df=8, P =0.128);  AUCROC=0.73±0.07 
 exp (b) is the odds ratio 
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Table5.12:Effectsofinsulin,milkyield,andIGFǦIondaystoconception
  95% CI for b  
Parameters in the model: Beta (b) 
 coefficient 
Lower Upper P  
Constant 3.65 3.210 4.096 0.001 
Insulin 0.98 .423 1.544 0.001
Milk yield 0.01 .006 .022 0.001
IGF-I -0.002 -0.0034 -0.0007 0.002 
Likelihood ratio test ( Ȥ2=31.5, df=4, P=0.001) 
Table5.13:Modelfittedvaluesfordifferentinsulinconcentrations
Insulin 
(ng/ml) 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 
Days to 
conception 
(days 
postpartum) 
57.4 
[46.43, 68.34] 
63.3 
[54.62,72.03] 
69.9 
[63.78, 75.94] 
77.1 
[73.16, 81.01] 
85.1 
[79.75, 90.34] 
93.8 
[83.79, 103.88] 
103.5 
[87.06,  120.02] 
114.2 
[89.87, 138.60] 
126.1 
[92.25,  159.85]
139.1 
[94.09, 184.06] 
 Row is mean with 95% CI 
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Table5.14:Effectofcirculatingadiponectinlevels(ADPLEVELS)onmetabolichormonesandmetabolites
      
Treatment: ADP LEVELS   
Parameters: NORMAL

 n1
- HIGH n2 - SED

 P  
Adiponectin (ng/ml) 7.12 346 21.32 41 1.328 0.001 
Insulin (ng/ml) 0.40 337 0.42 40 0.043 0.730 
Glucagon (pg/ml) 95.2 178 96.6 38 9.38 0.885 
GH (ng/ml) 4.7 173 3.1 33 0.52 0.002 
Leptin (ng/ml) 1.66 338 2.30 40 0.367 0.081 
IGF-I (ng/ml) 118.7 167 154.9 30 14.78 0.015 
Glucose (mmol/l) 3.51 220 3.08 26 0.210 0.041 
Urea (mmol/l) 2.33 223 2.55 26 0.303 0.475 
BOHB (mmol/l) 0.66 223 0.53 26 0.070 0.093 
NEFA (mmol/l) 0.46 226 0.36 23 0.084 0.219 
 Columns are means 
-  n1 and n2 are the repeated observations of animals with NORMAL and HIGH circulating adiponectin levels, respectively. 
 SED = standard error of the difference between treatment means 
Table5.15:Effectofcirculatingadiponectinlevels(ADPLEVELS)onproductiontraits
Treatment: ADP LEVELS   
Parameters: NORMAL

 n1
- HIGH n2 - SED

 P 
DMI (kg/d) 21.7 316 19.5 36 0.99 0.028 
Milk Yield (kg/d) 44.1 316 38.2 36 2.17 0.01 
LWT (kg) 657.1 316 659.3 36 7.74 0.776 
BCS at calving 3.45 54 3.13 6 0.134 0.017 
MEBAL (MJ/d) -5.4 316 -6.2 36 2.18 0.697 
ǻBCS (units 1-5) 0.70 53 0.25 6 0.185 0.015 
 Columns are means 
-  n1 and n2 are the repeated observations of animals with NORMAL and HIGH circulating adiponectin levels, respectively. 
  SED = standard error of the difference between treatment means 
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Figure 5.12: The basic model: Glucose interrelationships with adiponectin, BCS, metabolites, and metabolic hormones (n= 60; Ȥ2 =5.9, df
=15, P=0.981; Bollen-Stine nonparametric bootstrap P=0.954, N=1,000 samples; CFI=1.00; NFI=0.918; RMSEA=0.0001; AIC=83.51; DIC=86.02,
P=0.62, Effective number of parameters=33.32, convergence was achieved after (68,500)*2 burn-outs, 500 samples per each burn-in, convergence
cut-off limit 1.002). In this basic model, single headed arrows (ĺ) represent effects of BCS, metabolites, and metabolic hormones on glucose, and
they are quantified as standardized regression coefficients placed in the middle of the arrows. Double headed arrows represent partial correlations
and their coefficients are approximately located in the middle of arrow curvature. Purple single headed arrows (ĺ) and red double headed arrows (3
) mark significant effects or correlations (P<0.05), whereas dark blue single headed arrows (ĺ) and dark blue double headed arrows (3 ) mark non-
significant effects or correlations. Thus, the correlations INS3 LPN (0.34, P=0.012), LPN3 GH (-0.35, P=0.01), and GH3 ADP (-0.24, P=0.042) and
the effects (ĺ) of INS (0.24, P=0.036), GLGON (-0.23, P=0.036), BOHB (-0.36, P=0.001), and ADP (-0.26, P=0.014) on glucose are significant.
Partial correlation coefficients and standardized regression coefficients are interpreted the same, as classical correlation coefficients. Model squared
multiple correlations coefficient (which is equal to adjusted R
2
 of linear regression models) is 0.35. Variable e is the residual error of the model.
Model parameter estimates (mean±SE) are illustrated in Table B.1 in appendix. 
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Figure 5.13: Glucose interrelationships with adiponectin, BCS, metabolites, and metabolic hormones in cows with LOW previous milk
production (n= 30; Ȥ2=5.9, df=17, P=0.996; CFI=1.00; NFI=0.865; RMSEA=0.0001; AIC=79.86; DIC=83.17, P=0.56, Effective number of
parameters=24.18, convergence was achieved after (77,500)*4 burn-outs, 500 samples per each burn-in, convergence cut-off limit 1.002). In this
model, single headed arrows represent (ĺ) effects of BCS, metabolites, and metabolic hormones on glucose and they are quantified as standardized
regression coefficients placed in the middle of the arrows. Double headed arrows represent partial correlations and their coefficients are
approximately located in the middle of arrow curvature. Purple single headed arrows (ĺ) and red double headed arrows (3 ) mark significant effects
or correlations (P<0.05), whereas dark blue single headed arrows (ĺ) and dark blue double headed arrows (3 ) mark non-significant effects or
correlations. Thus, the correlations INS3 LPN (0.42, P=0.022) and the effects (ĺ) of INS (0.44, P=0.008), GLGON (-0.31, P=0.043), and ADP (-
0.31, P=0.041) on glucose are significant. Partial correlation coefficients and standardized regression coefficients are interpreted the same, as
classical correlation coefficients. Model squared multiple correlations coefficient (which is equal to adjusted R
2
 of linear regression models) is 0.39.
Variable e is the residual error of the model. Model parameter estimates (mean±SE) are illustrated in Table B.1 in appendix. 
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Figure 5.14: Glucose interrelationships with adiponectin, BCS, metabolites, and metabolic hormones in cows with HIGH previous milk 
production (n= 30; Ȥ2=3, df=13, P=0.998; CFI=0.998; NFI=0.966; RMSEA=0.001; AIC=85.01; DIC=88.29, P=0.43, Effective number of 
parameters=23.34, convergence was achieved after (89,500)*4 burn-outs, 500 samples per each burn-in, convergence cut-off limit was 1.002). In this 
model, single headed arrows (ĺ) represent effects of BCS, metabolites, and metabolic hormones on glucose and they are quantified as standardized
regression coefficients placed in the middle of the arrows. Double headed arrows represent partial correlations and their coefficients are 
approximately located in the middle of arrow curvature. Purple single headed arrows (ĺ) and red double headed arrows ( 3  ) mark significant 
effects or correlations (P<0.05), whereas dark blue single headed arrows (ĺ) and dark blue double headed arrows ( 3  ) mark non-significant effects 
or correlations. Thus, the correlations of INS3 LPN (0.39, P=0.02), INS3 BCS (0.58, P=0.003), INS3 NEFA (0.45, P=0.02), LPN3 NEFA(0.29,
P=0.05), LPN3 GLGON(0.48, P=0.004), LPN3 GH(-0.44, P=0.01),  BCS3 GH(-0.40, P=0.027), GH3 BOHB(-0.31, P=0.05), GH3 ADP(-0.39,
P=0.036), GLUGON3 BCS(-0.28, P=0.049), and ADP3 BCS(0.34, P=0.031),  and the effects (ĺ) of INS (0.45, P=0.035), BCS (-0.51, P=0.01), and 
BOHB (-0.48, P=0.001) on glucose are significant. Partial correlation coefficients and standardized regression coefficients are interpreted the same,
as classical correlation coefficients. Model squared multiple correlations coefficient (which is equal to adjusted R
2
 of linear regression models) is 
0.40. Variable e is the residual error of the model. Model parameter estimates (mean±SE) are illustrated in Table B.1 in appendix. 
”Chapter5Circulatingadiponectinlevels&glucosehomeostasis


171

5.5.DISCUSSION
 
 
 
5.5.1 Effect of circulating adiponectin levels on metabolic hormones,
metabolites,productivetraits,andreproductiveperformance
 
 
Raddatz et al., (2008) reported that individual cows had consistently high or low 
adiponectin levels throughout the sampling period and this result is in agreement with the 
present study. Moreover, the present study found that the group of the cows showed 
persistently HIGH adiponectin levels had 3 times higher circulating adiponectin than cows 
with consistently NORMAL adiponectin levels. The present study for first time, to the best 
of our knowledge, analyzes the effects of differences observed in circulating adiponectin 
levels in dairy cows. These differences were associated with differences in metabolic, 
hormonal, productive and reproductive traits. Unfortunately, only 10% of cows in this 
experiment expressed HIGH adiponectin levels. This point was a drawback in the 
statistical analysis because the data were unbalanced and this limits the conclusions. 
Nevertheless, large differences were observed in metabolic, hormonal, productive and 
reproductive traits, and different patterns in metabolic and reproductive regulation were 
demonstrated between cows expressing NORMAL and HIGH adiponectin levels. 
 
In the present study, cows with HIGH adiponectin levels had lower GH and glucose than 
cows with NORMAL adiponectin levels. Moreover, cows with HIGH adiponectin levels 
had trends for higher circulating leptin and BOHB than cows with NORMAL adiponectin 
levels. Cows with HIGH adiponectin levels ate less feed and produced less milk than cows 
with NORMAL adiponectin profiles. Finally, cows with HIGH adiponectin levels lost less 
BCS postpartum, and had lower BCS at calving than cows with NORMAL adiponectin 
levels. Studies in humans and rodents indicate that the relation between adiponectin and 
GH is negative (Lam et al., 2004; Nilsson et al., 2005; Rodriguez-Pacheco et al., 2007). In 
accordance with this, cows with HIGH adiponectin levels had lower GH than cows with 
NORMAL adiponectin levels. It is known that GH has rapid direct catabolic actions 
(enhances lipolysis, decreases lipogenesis and restricts glucose transport) whereas 
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adiponectin has insulin-sensitizing actions (decreases glucose output, increases FFA 
oxidation, and increases influx of NEFA) (Davidson, 1987; Lucy, 2000). Thus, low GH 
and high adiponectin in cows with HIGH adiponectin levels may explain why these 
animals had lower glucose and a trend for lower BOHB. 
 
In humans, acromegalic and anorexia nervosa patients expressed decreased circulating 
leptin and increased circulating GH (Popovic et al., 2001; Scacchi et al., 1999) and this 
may indicate the relationship between GH and leptin is negative at least in extreme 
conditions with elevated circulating GH. Also, Leifers et al. (2005) suggested that leptin 
expression in adipose tissue is possibly regulated in early lactating cows by the negative 
impact of GH. Block et al. (2001) also demonstrated that the correlation between GH and 
leptin is negative. Moreover, restriction of energy intake suppresses GH secretion in 
rodents, but stimulates it in humans and ruminants (Block et al., 2001; Nagatani et al., 
2000). In line with these results, cows with HIGH adiponectin levels in this experiment had 
low GH and DMI, and a trend for high leptin. It is known that the main central effect of 
leptin is suppression of food intake (Chilliard et al., 2005), and this may explain why cows 
with HIGH adiponectin levels in this experiment had lower DMI than cows with 
NORMAL adiponectin levels. Furthermore, leptin stimulates free fatty acids (FFA) 
oxidation and increases glucose uptake in the skeletal muscles, and decreases glucose 
output and increases FFA oxidation in the liver (Yildiz & Haznedaroglu, 2006; Kokta et 
al., 2004; Macajova et al., 2004). This may provide further explanation why glucose was 
low, and BOHB had a trend to be low in cows with HIGH adiponectin levels. In the 
present study, cows with HIGH adiponectin levels had higher adiponectin and a tendency 
for higher leptin than cows with NORMAL adiponectin levels. Some studies suggest that 
the relationship between adiponectin and leptin is negative (Matsubara et al., 2002; 
Huypens, 2007). However, other studies reported positive correlations between leptin and 
adiponectin (Pardo et al., 2004; Rossi et al., 2005) or no correlation (Park et al., 2004). 
However, in acromegalic patients GH down-regulated both circulating adiponectin and 
leptin (Popovic et al., 2001; Lam et al., 2004). Thus, at least in extreme conditions, it is 
possible for adiponectin and leptin to be positively correlated, especially when circulating 
GH is very high or very low. In the present study, cows with HIGH adiponectin levels had 
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approximately 34% lower circulating GH compared with cows with NORMAL 
adiponectin levels, and maybe that is the reason why cows with HIGH adiponectin levels 
had higher circulating adiponectin and a trend for higher leptin than cows with NORMAL 
adiponectin levels. TNF-Į is another interesting adipokine and it has been found to exert 
regulatory roles on adiponectin and leptin. Classically, TNF-Į is increased in periparturient 
cows and decreased in early lactating cows (Ametaj, 2005). Also, TNF- Į is a potent 
inhibitor of adiponectin expression and secretion by adipose tissue, and negatively 
correlated with insulin sensitivity (Fasshauer et al., 2002; Ruan et al., 2002; Ronti et al., 
2006). Moreover, TNF-Į has been demonstrated to stimulate leptin (Zumbach et al., 1997) 
in humans. Unfortunately, the present study did not measure TNF- Į, but it is possible that 
this adipokine is the link that explains the high circulating leptin and adiponectin observed 
in cows with HIGH adiponectin levels. 
 
In early lactating cows, low circulating insulin is responsible for uncoupling of the GH –
IGF-I axis in the liver due to down-regulation of GH  receptors (Lucy; 2000). 
Consequently, IGF-I production in the liver is suppressed and the negative feedback of 
IGF-I at the level of the hypothalamus/ pituitary is removed, resulting in increased 
circulating GH. This situation can be restored by improving insulin sensitivity (Wathes et 
al., 2007; Garnsworthy et al., 2008a; Leroy et al., 2010). Cows with HIGH adiponectin 
levels had higher circulating IGF-I, but lower circulating GH than cows with NORMAL 
adiponectin levels in this experiment. However, circulating insulin did not differ between 
the two groups. In line with this experiment, animals with low IGF-I have greater 
circulating GH (Lucy, 2000). Elevated circulating GH can be the main reason for lower 
circulating IGF-I in cows with NORMAL adiponectin levels due to uncoupling of the GH–
IGF-I axis in the liver of these animals. It is known that IGF-I stimulates the synthesis of 
adiponectin (Williams et al., 2004) and that may explain why cows with HIGH adiponectin 
levels had elevated adiponectin and IGF-I. Moreover, the combination of high circulating 
adiponectin and leptin along with decreased glucose and the same levels of circulating 
insulin in cows with HIGH adiponectin levels may imply better insulin sensitivity of these 
animals. High insulin sensitivity is associated with weight gain, and accretion of condition 
is positively associated with circulating IGF-I (Wathes et al., 2007). IGF-I concentrations 
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were positively correlated with insulin sensitivity in humans (Sesti et al.,2005) and that 
might be another reason why circulating IGF-I was higher in cows with HIGH adiponectin 
levels. 
 
According to Meikle et al. (2004) leptin and IGF-I are positively correlated in 
periparturient dairy cows and this is in agreement with this study. Also, the lower 
circulating glucose for the same levels of circulating insulin in cows with HIGH 
adiponectin levels might suggest better response of insulin to glucose and thus better 
insulin sensitivity than cows with NORMAL adiponectin levels. Low insulin sensitivity is 
common in high yielding cows (Chilliard et al., 1998; Gutierrez et al., 2006). High GH 
concentrations not only stimulate milk production, but also stimulate glucose production in 
the liver, and adipose tissue mobilization. The resulting high circulating NEFA, BOHB, 
and GH inhibit insulin action and create a further state of peripheral insulin resistance 
(Leroy et al., 2010).  Furthermore, milk yield and IGF-I are negatively correlated (Wathes 
et al., 2007). In the present study, cows with NORMAL adiponectin levels had higher milk 
yield and greater BCS loss postpartum than cows with HIGH adiponectin levels and this 
also agrees with the lower circulating levels of IGF-I in cows with NORMAL adiponectin 
levels. 
 
Differences in productive traits were generally matched by differences in metabolic and 
hormonal profile in this experiment. Cows with HIGH adiponectin levels had lower DMI 
and ǻBCS, and produced lower milk yield than cows with NORMAL adiponectin levels. 
The lower DMI in cows with HIGH adiponectin levels may be was the result of elevated 
circulating leptin in these animals (as increased leptin suppresses feed intake). In addition, 
decreased circulating GH and glucose in cows with HIGH adiponectin levels may be was 
the main reason for decreased milk yield and decreased ǻBCS. It is known that fatter cows 
at calving lose more body condition than thinner cows (Garnsworthy & Topps, 1982), and 
this was also true in the present study because cows with HIGH adiponectin levels were 
thinner at calving and they lost less condition throughout the experiment compared to cows 
with NORMAL adiponectin levels. Moreover, BOHB had a tendency to be elevated in 
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cows with NORMAL adiponectin levels and that indicates greater dependence on fat tissue 
mobilization for supporting increased milk yield. 
 
Reproductive functions are closely related to nutritional status (Boland et al., 2001; 
Garnsworthy et al., 2008; Santos, 2007). Adipokines such as leptin and adiponectin are 
known to be implicated in reproductive functions at different levels, including central 
effects on the hypothalamus and pituitary, peripheral effects on the ovary and reproductive 
tract, and direct effects on the oocyte and embryo (Mitchell et al., 2005). In the present 
study, cows with HIGH adiponectin levels showed higher probability to become pregnant 
than cows with NORMAL adiponectin levels. Moreover, cows with NORMAL milk 
progesterone profile were more likely to be pregnant than cows with ABNORMAL milk 
progesterone profile, and  there was a tendency for non-random association between cows 
expressing HIGH circulating adiponectin levels and cows with NORMAL milk 
progesterone profile. This may explain in part the higher pregnancy rate in cows with 
HIGH adiponectin levels, but it needs to be investigated further.  
 
The present study showed that the association of ǻBCS with the probability of a cow to be 
pregnant was non linear. Furthermore, cows with HIGH adiponectin levels lost less BCS 
(0.25 units versus 0.70 units) than cows with NORMAL adiponectin levels. Moreover, 
cows losing 0.25 units of BCS or less were more likely to become pregnant than cows 
losing 0.70 units or more (Figure 5.3). This is another explanation for the higher pregnancy 
rate in cows with HIGH adiponectin levels (Table 5.7). Also, the association of ǻBCS with 
days to first oestrus was negative (Figure 5.7) in the present study and this may explain 
why cows with HIGH adiponectin levels had fewer days to first oestrus than cows with 
NORMAL adiponectin levels (Table 5.7). 
 
IGF-I was associated with the probability for a cow to become pregnant in this experiment. 
Cows with HIGH adiponectin levels had higher circulating IGF-I than cows with 
NORMAL adiponectin levels. Cows with average circulating IGF-I equal to or greater than 
155 ng/ml throughout the experimental period were more likely to become pregnant than 
cows with average circulating IGF-I equal to or less than 120 ng/ml. Also, milk yield was 
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negatively associated with the probability of cows to be pregnant in the present study. 
These may further explain the higher pregnancy rate in cows with HIGH adiponectin 
levels. 
 
Cows with HIGH adiponectin levels had fewer days to first oestrus than cows with 
NORMAL adiponectin levels, and days to first oestrus were positively associated with the 
probability of cows to express ABNORMAL milk progesterone. Also, circulating 
adiponectin was negatively associated with the probability of cows to express 
ABNORMAL milk progesterone profile. Taken together these findings may explain why 
in this experiment there was a tendency for non-random association between cows 
expressed HIGH circulating adiponectin levels and cows with NORMAL milk 
progesterone profile. According to Dupont et al. (2008) adiponectin activates AMPK and 
that leads to decreased steroidogenesis in the granulosa cells. Indeed, in vitro studies 
showed a possible role of adiponectin in modulating ovarian steroidogenesis (Ledoux  et 
al., 2006; Lagaly et al., 2008; Chabrolle et al., 2009; Gutman et al., 2009; Pierre et al., 
2009; Maillard et al., 2010), but results are controversial, which may imply species-
specific differences in the regulation of steroidogenesis by adiponectin (Dupont et al., 
2008; Brochu-Gaudreau et al., 2010).. Moreover, women treated with chorionic 
gonadotrophin expressed increased circulating adiponectin, which correlated with 
circulating progesterone and oestradiol (Liu et al., 2006). Furthermore, short-term 
treatment of rat pituitary gonadotroph cells with recombinant murine adiponectin abolishes 
GnRH-induced LH secretion (Rodriguez-Pacheco et al., 2007). Adiponectin has been 
detected in porcine and human follicular fluid (Ledoux et al., 2006; Chabrolle et al., 2009) 
and AdipoR1 and AdipoR2 are present in theca and granulosa cells, oocytes, and the 
corpus luteum in dairy cows (Tabandeh et al., 2010). However, either AdipoR1 or 
AdipoR2 knock-out mice is fertile, and this may imply adiponectin is not necessary for 
normal ovarian function (Campos et al., 2008; Brochu-Gaudreau et al., 2010).The effect of 
adiponectin on milk progesterone profile needs to be investigated further. 
 
Treatment with leptin reverses fasting-induced anoestrus in Syrian hamsters (Schneider et 
al., 1998). Moreover, female mice injected with leptin reproduced up to 9 days earlier than 
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controls and showed earlier maturation of the reproductive tract (Chehab et al., 1997). 
Furthermore, higher leptin concentrations were associated with shorter intervals to first 
observed estrus in dairy cows (Liefers et al., 2003). Leptin was negatively associated with 
days to first oestrus in this experiment, which is in line with the afore-mentioned studies. 
Moreover, cows with HIGH adiponectin levels had lower days to first oestrus and a 
tendency for higher leptin than cows with NORMAL adiponectin levels. Thus, the 
tendency for higher leptin may explain the lower days to first oestrus in cows with HIGH 
adiponectin levels. 
 
In lactating cows, delayed resumption of cyclicity is associated with decreased circulating 
leptin, whereas increased circulating leptin resulted in improved reproductive performance 
(Kadokawa et al., 2000; Block et al., 2001; Liefers et al., 2003; Meikle et al., 2004; 
Konigsson et al., 2008). According to Meikle et al. (2004) cows with better reproductive 
performance had higher circulating IGF-I and Butler et al. (2000) found a negative 
relationship between postpartum circulating IGF-I and the interval to the resumption of 
ovarian cyclicity. Also, Huszenicza et al. (2001) found higher IGF-I levels in cows with 
ovulation occurring within 35 days postpartum. In the present study, cows with HIGH 
adiponectin levels had higher IGF-I, leptin (tendency), and reproductive performance than 
cows with NORMAL adiponectin profiles and those findings are generally in agreement 
with the above mentioned studies. 
 
It is known that cows with high genetic merit show increased incidence of delayed 
commencement of luteal activity (CLA) (Windig et al., 2008) and increased circulating 
GH and milk yield (Veerkamp et al., 2003). Moreover, cows with greater milk production 
have lower peak progesterone concentrations (Windig et al., 2008; Taylor et al., 2003; 
Remppis et al., 2011) and secretion of progesterone is reduced by energy deficit (Villa-
Godoy et al., 1988). According to Veerkamp et al. (2000) increasing genetic merit for feed 
intake improves CLA in dairy cows. Moreover, cows in higher parities are more at risk of 
suffering from prolonged luteal phases (Opsomer et al., 2000). In accordance with these 
studies, multiple logistic regression analysis demonstrated that the risk for abnormal milk 
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progesterone profile increased with milk yield, GH (tendency), and parity (tendency), 
whereas it decreased with DMI (tendency) in this experiment. 
 
It has been shown that ovarian follicular cyst formation frequently occurs in the early 
postpartum period when the cow changes from the acyclic state during pregnancy to the 
establishment of regular cyclicity (Webb et al., 1998; Vanholder et al., 2006). Low 
circulating IGF-I in early lactating cows could predispose to anovulation and development 
of cystic follicles (Zulu et al., 2000). Moreover, decreased circulating insulin and insulin 
resistance in early lactating cows may affect cyst formation (Vanholder et al., 2005) 
whereas leptin may play a role in cyst development as a minimum level of circulating 
leptin is required to induce the first postpartum LH surge (Vanholder et al., 2006). 
Furthermore, cows with cysts were associated with higher milk production (Garverick, 
1997; Webb et al., 1998) and cows with high circulating NEFA after calving were twice as 
likely to develop cystic ovarian disease (Jackson et al., 2011). Additionally, Borromeo et 
al. (1998) demonstrated that GH concentrations in plasma and follicular fluid were higher 
in dairy cows with cystic follicles and Kawashima et al. (2007) showed that cows did not 
ovulate had higher circulating GH and lower circulating glucose during the peri-partum 
period than cows ovulated. In aggreement with the above mentioned studies, multiple 
logistic regression analysis demonstrated a negative effect on cystic body formation of 
circulating glucose and insulin, whereas circulating GH and NEFA had a positive effect on 
cystic body formation. Although all the animals expressed HIGH adiponectin levels were 
assessed without cystic bodies, there was no association between adiponectin level and 
follicular cysts. However, this needs to be investigated further as it is possibly biased by 
the small numbers of cows observed with follicular cysts (only 8 out of 60) and the small 
number of cows with HIGH adiponectin levels (6 out of 60) (Table 5.9). Moreover, 
follicular cyst formation delayed days to first oestrus in the present study (Figure 5.6) and 
may be another explaination why cows with HIGH adiponectin levels had fewer days to 
first oestrus than cows with NORMAL adiponectin levels (Table 5.7). 
 
Interval from calving to conception was not affected by circulating adiponectin levels, 
whereas days to conception positively associated with days to first oestrus, and cows with 
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HIGH adiponectin levels had fewer days to first oestrus (43 days versud 56 days) than 
cows with NORMAL adiponectin levels in the present study. According to Figure 5.8 
animals with 43 days to first oestrus (HIGH adiponectin levels) did not have statistically 
different days to conception (74 days versus 80 days) compared with animals with 56 days 
to first oestrus (NORMAL adiponectin levels). Insulin was the main factor influenced days 
to conception, but circulating insulin was not different between cows with HIGH and 
NORMAL adiponectin levels. This latter may further explain why interval from calving to 
conception was unaffected by circulating adiponectin levels. 
   
Why individual cows had consistently high or low adiponectin levels is difficult to explain 
in this experiment. In humans, circulating adiponectin has a strong genetic component with 
heritability estimated to be between 30% and 50% (Comuzzie et al., 2001). Moreover, low 
circulating adiponectin is observed in several forms of diabetes, with insulin resistance, 
and in non-alcoholic fatty liver disease (Xu et al., 2007).  In dairy cows, there has been no 
genetic association study to examine the role of adiponectin polymorphisms on indices of 
insulin sensitivity, circulating GH levels, fatty liver disease, and glucose tolerance. 
However, it is possible that insulin resistance, genetics, and fatty liver disease in dairy 
cows to regulate circulating adiponectin levels similarly to man. However, this hypothesis 
needs to be further investigated. 
 
To conclude, cows with HIGH adiponectin levels had fewer days to first oestrus and a 
higher probability to be pregnant than cows with NORMAL adiponectin levels. All, cows 
with HIGH adiponectin levels exhibited normal milk progesterone profiles. However, there 
were no significant difference between cows with HIGH adiponectin levels and cows with 
NORMAL adiponectin levels for days to pregnancy or follicular cyst formation. 
Differences in metabolic and hormonal profile and production traits may at least in part 
explain the differences in reproductive performance between cows with HIGH adiponectin 
levels and cows with NORMAL adiponectin levels. However, further work is required to 
clarify the reasons for existence of such “special” animals (with increased adiponectin, 
decreased GH, and superior fertility), and the relations of high circulating adiponectin with 
metabolic and hormonal profile, productive traits, and reproduction. 
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5.5.2.Interrelationshipsofadiponectinwithglucose,BCS,metabolichormones,
andmetabolitesinhighandlowyieldingcows
 
Path diagrams and structural equation modelling (SEM) analysis for all the 60 cows in this 
experiment proved that glucose balance in dairy cows was regulated by the negative 
influences of circulating adiponectin, BOHB, and glucagon, and the positive influence of 
circulating insulin on circulating glucose. It is known that high circulating adiponectin 
levels were associated with a lower risk of development of type 2 diabetes and adiponectin 
was found to negatively correlate with circulating glucose (Hotta et al., 2000; Weyer et al., 
2001; Spranger et al., 2003) and this is in agreement with the current study. Also, the 
hypoglycaemic effect of insulin action is antagonized by glucagon, and insulin is positively 
correlated with glucose (Brockman, 1978, 1979). Moreover, BOHB is negatively 
correlated with insulin and glucose in dairy cows (Drackley, 1999; Bobe et al., 2004; 
Veerkamp et al., 2003; Leroy et al., 2010). These findings are also in line with the current 
study. In the present study, GH, NEFA, leptin, and BCS had no direct effect on circulating 
glucose, but GH was negatively correlated with adiponectin and leptin, whereas leptin was 
positively correlated with insulin. Human obese patients showed decreased circulating GH 
and increased circulating leptin (Casanueva & Dieguez, 1998) whereas acromegalic and 
anorexia nervosa patients expressed decreased circulating leptin and increased circulating 
GH (Popovic et al., 2001; Scacchi et al., 1999). Also, studies in humans and rodents 
showed that the relation between adiponectin and GH is possibly negative (Lam et al., 
2004; Nilsson et al., 2005; Rodriguez-Pacheco et al., 2007). Insulin was positively 
correlated with leptin in periparturient and lactating dairy cows (Block et al., 2001; 
Garnsworthy et al., 2008c). These findings are also in agreement with the present study. 
 
Previous milk yield (PMY) was used in the present study as an indicator of genetic merit 
for milk yield. However, it is known that other factors, such as lactation persistency, BCS 
at calving, DMI, calving interval, parity, health status, and diet contribute to differences 
observed in milk yield (Rook & Thomas, 1983). Cows were grouped according to milk 
yield in the previous lactation (PMY) with a cut-off point between high and low yielding 
cows of 10,000 kg/cow/lactation. This cut-off point is higher than the current average yield 
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per cow in the UK (7,406 kg/cow/lactation) (DEFRA, 2011) and it was chosen to be as 
high as possible. This was to ensure that the nature of the differences observed in the PMY 
groups was mainly due to genetic differences between cows. All instances of ill health of 
cows were recorded in this experiment, although subclinical diseases cannot be excluded 
from the factors affecting PMY. Parity was not statistically different for high PMY cows 
compared to low PMY cows (the majority of the cows (39 out of 60) were in their 2
nd
 
lactation) and the length of lactation used to calculate PMY was 305 days. In addition, high 
PMY cows had higher milk yield, DMI, and BCS at calving and a trend for higher ǻBCS 
than low PMY cows in the present lactation, which is in agreement with the profile of the 
high genetic merit cow for milk production (Veerkamp et al., 2003). 
 
Structural equation modelling analysis for cows with LOW PMY revealed a simple 
network of interrelationships of adiponectin with glucose and other metabolic signals in 
these animals. In PMY LOW cows, glucose homeostasis was regulated by the positive 
effect of insulin and the negative effects of adiponectin and glucagon. GH was not related 
to leptin or adiponectin. It is known that low yielding cows have low circulating GH 
(Veerkamp et al., 2003), which is a possible reason for the lack of correlation between GH 
and adiponectin. In these PMY LOW cows, adiponectin was the main insulin sensitizing 
hormone due to its direct negative effect on circulating glucose, whereas leptin may have 
exerted insulin stimulatory effects because it was correlated with insulin. 
 
In contrast, PMY HIGH cows showed completely different patterns in regulating glucose 
homeostasis. In these animals, the relationships between metabolic hormones and 
metabolites were very complicated. It is known that selection for milk yield resulted in 
decreased circulating glucose and increased circulating GH and BCS (Roche et al., 2009; 
Coffey et al., 2003; Veerkamp et al., 2003). Possibly, that is the reason GH showed strong 
negative correlations with adiponectin and leptin. It has been demonstrated that GH is up-
regulated in human diabetes type 2 (Holt, 2003); high yielding cows tend to be genetically 
and phenotypically thinner (Garnsworthy, 2006); and fatter cows at calving lose more body 
fat than thinner cows (Garnsworthy & Topps, 1982). This latter might explain the strong 
negative correlations of BCS with glucose, glucagon and GH and the strong positive 
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correlations of BCS with insulin and adiponectin. Furthermore, glucose homeostasis in 
PMY HIGH cows was regulated by the positive effect of insulin and the negative effects of 
BCS and BOHB. In these cows, adiponectin did not play any direct role in regulating 
glucose balance (because it was strongly down-regulated by GH) but leptin, as in PMY 
LOW cows, was the main insulin stimulatory hormone because it was positively correlated 
with insulin. However, adiponectin was positively correlated with BCS and BCS had a 
significant effect on glucose balance. That means that, the greater was the BCS of the high 
yielding cows postpartum (cows that did not lose a lot of condition), the lower was the 
circulating GH and glucagon, and consequently the lower was the milk yield. Moreover, 
the lower the circulating GH, the higher was the circulating adiponectin, leptin, and 
BOHB. The higher the circulating leptin, the higher was the circulating insulin, NEFA, and 
glucose. Finally, this aetiological chain concludes to a profile of high yielding cows with 
elevated circulating adiponectin, leptin, insulin, glucose, NEFA, and BOHB. According to 
Figure 5.14, adiponectin and leptin are not active in terms of lowering glucose, and 
consequently that aetiology leads to elevated circulating glucose, insulin, NEFA, and 
BOHB which is common in human metabolic syndrome, insulin resistance, and diabetes 
mellitus. Oligomerisation of adiponectin structure is considered very important for its 
biological function (Berg et al., 2002; Barb et al., 2007) and could explain at least 
theoretically why high circulating adiponectin was possibly inactive under such 
physiological conditions. Moreover, impaired oligomerization might be an important 
causative factor for type 2 diabetes (Xu et al., 2007). The positive correlations of NEFA 
with insulin and leptin also imply insulin or/and leptin resistance in PMY HIGH cows 
(Krentz, 1996; Fam & Andrikopoulos, 2007; Myers et al., 2008). Indeed, many studies 
have reported low insulin sensitivity in early lactation cows (Sano et al., 1991, 1993; 
Chilliard et al., 1998; Gutierrez et al., 2006; Hayirli, 2006). Besides, if this aetiological 
chain runs for a high yielding cow which loses a lot of condition postpartum, then it would 
fit the profile of an animal with high GH, milk yield, and glucagon and low glucose, 
insulin, leptin, adiponectin, NEFA, and BOHB. Of course, this is an incorrect prediction of 
the model because at least NEFA and BOHB are reported to be elevated in such conditions 
(Jorritsma et al., 2003; Veerkamp et al., 2003). However, the majority of commercial cows 
are in-between the two main cases examined by the model, and other physiological 
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regulatory factors are likely to contribute to the whole complicacy of glucose homeostasis 
in high yielding cows. 
 
The main conclusion of this analysis is that the relationship between adiponectin and GH 
was generally antagonistic in dairy cows. Also, the relation between circulating glucose 
and circulating adiponectin was negative and that might indicate insulin sensitizing traits of 
adiponectin in dairy cows. Moreover, high yielding cows might regulate glucose 
homeostasis differently to low yielding cows, which was mainly achieved by higher 
secretion of GH and lower or inactive adiponectin. GH possibly down-regulated leptin and 
adiponectin, but this was mainly in high yielding cows. Leptin was positively correlated 
with insulin in both high yieldings and low yielding cows, and it was likely to exert insulin 
stimulatory effects. However, further work is needed to elucidate the perplexities of 
glucose homeostasis and its interrelationships with hormonal and metabolic profile in dairy 
cows. 
 
 
5.5.3Conclusions
 
In summary, the results from this study confirm that cows with circulating adiponectin 
levels up to three times normal had a better reproductive performance than cows with 
normal circulating adiponectin levels. In addition, differences in metabolic and hormonal 
profile and production traits may at least in part explain the superior fertility of cows with 
circulating adiponectin levels up to three times normal. More importantly, the relation 
between circulating glucose and circulating adiponectin was negative and that might 
indicate insulin sensitizing traits of adiponectin in dairy cows. Finally, high yielding cows 
might regulate glucose homeostasis differently to low yielding cows due to increased GH 
and decreased adiponectin concentrations. However, these results need to be investigated 
further 

6.Generaldiscussion
 
6.1.INTRODUCTION
 
The control of glucose homeostasis and homeorhesis is of outmost importance in 
understanding hormonal and metabolic profiles, relating to NEB in early lactation (Bell, 
1995; Bauman, 2000). The postpartum cow has to deal with energy deficit and the great 
demand for nutrients, especially glucose, to meet the high needs of the mammary gland 
(Butler & Smith, 1989; Bell, 1995; Nebel & McGilliard, 1998). Decreased insulin allows 
cows to partition glucose preferentially to the mammary gland, and increased circulating 
GH and prolactin facilitate this adaptation (Bauman & Currie, 1980). Elevated circulating 
NEFA, BOHB, and urea are mainly produced as a result of excessive mobilization of 
adipose and muscle tissue to support the demand for nutrients by the mammary gland 
(Bell, 1995; Grummer, 1995). Decreased circulating IGF-I may be a consequence of 
deteriorating functionality of the liver which in early lactation prioritizes intensification of 
processes such as gluconeogenesis, lipolysis, and ketogenesis (Butler et al., 2003; Wathes 
et al., 2007, 2008). Adiponectin, because of its insulin sensitising actions and its negative 
correlation with body condition (Berg et al., 2002; Matsuzawa et al., 2004; Kadowaki & 
Yamauchi, 2005), could be another putative regulator of metabolism during the transition 
from pregnancy to lactation (Mazaki-Tovi et al., 2005; Mitchell et al., 2005). Body 
condition score is considered an indirect measure of nutritional status (Short et al., 1990; 
Garnsworthy, 2006; Bewley & Schutz, 2008) and nutrition has been demonstrated to 
interact with reproduction (Boland et al., 2001; Garnsworthy et al., 2009).  
 
The overall objective of the present study was to examine the impacts of different 
nutritional and body condition treatments on metabolic and hormonal profiles, circulating 
adipokines, and reproductive performance in dairy cows. A special focus was directed to 
circulating adiponectin and its association with metabolic and hormonal status and 
reproduction. Work in this thesis has shown some novel effects of circulating adiponectin 
on cow fertility. In addition, the effects of lactational stage, diet, and BCS at calving on 
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circulating adiponectin were assessed. Also, adiponectin was shown to be present in bovine 
milk for the first time. Moreover, optimum insulin concentration in terms of reproduction, 
and its association with dietary and condition treatments was explored. Furthermore, a 
subpopulation of dairy cows with consistently high circulating adiponectin levels was 
identified for the first time, and the hormonal, metabolic, reproductive, and productive 
profiles of these animals were studied.  Last but not least, the association of adiponectin 
with glucose homeostasis and other metabolic and hormonal signals was determined in 
cows with different milk yield potential. To our knowledge, no other study has explored 
associations between circulating adiponectin and hormonal and metabolic stimulus with 
regard to milk yield potential in dairy cows. 
 
6.2.SUMMARYOFMAINPOINTS
 
6.2.1. Effect of diet and body condition score at calving on reproductive
performanceindairycows
 
Results from the present study demonstrated that feeding dairy cows with a HS diet or a 
HF diet for the first 4 months of lactation would not result in changing reproductive 
performance (probability of cows to be pregnant, days to first oestrus, and days to 
conception, were not affected by dietary treatment). That is mainly because important 
metabolic hormones (e.g. leptin, IGF-I, and GH), production traits (milk yield, BCS, 
ǻBCS, nadir week, and nadir BCS), and metabolites (e.g. NEFA and glucose) were not 
influenced by diet (Chapter 3). In addition, moderately elevated insulin concentration that 
exceeded optimum insulin concentration and induced by feeding dairy cows the HS diet 
may account for the higher probability to express ABNORMAL milk progesterone profile 
(Chapter 3). The results of the present study are not in agreement with the study of Gong et 
al (2002b) in which cows fed the HS diet had better reproductive performance than cows 
fed the HF diet. An explanation for the discrepancies between the present study and the 
study of Gong et al (2002b) could be that the animals were dietary manipulated for longer 
(up to 2 times) in the present study than the animals of the study of Gong et al. (2002b). 
Moreover, all animals exceeded minimum insulin concentration in terms of reproduction in 
the present study whereas some animals were below minimum insulin concentrations in the 
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study of Gong et al. (2002b) and that might be another explanation for discrepancies 
between the two studies (Chapter 3). 
 
The results of the present study clearly indicated that THIN cows at calving (BCS 3.25), 
which lost less than 0.5 units of BCS postpartum had better reproductive performance than 
FAT cows at calving (BCS>3.25), which lost more than 0.8 units of BCS postpartum 
(Chapter 3). FAT cows at calving had higher circulating NEFA and lower circulating IGF-I 
than THIN cows at calving. Elevated circulating NEFA may detrimentally affect follicular 
growth and development (Leroy et al., 2008, 2010) and reduced circulating IGF-I 
negatively influence postpartum reproductive performance (Butler et al., 2000; Huszenicza 
et al., 2001; Meikle et al., 2004). Moreover, THIN cows at calving had higher probability 
of being pregnant and lower probability of expressing irregular oestrous cycles than FAT 
cows at calving, although the animals had the same insulin concentration, which ranged 
from 0.4 to 0.6 ng/ml. This latter result could also explain why THIN cows showed 
superior reproductive performance compared with FAT cows in the present study (Chapter 
3).  
 
6.2.2.Reproductiveperformanceandoptimuminsulinconcentration
 
Long term moderately elevated insulin concentration (>0.3 ng/ml) had a negative impact 
on pregnancy rate and milk progesterone profile in the present study, whereas optimum 
insulin concentration that maximized pregnancy rate and minimized the probability for 
cows to express abnormal milk progesterone profile varied from 0.2 to 0.3 ng/ml. 
Furthermore, insulin concentration greater than 0.6 ng/ml reduced the probability of cows 
being pregnant towards zero, whereas insulin greater than 0.4 to 0.6 ng/ml tended to 
maximize the probability for cows to express an abnormal milk progesterone profile 
(Chapter 3). Also, insulin concentration greater than 0.7 ng/ml resulted in calving to 
conception interval greater than 100 days, whereas animals with insulin concentration 
within the range 0.2-0.3 ng/ml had a calving to conception interval of less than 70 days 
(Chapter 5). Therefore, the results suggest that optimum insulin concentration in terms of 
reproduction is within the range 0.2-0.3 ng/ml, whereas insulin concentration greater than 
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0.6 to 0.7ng/ml is detrimental for cow fertility. Interestingly, the current study found that 
BCS at calving was a critical modulator of fertility in lactating dairy cows when circulating 
insulin was suboptimum (0.4 ng/ml). Moreover, THIN cows at calving had higher 
probability to be pregnant and lower probability to express abnormal milk progesterone 
profile than FAT cows at calving, when the animals had approximately the same insulin 
concentration and insulin concentration ranged from 0.4 to 0.6 ng/ml. Thus, achieving a 
BCS of less than 3.25 units at calving is essential to ensure optimum cow fertility. 
Furthermore, cow fertility (pregnancy rate and milk progesterone profile) was not affected 
by dietary treatments when insulin concentrations were about the same and insulin ranged 
from 0.1 to 1 ng/ml. However, the current work showed that HF diet must be the preferable 
feeding strategy to maximise reproductive performance of dairy cows when insulin 
concentration ranges from 0.1 to 0.3 ng/ml and BCS at calving is equal or lower than 3.25 
units. 
 
6.2.3.Adiponectin

6.2.3.1.Measurementofcirculatingadiponectinindairycows
 
The present study showed that plasma adiponectin in dairy cows varied from 6.47±0.75 to 
11.15±1.06 ng/ml, and some cows had constantly elevated plasma adiponectin throughout 
the experiment. In addition, circulating adiponectin values were not normally distributed 
and mean circulating adiponectin was significantly greater than mean insulin, leptin, GH 
and glucagon. Furthermore, the high autocorrelation of circulating adiponectin values 
might indicate that plasma adiponectin concentration was tightly controlled genetically and 
other factors had only a minimal impact (Chapter 4).  
 
6.2.3.2.Measurementofadiponectininbovinemilk
 
Milk adiponectin concentration was measured for the first time in bovine milk and the 
mean concentration was 11.5±2.6 ng/ml (Chapter 4). This result is in agreement with the 
studies of Martin et al. (2006), Weyermann et al. (2006), and Bronsky et al. (2006) which 
confirmed the presence of adiponectin in human milk. Milk and plasma adiponectin 
”Chapter6Generaldiscussion


188

concentrations were similar in the current study, which may imply that milk adiponectin is 
excreted at concentrations similar to the peripheral circulation (Chapter 4). Adiponectin 
concentrations in human breast milk ranged from 3.9 to 87.9 ng/ml (Bronsky et al., 2006; 
Martin et al., 2006). Normal adiponectin concentrations in human serum ranged from 5 to 
30 ȝg/ml (Ahima, 2006) and this may imply adiponectin is present in human milk in 
concentration lower than in blood, which is not in agreement with the present study. Ohtani 
et al. (2011) demonstrated the existence of an autocrine-paracrine system of adiponectin 
action in bovine mammary gland and the presence of adiponectin receptors was shown in 
human breast cancer cell line MCF-7 (Dieudonne et al., 2006).However, there is no study 
that directly compared circulating and milk adiponectin or examined the action, synthesis, 
and excretion of adiponectin in the mammary gland. Human milk adiponectin 
concentrations decrease approximately 5% – 6% with each month of lactation (Newburg et 
al., 2010; Savino & Liguori, 2008). In the present study, milk adiponectin concentrations 
did not show the same trend, although samples were collected only for the first two months 
of lactation; nevertheless, adiponectin varied with days postpartum. Another finding of this 
study was that milk adiponectin was not different for cows with either high or low milk 
yield, but this needs to be confirmed (Chapter 4).  
 
The milk adiponectin assay, because it is non-invasive, offers the potential for more 
widespread studies in dairy cows under commercial conditions. It was intended to apply 
the technique on a larger scale in the present study, but time and financial constraints 
precluded this. The effects of adiponectin and adiponectin receptors in mammary gland and 
milk synthesis need to be elucidated by explicit experiments. 
 
6.2.3.3.The impactof lactational stage,dietandBCSat calvingon circulating
adiponectinindairycows
 
This study showed that, as in humans (Asai-Sato et al., 2006; Ritterath et al., 2008), the 
transition from pregnancy to lactation in dairy cows was associated with a reduction in 
plasma concentration of adiponectin. Moreover, the present study found that after the 4
th
 
week postpartum circulating adiponectin was significantly increased and remained at the 
same level until the 12
th
 week postpartum. Furthermore, this study suggests that after the 
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12
th
 week postpartum there was a significant reduction in circulating adiponectin (Chapter 
4).  
 
In the present study, stage of lactation affected the majority of circulating metabolic 
hormones, metabolites and production traits, but circulating adiponectin showed 
correlations only with circulating GH and postpartum BCS loss (ǻBCS). However, there 
was a weak negative association between plasma adiponectin and glucose. The weekly 
changing pattern of circulating adiponectin can be partially explained by the negative 
relationship between GH and adiponectin. This is the first in vivo study to demonstrate a 
negative relationship between GH and adiponectin in dairy cows (Chapter 4). 
 
There was no effect of either diet or BCS at calving on circulating adiponectin. Circulating 
GH and glucose were not altered by dietary and BCS treatments in this study and this was 
possibly the reason the diet and BCS at parturition, had no effect on circulating adiponectin 
concentrations (Chapter 4). However, dietary factors have modulated circulating 
adiponectin (Reis et al., 2010) in other species. High consumption of magnesium (Qi et al., 
2005; Cassidy et al., 2009), caffeine (Williams et al., 2008), n-3 PUFA (Duda et al., 2007), 
and dietary salt (Lely et al., 2007) are associated in humans with higher circulating 
adiponectin. Prepartum thiazolidinediones (TZD) administration dramatically decreased 
ǻBCS and NEFA and increased DMI and the proportion of dairy cows ovulating by 21 
days postpartum (Schoenberg et al., 2008; Smith & Overton, 2008). TZD is a known 
PPARȖ agonist, which increases adiponectin production in both humans and rodents (Xu et 
al., 2007; Yoon et al., 2009). It is likely that the therapeutic effects of TZD are mediated 
by induction of adiponectin (Xu et al., 2007; Yoon et al., 2009). TZD administration of 
cows requires drug approval; however, application of dietary strategies enhancing 
circulating adiponectin may be an inexpensive alternative. Thus, properly designed 
experiments need to be conducted in order to evaluate putative roles of nutrients in 
regulating circulating adiponectin in dairy cows 
 
A characteristic trait of circulating adiponectin is its negative correlation with adiposity in 
non-pregnant human and rodent models (Ahima, 2006). However, circulating adiponectin 
values throughout pregnancy are not correlated with maternal BMI in humans (Mazaki-
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Tovi et al., 2005; Jansson et al., 2008). According to Raddatz et al., (2008) and Puntenney 
(2006) adiponectin was not correlated with BCS in periparturient cows and this finding is 
in accordance with the current study. Thus, it is likely that BCS is not correlated with 
circulating adiponectin in periparturient and early lactating dairy cows. However, further 
research would determine if this hypothesis is correct.  
 
Postpartum BCS loss (ǻBCS) was negatively correlated with leptin and adiponectin in the 
current study and may be a useful tool to study circulating adipokines in periparturient and 
early lactating cows (Chapter 4). The negative correlation of leptin with BCS loss is 
documented in heifers (Leon et al., 2004) and this is in agreement with the finding of the 
present study. Weight and BMI loss lead to increased circulating adiponectin in humans 
(Reinehr et al., 2004; Bobbert et al., 2005; Engl et al., 2007), but this is not in line with the 
present study. A possible explanation for this discrepancy between the present study and 
human studies could be differences between human and bovine animal models in 
regulation of circulating adiponectin. Also, it is known that human adiponectin is down-
regulated when hyperinsulinemia and insulin resistance coexist (Kadowaki & Yamauchi, 
2005). The animals of the present study had moderately elevated insulin concentrations and 
that might be another reason why ǻBCS was negatively correlated with adiponectin. In 
humans, circulating adiponectin showed a strong negative relationship with visceral body 
fat, which is strongly related to BMI (Matsubara et al., 2002; Cnop et al., 2003; Lara-
Castro et al., 2006). It is uncertain if ǻBCS is related to visceral body fat of the cow.  

6.2.3.4. Circulating adiponectin and milk yield 
 
Evidence accumulated from in vitro studies suggests that human mammary epithelial cells 
of various cancer cell lines express receptors of adiponectin (Dieudonne et al., 2006; 
Treeck et al., 2008; Jarde et al., 2009). Treatment of cancer mammary epithelial cells with 
recombinant adiponectin deters their growth, by activating cell apoptosis pathways and by 
inhibiting the cell cycle (Dieudonne et al., 2006). Moreover, obesity causes suppression of 
circulating adiponectin levels (Kadowaki & Yamauchi, 2005) and genetic improvement of 
cows for higher milk yield results in increased postpartum BCS loss (Dechow et al., 2002) 
and circulating GH (Veerkamp et al., 2003). Furthermore, circulating GH was negatively 
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correlated with circulating adiponectin in dairy cows (as shown in Chapter 4) and 
adiponectin receptors were present in bovine mammary epithelial cells (Ohtani et al., 
2011). It is likely; therefore, to assume low circulating adiponectin (as a result of elevated 
GH concentrations) leads to increased milk production in high yielding cows.  High 
yielding cows lost more condition postpartum, ate more feed and had higher circulating 
GH, milk yield and DMI but lower circulating adiponectin, leptin, and insulin than low 
yielding cows in the current study (Chapter 4). Moreover, cows with circulating 
adiponectin levels up to three times normal (21.2±1.32 ng/ml) had lower GH and milk 
yield and higher leptin (tendency) than cows with normal circulating adiponectin levels 
(7.1±0.23 ng/ml) as shown in Chapter 5. This is the first study to suggest that due to 
increased circulating GH and its antagonistic relationship with adiponectin and leptin, high 
yielding cows may have lower circulating leptin and adiponectin concentrations than low 
yielding cows. 
 
6.2.3.5.Adiponectinandfeedintakeindairycows
 
This is the first study to show that adiponectin is likely to be related to DMI in dairy cows, 
but this relationship is minimal and dependent on BCS at calving (Chapter 4). Kubota et 
al., (2007) showed that adiponectin enhances AMPK activity in the murine arcuate 
hypothalamus through AdipoR1 receptor, and stimulates food intake. There is a need for 
further study of the effect of adiponectin on food intake. 
 
6.2.3.6.Effectofcirculatingadiponectinlevelsonreproductiveperformance
 
For the first time, a subpopulation of dairy cows with consistently high circulating 
adiponectin levels was identified, and the hormonal, metabolic, reproductive, and 
productive profiles of these animals were studied. Cows with circulating adiponectin levels 
up to three times normal (21.2±1.32 ng/ml) had a higher probability to be pregnant and 
fewer days to first oestrus than cows with normal circulating adiponectin levels (7.1±0.23 
ng/ml). Also, cows with circulating adiponectin levels up to three times normal had a 
tendency to be associated with normal milk progesterone profile than cows with normal 
circulating adiponectin levels. However, there were no significant difference between cows 
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with circulating adiponectin levels up to three times normal and cows with normal 
adiponectin levels in the interval from calving to conception and formation of follicular 
cysts. Differences in metabolic and hormonal profiles and reproductive and production 
traits may at least partly explain the differences in reproductive performance between cows 
with high circulating adiponectin and cows with normal circulating adiponectin levels 
(Chapter 5). 
 
Unfortunately, only 10% of cows in this experiment expressed circulating adiponectin 
level up to three times normal. In humans, circulating adiponectin has a strong genetic 
component with heritability to be estimated between 30% and 50% (Comuzzie et al., 
2001). Moreover, the high autocorrelation of circulating adiponectin values in the present 
study may indicate that plasma adiponectin concentration is tightly regulated genetically. 
Genetic association studies need to be performed in dairy cows to investigate further if 
there is any association between adiponectin gene polymorphisms and indices of insulin 
sensitivity, circulating GH levels, circulating adiponectin levels, and glucose resistance. 
 
6.2.4.Glucosehomeostasis
 
Glucose balance in dairy cows was regulated mainly by the negative influence of 
circulating adiponectin, BOHB, and glucagon on circulating glucose, and the positive 
influence of circulating insulin on circulating glucose (Chapter 5).  
 
High yielding cows might regulate glucose homeostasis differently to low yielding cows, 
which was mainly achieved by higher secretion of GH and lower or inactive adiponectin. 
GH possibly down-regulated leptin and adiponectin, but this was mainly in high yielding 
cows. Leptin was positively correlated with insulin in both high yielding and low yielding 
cows, and it was likely to exert insulin stimulatory effects (Chapter 5).  
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6.2.5.Reproductiveperformanceandadipokines
 
Reproductive indices (such as pregnancy rate, days to first oestrus, interval from calving to 
conception, milk progesterone profile, and follicular cyst formation) were measured and 
the effects of circulating adiponectin and leptin were examined. Leptin was negatively 
associated with days to first oestrus in the present study (Chapter 5), and this is in 
agreement with the studies of Liefers et al. (2003), Kadokawa et al. (2000), Block et al. 
(2001), and Meikle et al. (2004) in dairy cows.  
 
Circulating adiponectin was negatively associated with the probability of cows to express 
abnormal milk progesterone profiles and cows with circulating adiponectin levels up to 
three times normal had a tendency to be associated with normal milk progesterone profiles 
(Chapter 5). According to Campos et al. (2008) there is plenty of evidence to support a 
beneficial role of adiponectin in reproduction, but it is not yet clear that adiponectin is 
required for normal reproductive performance. This is the first study to suggest that 
hypoadiponectineamia might be associated with increased milk production and a 
predominance of atypical milk progesterone profiles. This could be another mechanism 
that leads to infertility in the modern dairy cow; however, explicit experimentation is 
needed to further investigate this hypothesis. 
 
 
6.3.INTEGRATIONOFRESULTSANDIMPACTONREPRODUCTIVEMANAGEMENT
 
Cow fertility was the final output of complicated interactions of BCS at calving, diet, 
metabolic and hormonal stimulus, production traits, and reproductive indices in the current 
project. An overview of factors influenced reproductive indices and subsequent cow 
fertility is presented in Figure 6.1.  
 
Results in this thesis have demonstrated the predominant role of insulin in cow fertility.
Pregnancy rate, interval from calving to conception, and milk progesterone profile were 
associated with insulin and analysis showed that optimum insulin concentration that 
benefited these indices was within the range 0.2 to 0.3 ng/ml, whereas insulin 
concentration greater than 0.6 to 0.7 ng/ml deteriorated them. However, analysis in Chapter 
”Chapter6Generaldiscussion


194

5 showed that insulin concentration greater than 0.6 to 0.7 ng/ml could benefit cow fertility 
due to decreased incidence of follicular cyst formation. Thus, insulin effects on fertility can 
vary significantly according to insulin concentrations and reproductive indices assessed.
Follicular cyst formation positively associated with days to first oestrus and HS diet 
increased circulating insulin in this study. This latter may suggest that HS diets can be used 
to benefit fertility in dairy herds with history of low insulin concentration, increased 
incident of follicular cyst formation, and delayed onset of postpartum ovarian activity. 
However, it needs to be further elucidated. 
 
Proportion of atypical oestrous cycles was low and pregnancy rate was high when insulin 
concentration was within the optimum range in the current project. Also, the pregnancy 
rate was higher when the proportion of atypical oestrous cycles was lower. Therefore, cow 
fertility was maximized when insulin concentration was within the optimum range. 
Moreover, optimum calving interval is 12 months in dairy cows (Ball & Peters, 2004) and 
maintenance of insulin concentration within the optimum range can assure on time 
reproduction of commercial dairy herds, which is important for their profitability. 
Consequently, results of this study support the concept that cow fertility will be enhanced 
if insulin concentration is within the range 0.2 to 0.3 ng/ml for a period of 4 months 
postpartum.  This significant finding should be taken in account when a postpartum dietary 
strategy is designed to improve reproductive performance of dairy cows. Of the managerial 
tools studied in the current project, HS and HF diets showed a potential to regulate insulin 
concentrations and should be components of an integrated management strategy that 
ensures better cow fertility. However, long term use of HS diet should be avoided because 
it increases the proportion of irregular oestrous cycles. 
 
Results of this study support the concept that ǻBCS and BCS at calving are critical 
modulators of fertility in lactating dairy cows. Optimum range of ǻBCS in terms of 
reproduction was 0.25-0.50 units of BCS, whereas ǻBCS greater than 0.70-0.80 units of 
BCS was detrimental for cow fertility. Moreover, THIN cows at calving (BCS 3.25) had 
better reproductive performance than FAT cows at calving (BCS>3.25). Furthermore, the 
results demonstrated that optimum insulin concentration was dependent on BCS at calving 
in lactating dairy cows and THIN cows at calving (BCS 3.25) had better reproductive 
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performance than FAT cows at calving (BCS>3.25) when insulin concentration was within 
the range 0.4-0.6 ng/ml. Also, THIN cows at calving had lower ǻBCS and circulating 
NEFA, and higher circulating IGF-I than FAT cows at calving. NEFA was positively 
associated with follicular cyst formation and IGF-I was positively associated with 
pregnancy rate, and negatively with interval from calving to conception in the current 
study. In addition, ǻBCS was positively associated with days to first oestrus and negatively 
with pregnancy rate. Therefore, achieving a BCS of less than 3.25 units at calving is 
essential to ensure optimum cow fertility. The results also suggest that HF diet must be the 
preferable feeding strategy to maximize reproductive performance of lactating dairy cows 
when insulin concentration ranges from 0.1 to 0.3 ng/ml and BCS at calving status is 
THIN. 
 
The main effects of adipokines on reproduction were: adiponectin negatively influenced 
the proportion of animals expressed irregular oestrous cycles, whereas leptin negatively 
influenced days to first oestrus. ǻBCS was negatively correlated with leptin and 
adiponectin and may be a useful tool to study circulating adipokines in periparturient and 
early lactating dairy cows. Moreover, animals with HIGH adiponectin levels were thin at 
calving (ǻBCS=0.25, BCS at calving= 3.13) whereas animals with NORMAL adiponectin 
levels were fat at calving (ǻBCS=0.70, BCS at calving= 3.45). This latter may further 
explain why animals with HIGH adiponectin levels showed superior reproductive 
performance. 
 
In summary, the results from this study suggest that an integrated management strategy 
that maximizes cow fertility should be based on the following principles:  
 
(1) Optimum insulin range (0.2-0.3 ng/ml) must be maintained for a period of 4 months 
postpartum. 
(2) BCS at calving of less or equal than 3.25 units must be achieved 
(3) ǻBCS optimum range (0.25-0.50 units of BCS) must not be exceeded for a period of 4 
months postpartum. 
(4) Selected prepartum and postpartum feeding strategy must meet the above-mentioned 
goals.   
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Figure 6.1: Overview of factors influenced reproductive indices and subsequent cow fertility in the present project. ‹ Pregnancy rate
(expressed as probability for cows to be pregnant) was affected mainly by BCS at calving (Chapter 3), postpartum BCS loss (ǻBCS) (Chapter 5), circulating
insulin (Chapter 3), circulating IGF-I (Chapter 5), milk yield (Chapter 5), parity (Chapter 3), and milk progesterone profile (Chapter 3 & 5). Also, circulating
adiponectin levels had an effect on pregnancy rate (Chapter 5), whereas pregnancy rate was not influenced by dietary treatments (Chapter 3). ›Interval from
calving to conception was influenced by BCS at calving (Chapter 3), circulating insulin (Chapter 5), circulating IGF-I (Chapter 5), and milk yield (Chapter 5); it
was unaffected by the dietary treatments (Chapter 3) and circulating adiponectin levels (Chapter 5). Also, days to conception was influenced by days to first
oestrus (Chapter 5). ﬁMilk progesterone profile (expressed as probability for cows to express abnormal milk progesterone profile) was affected mainly by the
dietary and BCS at calving treatments (Chapter 3), circulating insulin (Chapter 3), days to oestrus (Chapter 5), circulating adiponectin (Chapter 5), glucose
(Chapter 3), parity (Chapter 3), and milk yield (Chapter 5). Also, cows with circulating adiponectin levels up to three times normal had a tendency to be non-
randomly associated with normal milk progesterone profile (Chapter 5). Moreover, milk progesterone profile showed a trend to be influenced by circulating GH
(Chapter 5) and feed intake (Chapter 5). ﬂ Days to first oestrus was affected mainly by ǻBCS (Chapter 5) and leptin (Chapter 5). Also, circulating adiponectin
levels had an effect on days to first oestrus (Chapter 5), whereas days to first oestrus was not influenced by the dietary and BCS at calving treatments (Chapter
3). ‒Follicular cyst formation was affected mainly by circulating insulin, glucose, GH, and NEFA (Chapter 5). Also, follicular cyst formation positively
associated with days to first oestrus. Positive sign (+) indicates positive effect or association, whereas negative sign (-) indicates negative effect or association. 
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6.4.LIMITATIONSOFTHESTUDY 
 
There are certain limitations in the present study that need to be acknowledged. The first 
limitation concerns the experimental design, which was repeated measurements (Davis, 
2002). The data obtained from this study were panel or longitudinal data. Cows were the 
panels and treatments were nested within week of experiment. Repeated measurement 
design, was seen as the most appropriate design for the present study because it allowed 
definition of individual patterns of adiponectin values (Chapter 5). In contrast, cross-
sectional designs would require significantly more cows at different stages of lactation to 
achieve the same statistical power, without allowing assessment of individual patterns 
(Minkle, 1997; Davis, 2002; Liu & Li, 2005).  
 
Missing or incomplete data are inherent in studies where repeated measurements are 
obtained from animals (Little & Rubin, 1987; Allison, 2001; Frees, 2004). However, 
missing data in panel studies can be handled by maximum likelihood (ML), restricted 
maximum likelihood (REML), and multiple imputation estimation (MI) (Allison, 2001; 
Schafer, 1997; Frees 2004; Enders, 2010) methods. Generalized linear models (GLM), 
generalized estimating equations (GEE), and log-linear Poisson models utilize ML to 
calculate parameter estimates and were used in the present study (McCullagh & Nelder, 
1989; Lindsey, 1997; Dobson, 2002).  GEE and GLM do not assume normality, but allow 
choice of error distribution and link function, leading to more efficient parameter estimates 
(McCullagh & Nelder, 1989; Lindsey, 1997). 
 
The second limitation concerns measurement of plasma and milk adiponectin. There was 
no species specific validated RIA kit for measuring bovine adiponectin. Serial dilution of 
bovine plasma and fat-free milk led to samples contained adiponectin concentrations below 
the sensitivity of the assay. Thus, validation of the method was not feasible. However, the 
Linco kit has been used for cows (Raddatz et al., 2008), horses (Gordon & McKeever, 
2005; Gordon et al., 2006; Kearns et. al., 2006; Pratt et al., 2005), and dogs (Gayet et al., 
2007; Brunson et al., 2007). Adiponectin was assessed in bovine milk by using the same 
kit, which is an extra reason to believe that kit can at least in part measure bovine 
adiponectin. Circulating adiponectin, as measured by the Linco kit, revealed some of its 
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basic heterologous traits (Chapter 4), but development of a species specific bovine kit to 
measure circulating adiponectin might offer an opportunity to estimate plasma adiponectin 
more precisely in cattle.  Analysis of circulating adiponectin levels in Chapter 5 was 
retrospective and few animals expressed HIGH adiponectin levels. Retrospective analysis 
is susceptible to bias error sources, but when the examined trait is rare or takes a long time 
to develop this design is the best choice in practice (Woodward, 1999). 
 
Parameter estimation in structural equation models uses maximum likelihood (ML), which 
is based on certain assumptions (i.e. large sample and multivariate normality). It is known 
that combining small sample sizes, non-normal data, and weak empirical relationships 
between variables can lead to estimation problems and unreliable results (Werner & 
Schermelleh-Engel, 2009). It is questionable if the findings of the present study (Chapter 
5) can be generalized beyond the cases studied. However, the research findings of the 
present study concerning glucose homeostasis should be tested in larger numbers of 
animals, to refine the models suggested. 
 
As discussed above, another limitation of the analysis in the present study was that 
reproductive performance (Chapter 3 & 5) was assessed in a small sample of cows. 
Moreover, reproductive hormones were not measured in the present study. Milk 
progesterone profile was transformed to a binominal variable with two levels (NORMAL 
and ABNORMAL). This was the best approach in practice because only a small minority 
of animals expressed DOV1, DOV2, PCL1, and PCL2, although the components of 
ABNORMAL milk progesterone patterns are not exactly the same in terms of reproduction 
(Lamming & Darwash, 1998; Taylor et al., 2003).  
 
Another consideration is that BCS at calving was generally high in both BCS groups 
(Chapter 3, 4, & 5), so the groups consisted of fat versus over-fat cows. Because some 
hormonal and metabolic traits (e.g. adiponectin and leptin) are affected by adiposity, and 
the differences between the BCS groups were small, they possibly did not allow significant 
responses to be investigated fully. 
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6.5.RECOMMENDATIONSFORFURTHERRESEARCH 
 
The research conducted in this project has led to some novel results and conclusions. The 
purpose of this section is therefore to identify and discuss the need for further research. 
The areas of further research include the following: 
 
There is a critical need for additional comprehensive studies on the potential for 
reproductive performance in dairy cows to be modulated by BCS at calving and insulin. It 
is important to determine the best BCS at calving and optimum insulin concentration range 
in terms of reproduction, and what are the best management approaches for obtaining an 
optimum ǻBCS and insulin range. Moreover, experiments need to be conducted to give a 
better understanding of the importance and role of insulin and ǻBCS in fertility and 
productivity of dairy cows, and their association with hormonal and metabolic profiles. 
 
It is known that genetic selection for milk yield led to higher circulating GH in dairy cows 
(Veerkamp et al., 2003) and insulin resistance is commonly observed in early lactating 
cows (Sano et al., 1991, 1993). This makes the early lactating dairy cow the most suitable 
animal model to study associations of adiponectin with GH and glucose. In the present 
study, the relationship between adiponectin and GH was antagonistic and the relation 
between circulating glucose and adiponectin was also negative.  However, additional 
research is needed to confirm this negative association and the causes. 
 
The current prevalence of obesity in humans in the UK is around 20%, but rates are 
increasing rapidly (Norman, 2010). Obesity is related to diabetes mellitus and both are 
associated with metabolic complications such as hypoadiponectineamia, and subfertility 
(Ramsay et al., 2006). Increased risk of breast cancer is also associated with reduced 
circulating adiponectin (Mantzoros et al., 2004). Bovine adiponectin protein sequence 
shares about 85% homology with human adiponectin protein sequences (Berg et al., 2002). 
Interestingly, the presence of the insulin-sensitizing adipokine adiponectin in fat-free cow 
milk was ascertained by the present study. According to Xu et al. (2007) direct 
supplementation of recombinant adiponectin in human subjects is extremely expensive. 
Thus, consumption of fat-free cow milk (or dairy products) could be an alternative 
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inexpensive source of adiponectin for humans, but this needs to be elucidated further by 
interdisciplinary research. Furthermore, 10% of the animals in the present study expressed 
circulating adiponectin levels up to three times normal, and milk and plasma adiponectin 
concentrations were similar, which may imply that milk adiponectin is excreted at 
concentrations similar to those found in blood. If that is the case, then selection of animals 
with circulating adiponectin levels up to three times normal would allow production of 
distinctive label milk with high adiponectin. However, explicit experimentation is needed 
to investigate if this hypothesis is true.  
 
 
6.6.OVERALLCONCLUSIONS
 
This thesis has confirmed previous reports indicated that BCS at calving is a critical 
regulator of fertility in lactating dairy cows. THIN cows at calving (BCS3.25), which lost 
less than 0.5 units of BCS (ǻBCS) during the first 4 months of lactation, had superior 
reproductive performance, and that was because of increased circulating IGF-I and 
decreased circulating NEFA. Moreover, this study clearly showed that there was an 
optimum insulin concentration (0.2 to 0.3 ng/ml) necessary for normal reproductive 
performance, while insulin concentration greater than 0.6 ng/ml impaired reproductive 
performance in lactating dairy cows. The results strongly suggested that optimal 
reproductive performance of dairy cow was dependent on insulin concentration and BCS at 
calving. 
 
Adiponectin showed a potential to regulate glucose homeostasis and feed intake in the 
current study, and it was detectable in bovine milk. Also, genetic selection for milk 
production due to increased circulating GH and its antagonistic relationship with 
adiponectin may lead to hypoadiponectineamia in modern high yielding cows. More 
importantly, hypoadiponectinemia could be another mechanism that contributes to poor 
fertility in dairy cows. Based on the results of the present study, adiponectin is a plausible 
regulator of metabolism and reproduction in dairy cows. Nevertheless, the specific role of 
adiponectin in bovine physiology is yet to be clarified. 

APPENDIX
 
 
 
 
A.1.BloodsamplingandpostǦcollectionprocessing
 
Blood samples for hormonal assays, and plasma metabolites were collected from the 
coccygeal veins of cows into evacuated 10 ml vacutainer tubes (BD Vacutainer Systems
®
, 
Belliver Industrial Estate, Plymouth, UK) containing heparin anticoagulant. The blood 
samples were collected on ice and centrifuged within 10 minutes at 3000 rpm for 15 
minutes at 4 ºC. Plasma samples was separated into duplicate aliquots and stored frozen in 
5 ml screw cap containers at -20 ºC until subsequently assayed. 
 
 
A.2.Experimentaldiets
 
The two diets were formulated to be iso-energetic (ME~12.5 MJ/kg DM) and iso-
nitrogenous (CP~180 g/kg DM). The only difference between the two diets was that the 
High Starch diet had higher starch content than the High Fat diet (182 g/kg DM versus 98 
g/kg DM ) and the High Fat diet had higher fat content than the High Starch diet (53 g/kg 
DM  versus 39 g/kg DM).  
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TableA.1:FormulationandcompositionofHighStarchandHighFatdietsȋ
etal., ? ? ? ?Ȍ  DIET
HIGHSTARCH
[HS] HIGHFAT[HF]
1. Ingredients(g/kgDM):   
  ? ? ?  ? ? ?ȀǦ  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ? ?  ? ?  ? ?  ? ?  ? ?  ? ?	a  ? ?  ? ?b  ? ?  ? ? ? ? ? ?  ? ? ? ?
2. Composition:ȋg/kgȌ  ? ? ?  ? ? ?ȋMJ/kgȌ  ? ?Ǥ ?  ? ?Ǥ ?ȋg/kgȌ  ? ? ?  ? ? ?	ȋg/kgȌ  ? ? ?  ? ? ?ȋg/kgȌ  ? ? ?  ? ?ȋg/kgȌ  ? ?  ? ?	ȋg/kgȌ  ? ?  ? ?
 
 
DM, Dry Matter; ME, Metabolisable Energy; CP, Crude Protein; NDF, Neutral Detergent Fibre 
a Megalac, calcium salts of palm fatty acids; Volac International, Royston, UK.  
b Bibby HiPhos: ABN Ltd, Peterborough: Calcium, 18%; Phosphorus, 10%; Magnesium, 5%; Salt, 
17%; Copper, 2000 mg/kg; Manganese, 5000 mg/kg; Cobalt, 100 mg/kg; Zinc, 6000 mg/kg; Iodine, 
500 mg/kg; Selenium, 25 mg/kg; Vitamin A, 400,000 IU/kg; Vitamin D3 80,000 IU/kg; Vitamin E, 
1000 mg/kg.  
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A.3.Measurementofadiponectininbloodplasma(LincoResearchkit
#HADPǦ61HK)
 
A.3.1.10xAssayBuffer
Final concentration upon dilution is 10.0 mM Phosphate Buffer,  pH 7.6 containing  0.08% 
Sodium Azide, 
0.1 % RIA Grade BSA 
Quantity: 50 ml/vial 
Preparation: The content of the vial was diluted with 450 ml deionized water. 
 
A.3.2.Antiserum
Rabbit anti-Adiponectin Antibody 
Quantity: 13 ml/vial 
Preparation: Ready to use 
 
A.3.3.125IǦAdiponectin
125
I-Adiponectin Label (specific activity 67.7 ȝCi/ȝg) lyophilized for stability. Freshly 
iodinated label contains <3 ȝCi, (<111 kBq). 
Quantity: 13.5 ml/vial upon hydration 
Preparation: 
125
I-Adiponectin was hydrated with 13.5 ml of 1x Assay Buffer and allowed to 
sit at room temperature for 30 minutes, with occasional gentle mixing. 
 
A.3.4.Standards
Purified Recombinant Adiponectin, 200 ng/ml lyophilized for stability 
Quantity: 1 ml upon hydration 
Preparation: The Purified recombinant adiponectin was hydrated with 1 ml deionized 
water. 
 
A.3.5.Qualitycontrols1&2
Purified recombinant adiponectin lyophilized for stability 
Quantity: 1 ml/vial upon hydration 
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Preparation: The Purified Recombinant Adiponectin reconstituted with 1 ml deionized 
water and mixed well. 
 
A.3.6.RabbitCarrier
30% Normal Rabbit Serum 
Quantity: 2 ml/vial 
Preparation: Ready to use 
 
A.3.7.PrecipitatingReagent(chilledat4oCbeforebeingused)
Goat anti-Rabbit IgG Serum, 3% PEG and 0.05% Triton X-100 in 0.05 M Phosphosaline, 
0.025 M EDTA, 
0.08% Sodium Azide 
Quantity: 130 ml/vial 
Preparation: Ready to use 
 
 
A.3.8.Preparationofstandards
Standards were prepared in polypropylene tubes on the day of use, as specified in the 
tables below. 
 
 
Standardsconcentration
(ng/ml) VolumeofDeiodinizedWater
toadd VolumeofStandardstoadd ? ? ?  ?ml   ?
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Stds Stdconcentration
(ng/ml)
VolumeofAssay
Buffertoadd
VolumeofStdtoadd
(SerialDilutions) ?  ? ? ?  ?Ǥ ?ml   ?Ǥ  ?ml ? ?  ng/ml ?  ? ?  ?Ǥ ?ml  ?Ǥ ?ml ? ? ?ngml ?  ? ?  ?Ǥ ?ml   ?Ǥ  ?ml ? ?ngml ?  ? ?Ǥ ?  ?Ǥ ?ml   ?Ǥ  ?ml ? ?ng/ml ?  ?Ǥ ? ?  ?Ǥ ?ml  ?Ǥ ?ml ? ?Ǥ ?ng/ml ?  ?Ǥ ? ? ?  ?Ǥ ?ml   ?Ǥ  ?ml ?Ǥ ? ?ng/ml ?  ?Ǥ ? ?  ?Ǥ ?ml  ?Ǥ ?ml ?Ǥ ? ? ?ng/ml ?  ?Ǥ ? ?  ?Ǥ ?ml   ?Ǥ  ?ml ?Ǥ ? ?ng/ml


A.3.9.AssayProcedure
The Adiponectin assay was run in 2 days as follows: 
 
1
st
 Day: 
6Polypropylene tubes were labeled. 
6 300 ȝl of Assay Buffer pipetted to the Non-Specific Binding (NSB) tubes (3-4). 
6 200 ȝl of Assay Buffer added into the Reference (Bo) tubes (5-6). 
6100 ȝl of Assay Buffer added to tubes seven through the end of the assay. 
6100 ȝl of Standards and Quality Controls added in duplicate into tubes. 
6100 ȝl of each sample (undiluted) in duplicate pipetted to tubes. 
6100 ȝl of 125I-Adiponectin pipetted to all tubes. 
6100 ȝl of Adiponectin Antibody pipetted to all tubes except Total Count tubes (1-2) and 
NSB tubes (3-4). 
6 All tubes were vortexed, covered and incubated overnight (20-24 hours) at room 
temperature. 
 
2
nd
 Day: 
610 ȝl of Rabbit Carrier pipetted to all tubes except Total Count tubes (1-2). 
61.0 ml of cold (4°C) Precipitating Reagent was added to all tubes except Total Count 
tubes (1-2). 
6All tubes were vortexed and incubated 20 minutes at room temperature. 
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6All tubes were centrifuged at 3,000 rpm for 30 minutes except Total Count tubes (1-2). 
6The supernatant was decanted immediately from all tubes except TC tubes. 
6Tubes left to drain for 60 seconds and the pellet counted for 1 minute on the gamma 
counter. 
 
Results were calculated automatically by the instrument software (Multicalc, Wallac, 
Stockholm, Sweden). 
 
The assays run five times and a composite standard curve (a plot of B/B0 against 
adiponectin concentration) was created (Figure A.1). Sensitivity of the assay, expressed as 
effective dose 80% (ED80), was calculated from this composite standard curve, and it was 
2.33±0.08 ng/ml. 
 
Serial dilution of bovine plasma (1/2, 1/3, 1/5, 1/7, and 1/10) led to samples contained 
adiponectin concentrations below the sensitivity of the assay. Thus, validation of the 
method by showing parallelism was not feasible. 
 
A.3.10.Equipment
11277 Gammamaster, LKB, Wallac, Stockholm, Sweden. 
2. Jouan KR422 Centrifuge. 
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Figure A.1: Composite standard curve of plasma adiponectin assay. A plot of B/B0 against adiponectin concentration was created for five 
consequtive runs of plasma adiponectin assay. Sensitivity of the assay, expressed as effective dose 80% (ED80), was calculated from this 
standard curve, and it was 2.33 ng/ml. 
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A.4. Measurement of adiponectin in bovine milk (Linco Research kit
#HADPǦ61HK)
 
Milk samples were collected from 6 cows in different stage of lactation. All samples were 
collected between 15:00 and 17:00 in the afternoon and left in the fridge (0 to 4 
o
C) over 
night. Because lipids interfere with radioimmunoassay (RIA), skim milk was used. 4 ml of 
whole milk of each cow was added in 6 tubes. Milk samples were vortexed and skim milk 
(aqueous phase) was obtained by centrifugation (1500g, 20 min, 4°C), after which the fat 
layer was removed and weighted in electronic balance (Mettler Toledo, Leicester, UK). 
Immunoreactive adiponectin was assessed in duplicate by using a commercial RIA kit 
(Linco Research, St Charles, MO) with the use of 100 ȝl of skim milk. The adiponectin kit 
assay performed as described previously and adiponectin concentration in skim milk was 
measured.  
 
The assays run one time and a standard curve (a plot of B/B0 against adiponectin 
concentration) was created (Figure A.2). Sensitivity of the assay, expressed as effective 
dose 80% (ED80), was calculated from this standard curve, and it was 2.14 ng/ml. 
 
Serial dilution of bovine fat free milk (1/2, 1/3, and 1/5) led to samples contained 
adiponectin concentrations below the sensitivity of the assay. Thus, validation of the 
method by showing parallelism was not possible. 
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Figure A.2: Standard curve of milk adiponectin assay. A plot of B/B0 against adiponectin concentration was created for one run of milk
adiponectin assay. Sensitivity of the assay, expressed as effective dose 80% (ED80), was calculated from this standard curve, and it was 2.14
ng/ml. 
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A.5.Measurement ofmilk progesterone (ELISA kit,Ridgeway Scientific)
anddeterminationofmilkprogesteroneprofile
 
 
Whole milk samples were analyzed for progesterone concentrations using a microtitre plate 
enzyme-linked immunosorbant assay (ELISA) kit (Ridgeway Scientific, Alvington, UK), 
validated by Sauer et al. (1986). 
 
Samples were removed from the refrigerator (stored at 4°C after addition of Lactab MkIII 
tablets) at least 3 hours before analysis and warmed to 25° C. The plates are also brought at 
room temperature, the foil stripped from the wells and the wells emptied and tapped dry. 
To each well 10 ȝl of sample or standard (1 to l0 ng/ml progesterone in milk from an 
oestrus animal) was added, followed by 200 ȝl of progesterone-enzyme label 
(progesterone- 11 -Į glucuronide-alkaline phosphatase). The plate was then vortexed and 
left for 1 - 1.5 hours at room temperature. 
 
After incubation the plate was washed three times with cold water and tapped dry each 
time. Finally 200 ȝl of substrate in substrate buffer was added, and the plates vortexed 
again and left for developing the color. The samples were read on a 570 nm plate reader. 
Quality control samples could not be stored for the entire period of the trial. New quality 
control samples were selected from previously analyzed samples.  
 
The reliable reading range of the ELISA was from 1.5 to 10.5 ng/ml. Samples reading < 
1.5 ng/ml were taken as 1.5 ng/ml; samples reading >10.5 ng/ml were diluted to bring the 
reading within range. If the coefficient of variation (CV) of duplicate sample readings was 
> 15%, the analysis was repeated. The intra- and inter-assay coefficients of variation were 
< 15 and 6.6%, respectively. 
 
Milk progesterone was measured twice in a week (either Monday and Thursday or Tuesday 
and Friday mornings) and a rise in progesterone was defined as above 3 ng/ml for two 
consecutive samples (Lamming & Darwash, 1998; Garnsworthy et al., 2009).  
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Progesterone profiles were used to classify estrous cycles as normal or abnormal (DOV1, 
DOV2, PCL1 or PCL2), following the definitions of Lamming & Darwash (1998) (Table 
A.2). 
 
 
 
TableA.2:Definition of atypical ovarian activity indairy cattleusingmilk
progesteroneprofileȋƬǡ ? ? ? ?Ȍ
Atypicalreproductivepattern Definition
(DOV1)
 ? ? ?ng/ml ? ? ?Ǧǡ
(DOV2)
 ? ? ?ng/ml ? ? ?Ǥ
ǡ
(PLC1)
 ? ? ?ng/ml ? ? ?Ǥǡ(PCL2)  ? ? ?ng/ml ? ? ?Ǥ
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A.6.Measurementofmetabolitesinbloodplasma
 
Blood plasma samples were analyzed for the following metabolites on a Bayer opera 
autoanalyzer (Bayer UK Ltd). 
 
A.11.1.Urea
Plasma Urea concentrations were determined in a single assay, using a kit supplied by 
Bayer (Bayer kit T01 182356). The method was based on Urea hydrolyzation in the 
presence of water and urease. The coefficient of variation was less than 5%.
 
A.11.2.Glucose
Plasma glucose concentrations were determined in a single assay using a kit supplied by 
Bayer (Bayer kit T01 183356). The method was based on hexokinase catalytic 
phosphorylation of plasma glucose. The coefficient of variation for samples was less than 
5%.  
 
A.11.3.ȾǦhydroxybutyrate(BOHB)
Plasma ȕ-hydroxybutyrate concentrations were determined using an enzymatic kit supplied 
by Randox (Ranbut RB 1008). The method was based on the oxidation of D-3-
hydroxybutyrate to acetoacetate by the enzyme 3-hydroxybutyrate dehydrogenase. The 
coefficient of variation for samples was less than 5 %.  
 
A.11.4.NonǦesterifiedfattyacids(NEFA)
Plasma NEFA concentrations were determined using an enzymatic kit supplied Waiko 
(Waiko kit NEFA-C). The method was based on the acylation of coenzyme A by the fatty 
acids in the presence of added acyl-CoA synthetase. The coefficient of variation for 
samples was less than 5 %. 
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B.1.Parameterestimatesofmodelswereusedtoexploreinterrelationshipsof
adiponectinwithglucose,BCS,metabolichormones,andmetabolites ( ?)

TableB.1: Model parameter estimates 
  
 TYPE OF MODEL 
Estimates: BASIC MODEL  LOW PMY  HIGH PMY  
Glucose 
(mmol/l) 
3.40±0.478 3.38±0.551 3.42±0.626 
Insulin (INS) 
(ng/ml) 
0.41±0.012 0.42±0.019 0.40±0.015 
Glucagon (GLGON) 
(pg/ml) 
95.1±2.47 98.9±3.51 91.2±3.3 
Adiponectin (ADP) 
(ng/ml) 
8.5±0.72 9.9±1.15 7.2±0.82 
Leptin (LPN) 
(ng/ml) 
1.73±0.115 1.9±0.203 1.57±0.106 
GH 
(ng/ml) 
4.55±0.266 4.16±0.37 4.95±0.394 
BOHB 
(mmol/l) 
0.65±0.029 0.60±0.032 0.69±0.049 
NEFA 
(mmol/l) 
0.43±0.033 0.45±0.057 0.40±0.036 
BCS 
(units 1-5) 
2.76±0.037 2.76±0.056 2.77±0.052 
 Columns are means±SE.  

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